{"PMC3892599": [["Description of the epidemic ::: IntroductionAfter extensive data cleaning and collection of additional information, the resulting database of SARS in mainland China contained 5327 probable cases, of whom 343 died, giving a case fatality ratio (CFR) of 6.4%.", [["SARS", "DISEASE", 142, 146], ["SARS", "PROBLEM", 142, 146], ["CFR", "TEST", 244, 247]]], ["The epidemic spanned a large geographical extent (170 counties of 22 provinces) but clustered in two areas: first in Guangdong Province, and about 3 months later in Beijing with its surrounding areas Shanxi, Inner Mongolia Autonomic Region, Hebei and Tianjin.", [["The epidemic", "PROBLEM", 0, 12], ["Inner Mongolia Autonomic Region", "TREATMENT", 208, 239], ["epidemic", "OBSERVATION_MODIFIER", 4, 12], ["large", "OBSERVATION_MODIFIER", 23, 28], ["geographical", "OBSERVATION_MODIFIER", 29, 41], ["extent", "OBSERVATION_MODIFIER", 42, 48], ["Inner", "ANATOMY_MODIFIER", 208, 213], ["Mongolia Autonomic", "ANATOMY", 214, 232]]], ["Figure 1 shows the temporal distribution of SARS in the six most seriously affected geographic areas of mainland China.", [["SARS", "DISEASE", 44, 48], ["SARS", "PROBLEM", 44, 48], ["temporal", "OBSERVATION_MODIFIER", 19, 27], ["distribution", "OBSERVATION_MODIFIER", 28, 40], ["SARS", "OBSERVATION", 44, 48], ["six", "OBSERVATION_MODIFIER", 56, 59], ["most", "OBSERVATION_MODIFIER", 60, 64], ["seriously", "OBSERVATION_MODIFIER", 65, 74], ["affected", "OBSERVATION_MODIFIER", 75, 83], ["geographic", "OBSERVATION_MODIFIER", 84, 94], ["areas", "OBSERVATION_MODIFIER", 95, 100], ["mainland China", "ANATOMY", 104, 118]]], ["Spatiotemporal analyses indicated that the spread of SARS occurred in two different patterns.7 In the early period of the epidemic, especially before strict control measures were taken, SARS spread to new areas incidentally through air travel of certain index cases.", [["SARS", "DISEASE", 53, 57], ["SARS", "DISEASE", 186, 190], ["Spatiotemporal analyses", "TEST", 0, 23], ["SARS", "PROBLEM", 53, 57], ["strict control measures", "TREATMENT", 150, 173], ["SARS", "PROBLEM", 186, 190], ["spread", "OBSERVATION_MODIFIER", 43, 49]]], ["Thereafter, human travel along local transportation routes influenced the transmission of SARS.", [["SARS", "DISEASE", 90, 94], ["human", "ORGANISM", 12, 17], ["human", "SPECIES", 12, 17], ["human", "SPECIES", 12, 17], ["SARS", "PROBLEM", 90, 94]]], ["The epidemic period in middle-north China was shorter than in South China, but the geographic spread was wider.", [["epidemic", "OBSERVATION_MODIFIER", 4, 12], ["period", "OBSERVATION_MODIFIER", 13, 19], ["middle", "ANATOMY_MODIFIER", 23, 29], ["north China", "ANATOMY", 30, 41], ["geographic", "OBSERVATION_MODIFIER", 83, 93], ["spread", "OBSERVATION", 94, 100]]], ["SARS not only spread locally, but also diffused quickly and resulted in several outbreaks close to Beijing city.", [["SARS", "DISEASE", 0, 4], ["SARS", "PROBLEM", 0, 4], ["spread", "OBSERVATION_MODIFIER", 14, 20], ["diffused", "OBSERVATION_MODIFIER", 39, 47], ["several", "OBSERVATION_MODIFIER", 72, 79], ["outbreaks", "OBSERVATION", 80, 89]]], ["In contrast, the SARS epidemic in South China was mainly limited to Guangdong Province.", [["SARS", "DISEASE", 17, 21]]], ["Transportation routes accelerated the spread of SARS in mainland China.", [["SARS", "DISEASE", 48, 52], ["SARS", "PROBLEM", 48, 52], ["SARS", "OBSERVATION", 48, 52]]], ["However, especially national highways and inter-provincial freeways appeared to play a role, whereas railways seemed to be less important.7 For the definition of SARS cases a distinction was made between probable and suspected cases on the basis of contact history and number and severity of symptoms.", [["SARS", "DISEASE", 162, 166], ["symptoms", "PROBLEM", 292, 300]]], ["Feng et al. provide a tabulated overview of the case criteria of SARS in the different time periods of the epidemic.6 In China, it was only possible late in the epidemic to confirm SARS through serological tests and serological confirmation was not included in the case definitions.", [["SARS", "DISEASE", 65, 69], ["SARS", "DISEASE", 181, 185], ["SARS", "PROBLEM", 65, 69], ["SARS", "PROBLEM", 181, 185], ["serological tests", "TEST", 194, 211], ["serological confirmation", "TEST", 216, 240]]], ["In a study comparing clinical characteristics of probable and suspected cases it was found that although symptoms hardly differed, there were clearly different haematological profiles, justifying the distinction between probable and suspected cases and confirming that the suspected cases most likely did not have SARS.8Description of the epidemic ::: Introduction", [["SARS", "DISEASE", 314, 318], ["a study", "TEST", 3, 10], ["symptoms", "PROBLEM", 105, 113], ["SARS", "PROBLEM", 314, 318]]]], "PMC7115774": [], "e6d2c77d66f454cc4af9af8e81148b5b6959146c": [["Threats and preparation for new outbreaksThese two stories could have happened in Spain, Italy, the Netherlands, the USA or Canada.", [["new outbreaks", "PROBLEM", 28, 41]]], ["NH residents have been the most affected by COVID-19 in many countries (1) , representing as many as half of all deaths for COVID-19 in a number of European countries, over three quarters in Canada and around 40% in the USA, according to some of the latest available data sources ( Figure 1) .", [["deaths", "DISEASE", 113, 119], ["COVID", "TEST", 124, 129]]], ["Despite cross and within-country heterogeneity in policies, responsibilities and funding for long-term care (2), NHs share many common threads in infrastructure, organization and workforce (3) , including low staff to resident ratios; low paid staff; low skill-mix and high staff turnover, creating environments with minimal resilience to adverse events.Threats and preparation for new outbreaksCritical errors have been replicated by different countries, despite initial warnings (5) , including the lack of prioritization of NHs for the organization and provision of protective measures (PPEs), delays in testing of workers and patients and support staff shortages (3, 4) , contributing to the spread of infection and the capacity to meet infection control protocols and provide adequate care.", [["infection", "DISEASE", 706, 715], ["infection", "DISEASE", 741, 750], ["patients", "ORGANISM", 630, 638], ["patients", "SPECIES", 630, 638], ["long-term care", "TREATMENT", 93, 107], ["adverse events", "PROBLEM", 339, 353], ["new outbreaks", "PROBLEM", 382, 395], ["Critical errors", "PROBLEM", 395, 410], ["protective measures", "TREATMENT", 569, 588], ["infection", "PROBLEM", 706, 715], ["the capacity", "PROBLEM", 720, 732], ["infection control protocols", "TREATMENT", 741, 768], ["infection", "OBSERVATION", 706, 715]]], ["In most countries, deaths have mainly occurred within the NHs themselves, as, during the most critical phases of the pandemic, admission criteria have limited access of NH residents to secondary care.", [["deaths", "DISEASE", 19, 25], ["NH residents", "TREATMENT", 169, 181]]], ["This may have contributed to further spreading SARS-CoV-2 within facilities and has led to questions about levels of medical and palliative care, with palliative care and access to integrated medical care already undeveloped (6) .", [["SARS", "DISEASE", 47, 51], ["further spreading SARS", "PROBLEM", 29, 51], ["medical and palliative care", "TREATMENT", 117, 144], ["palliative care", "TREATMENT", 151, 166]]], ["There are very few international examples of actions to increase health care, either within homes (7, 8) or by providing care in hospitals or sub-acute facilities (9) during the crisis.Threats and preparation for new outbreaksCOVID-19 has shown us that during a pandemic LTC facilities such as NHs require adequate PPEs (and training in its use), quick diagnostic testing and measures to alleviate staff shortages, which account for additional demands and include the provision of reinforcement teams (8) .", [["the crisis", "PROBLEM", 174, 184], ["new outbreaksCOVID", "TEST", 213, 231], ["a pandemic LTC facilities", "TREATMENT", 260, 285], ["adequate PPEs", "TREATMENT", 306, 319], ["quick diagnostic testing", "TEST", 347, 371], ["very", "OBSERVATION_MODIFIER", 10, 14], ["few", "OBSERVATION_MODIFIER", 15, 18]]], ["Protocols for infection control rely on sufficient space to allow social distancing (10) and isolation, but many countries still rely heavily on physical structures where shared rooms are common.", [["infection", "DISEASE", 14, 23], ["Protocols", "TREATMENT", 0, 9], ["infection control", "TREATMENT", 14, 31], ["isolation", "TREATMENT", 93, 102], ["infection", "OBSERVATION", 14, 23]]], ["Nevertheless, isolation needs to be balanced with the need to avoid immobility and maintain social and family connections (where technology can provide some solutions but may not be suitable for residents with advanced dementia) (11) .Threats and preparation for new outbreaksThe growing COVID-19 death toll in NHs internationally has resurfaced the discussion on care, quality, workforce and living conditions.", [["dementia", "DISEASE", 219, 227], ["death", "DISEASE", 297, 302], ["isolation", "TREATMENT", 14, 23], ["immobility", "PROBLEM", 68, 78], ["advanced dementia)", "PROBLEM", 210, 228], ["new outbreaks", "PROBLEM", 263, 276], ["growing", "OBSERVATION_MODIFIER", 280, 287]]], ["It has also undermined public confidence in NHs, which were experiencing problems long before this crisis.", [["this crisis", "PROBLEM", 94, 105], ["public confidence", "OBSERVATION", 23, 40]]], ["Compared with same-aged community dwelling older adults, nursing home residents accumulate more clinical complexity, multi-morbidity and frailty overtime (12 alternative models for long-term services and supports are often better suited to meet older adults' preferences and needs (13) .", [["multi-morbidity", "DISEASE", 117, 132], ["long-term services", "TREATMENT", 181, 199]]], ["In other countries though, underdeveloped home care and lack of integrated support for people with complex care needs, has led to increased demand, overwhelming LTC facilities and subsequently leading to more hospitalizations (2) .", [["people", "ORGANISM", 87, 93], ["people", "SPECIES", 87, 93], ["increased demand", "PROBLEM", 130, 146]]], ["These challenges highlight the need for a deep, open, societal discussion on the future of LTC facilities, and long-term care models for older adults.", [["long-term care models", "TREATMENT", 111, 132]]], ["This pandemic might represent, at least, an opportunity to redesign a sustainable model (4) .Home as the place to stayMultiple surveys suggest that most older adults prefer to remain in their homes as long as possible (14) .", [["adults", "ORGANISM", 159, 165]]], ["For people who decide or need to move for health or socio-economic needs, co-housing, sheltered housing or assisted living are valuable alternatives, although these options are not always viable with transitions across the boundary between the third and fourth age and adaptation to increasing care needs proving challenging (15) .Home as the place to stayIn the US, the Program of All-Inclusive Care for the Elderly (PACE) has been effective in supporting older adults at home who would otherwise fulfill the criteria to be institutionalized (16) , through integrated provision of health and social care after a comprehensive assessment of needs, at a single entry point.", [["people", "ORGANISM", 4, 10], ["people", "SPECIES", 4, 10], ["the Elderly (PACE", "TREATMENT", 405, 422], ["a comprehensive assessment", "TEST", 611, 637]]], ["The community nursing care model in the Netherlands (epitomized by Buurtzorg) enables older people to remain at home by provision of community nursing services, which can be highly intensive (17) and facilitates specialist geriatric care at home in case of complex problems or crises.", [["people", "ORGANISM", 92, 98], ["people", "SPECIES", 92, 98], ["complex problems", "PROBLEM", 257, 273], ["crises", "PROBLEM", 277, 283]]], ["To achieve this, investments in community nursing and specialist intermediate care services at home (18) are essential.Home as the place to stayDuring the pandemic, we have learned that NHs, in their current form and with current resources and priority applied to them (for PPE, testing, medical support), are an unsafe place to remain.", [["PPE", "TREATMENT", 274, 277], ["testing", "TEST", 279, 286], ["medical support", "TREATMENT", 288, 303]]], ["Rethinking NH care might mean that home is the safest place, but also the place where older persons can decide for themselves what risks are acceptable and quality of life can be achieved.", [["persons", "ORGANISM", 92, 99], ["persons", "SPECIES", 92, 99]]], ["Although a strategy towards deinstitutionalization of care is not new, in many countries, within the EU, it has been under-developed, while the number of long-term care beds has increased (2).Improving quality and person-centeredness in NHs is urgentIf home-care is the base of the future system, is there a role for institutional-based care?", [["person", "SPECIES", 214, 220], ["deinstitutionalization of care", "TREATMENT", 28, 58], ["long-term care beds", "TREATMENT", 154, 173], ["institutional-based care", "TREATMENT", 317, 341], ["new", "OBSERVATION_MODIFIER", 66, 69], ["increased", "OBSERVATION_MODIFIER", 178, 187]]], ["In the case of people with very complex needs, such as people with late-stage dementia, home care might not always be a viable option.", [["dementia", "DISEASE", 78, 86], ["people", "ORGANISM", 15, 21], ["people", "ORGANISM", 55, 61], ["people", "SPECIES", 15, 21], ["people", "SPECIES", 55, 61], ["late-stage dementia", "PROBLEM", 67, 86], ["stage", "OBSERVATION_MODIFIER", 72, 77], ["dementia", "OBSERVATION", 78, 86]]], ["Depending on the situation, moving to a NH is not necessarily associated with a decreased quality of life (21) .", [["NH", "CHEMICAL", 40, 42]]], ["Certainly, NHs need new policies, models and investments including: -person and relationship-centered care allowing real flexibility and choices to improve quality of care (22) , shared decision-making, meaningful activities and social interactions (23) , adaptation to the needs of people with dementia(24), promotion of healthier lifestyles, and embracement of new technologies which hold the potential to increase quality of life in NHs; -participation of older people and their caregivers in the concept, design, implementation and oversight of NHs(25); -an \"age-friendly\" environment, with enough space to guarantee privacy (and potentially to facilitate segmentation during a pandemic) and well-designed outdoor spaces; -an adequate size: smaller or middle-scale homelike structures would avoid the excessive standardization of routines of large-scale institutions (26) ; -training and support for nursing aides or assistants (also named auxiliary nurses or personal support workers), recreational therapists and volunteers, who also play a key role; -robust, continued healthcare, with 24 hour registered nurses, plus central roles for physical and occupational-therapists, social workers, psychologists, nutritionists and pharmacists.", [["dementia", "DISEASE", 295, 303], ["people", "ORGANISM", 283, 289], ["people", "ORGANISM", 465, 471], ["volunteers", "ORGANISM", 1019, 1029], ["person", "SPECIES", 69, 75], ["people", "SPECIES", 283, 289], ["people", "SPECIES", 465, 471], ["dementia", "PROBLEM", 295, 303], ["new technologies", "TREATMENT", 363, 379], ["smaller or middle-scale homelike structures", "PROBLEM", 745, 788], ["large-scale institutions", "TREATMENT", 846, 870], ["size", "OBSERVATION_MODIFIER", 739, 743], ["smaller", "OBSERVATION_MODIFIER", 745, 752], ["middle", "ANATOMY_MODIFIER", 756, 762]]], ["Any medical support (even with ad-hoc trained figures such as in the Dutch model) needs to be integrated with community-based services and support; -individualized care plans, focused on secondary and tertiary prevention and rehabilitation and early palliative care; -clear care pathways linking NHs to intermediate or postacute care, (where available) and to acute care, to prevent residents from being overlooked or discriminated upon in access to health care of the basis of age, or place of residence; -standardized tools for comprehensive, bio-psycho-social assessment of the resident (including functional capacity and frailty) and agreed outcomes, in order to monitor health trajectories and provide data of public health interest.Principles to reshape long term careIndependent of the setting (private home or nursing home), there are shared principles to take into account.", [["Any medical support", "TREATMENT", 0, 19], ["secondary and tertiary prevention", "TREATMENT", 187, 220], ["rehabilitation", "TREATMENT", 225, 239], ["early palliative care", "TREATMENT", 244, 265], ["reshape long term care", "TREATMENT", 752, 774]]], ["Different evidence-based and policy documents support the main pillars of a new model for long-term care, summarized in Table 1 .", [["long-term care", "TREATMENT", 90, 104]]], ["Older persons' preferences and the active involvement of them and their caregivers', must be the starting point (27) .", [["persons", "SPECIES", 6, 13]]], ["Integrated health and social care should be modelled accordingly, with prevention of disability and rehabilitation as common aims (2) .", [["disability", "DISEASE", 85, 95], ["social care", "TREATMENT", 22, 33], ["rehabilitation", "TREATMENT", 100, 114]]], ["Specialists in geriatrics and gerontology (16) should be involved in both conceptual and management aspects, as well as providing care in cases of complex clinical needs and for specialized timelimited interventions at home during health crises (18) .", [["specialized timelimited interventions", "TREATMENT", 178, 215]]], ["At an individual level, each older person deserves an individualized care plan and an advanced care plan, based on a comprehensive geriatric assessment, using principles of person-centered care and through a shared decision making approach (28) .", [["person", "SPECIES", 35, 41], ["an advanced care plan", "TREATMENT", 83, 104], ["a comprehensive geriatric assessment", "TEST", 115, 151]]], ["At a structural level, investments for professional training to improve quality of care, as well as defining and monitoring care standards are crucial (2) .", [["professional training", "TREATMENT", 39, 60]]], ["Telemedicine solutions add value for continuing education, consultation, support and benchmarking (29) .Principles to reshape long term careNo doubt, pragmatic economic and financial considerations will shape model orientation and implementation for each context.", [["reshape long term careNo", "TREATMENT", 118, 142]]], ["The risk is that decisions will be driven on absolute costs within a narrow paradigm, such as reduction of hospital care or readmissions, rather than value based analyses or decisions (cost-quality or whole system impact).", [["hospital care", "TREATMENT", 107, 120]]], ["Also, if these solutions are not planned at a system level and provided at an acceptable cost, disparities, based on the socio-economic status of older people, will increase.", [["people", "ORGANISM", 152, 158], ["people", "SPECIES", 152, 158]]], ["Each mode of delivering long-term care must provide optimal standards of continuing care and maximum quality of life.", [["delivering long-term care", "TREATMENT", 13, 38], ["continuing care", "TREATMENT", 73, 88]]], ["More evaluation and research is needed to support decision and policy-making, in particular on the cost-effectiveness and cost-quality aspects for each specific country, region or system.", [["More evaluation", "TEST", 0, 15]]], ["So far, evidence on what works seems to point to person and relationship-centered solutions, combined with integrated health and social care, plus telehealth, to ensure timely, individualized responses to persons' needs.Contributors and sources:This work is the result of an international collaboration, between experts on geriatrics (Inzitari, Risco, Cesari, Buurman), long term care policy (Davey, Prvu Bettger), gerontological research (Kuluski, Prvu Bettger), healthcare management applied to older adults with complex needs (Varela, Inzitari) and caregivers of persons with dementia (Bennett), based in EU countries, in the UK and in North America.", [["dementia", "DISEASE", 579, 587], ["persons", "ORGANISM", 205, 212], ["persons", "ORGANISM", 566, 573], ["person", "SPECIES", 49, 55], ["persons", "SPECIES", 205, 212], ["persons", "SPECIES", 566, 573], ["healthcare management", "TREATMENT", 464, 485], ["dementia", "PROBLEM", 579, 587]]], ["All of these countries are experiencing a disproportionate rate of infection and therefore greater impact of COVID-19 in their care homes.", [["infection", "DISEASE", 67, 76], ["COVID-19", "CHEMICAL", 109, 117], ["a disproportionate rate of infection", "PROBLEM", 40, 76], ["COVID", "TEST", 109, 114], ["disproportionate", "OBSERVATION_MODIFIER", 42, 58], ["infection", "OBSERVATION", 67, 76], ["greater", "OBSERVATION_MODIFIER", 91, 98]]], ["All the co-authors actively participated in designing and writing the manuscript, and in adding relevant evidence; Lisa Bennett has reviewed and improved the manuscript from the caregivers' perspective; Inzitari, Davey and Prvu Bettger collected the data on mortality in care homes.", [["Inzitari", "TREATMENT", 203, 211]]], ["Marco Inzitari acts as guarantor of the article.Patient involvement:This manuscript is co-authored by Lisa Bennett, a caregiver of a person with dementia living in a care home, from in Toronto, Canada.Conflicts of Interest:We have read and understood Journal of Nutrition, Health & Ageing policy on declaration of interests and have no interests to declare related to this manuscript.Table 1Pillars to redefine long term care post COVID-19Table 1Older people and caregivers' involvement -The new model should be rooted in older peoples' preferences.Table 1-Older persons and their caregivers should participate in the concept, design, implementation and oversight of the model.Delivery of care-Care at home should be accessible and affordable, and alternatives to home, including care and nursing homes, should be homelike.Delivery of care-Adequate health and social care should be integrated.Delivery of care-Continuity of care with primary health and social care is warranted.Delivery of care-Specialists in geriatrics and gerontology should be involved in the design, management and overview.Delivery of care-Geriatricians should provide additional support for complex clinical needs (e.g. severe dementia) or time-limited interventions during health crises.Care at an individual level-Patient-centered care is pivotal across all aspects (personal care, activities, spaces should reflect person's preferences).Care at an individual level-Each person deserves an individualized care plan and an advanced care plan, based on a comprehensive geriatric assessment and shared decision-making.Care at an individual level-Prevention and rehabilitation, as well as early palliative care, are key.Organizational aspects-Investments in professional training and standardized monitoring of the extent to which care meets complex needs are relevant to improve quality.Organizational aspects-Frameworks for auditing person and relationship-centered care should be coproduced by people who receive long-term care.Organizational aspects-Telemedicine solutions are a valuable wide-scale support for continuing education, consultation, support and benchmarking.", [["dementia", "DISEASE", 145, 153], ["dementia", "DISEASE", 1200, 1208], ["people", "ORGANISM", 452, 458], ["persons", "ORGANISM", 563, 570], ["people", "ORGANISM", 1968, 1974], ["Patient", "SPECIES", 48, 55], ["person", "SPECIES", 133, 139], ["people", "SPECIES", 452, 458], ["persons", "SPECIES", 563, 570], ["person", "SPECIES", 1391, 1397], ["person", "SPECIES", 1446, 1452], ["person", "SPECIES", 1906, 1912], ["people", "SPECIES", 1968, 1974], ["dementia", "PROBLEM", 145, 153], ["redefine long term care", "TREATMENT", 402, 425], ["Delivery of care", "TREATMENT", 823, 839], ["social care", "TREATMENT", 860, 871], ["Delivery of care", "TREATMENT", 893, 909], ["social care", "TREATMENT", 953, 964], ["additional support", "TREATMENT", 1141, 1159], ["severe dementia)", "PROBLEM", 1193, 1209], ["an advanced care plan", "TREATMENT", 1494, 1515], ["a comprehensive geriatric assessment", "TEST", 1526, 1562], ["rehabilitation", "TREATMENT", 1633, 1647], ["professional training", "TREATMENT", 1729, 1750], ["standardized monitoring", "TEST", 1755, 1778], ["long-term care", "TREATMENT", 1987, 2001], ["Telemedicine solutions", "TREATMENT", 2025, 2047], ["a valuable wide-scale support", "TREATMENT", 2052, 2081], ["continuing education", "TREATMENT", 2086, 2106]]]], "b94d7f6b765b2b2d7a1ac715784971399adea7a6": [["IntroductionLinks between mycoplasmas and viruses are ancient, multiple and complex, and have been sometimes at the origin of unfortunate and persistent confusions.", [["IntroductionLinks", "TREATMENT", 0, 17], ["mycoplasmas", "TREATMENT", 26, 37], ["viruses", "TREATMENT", 42, 49], ["persistent confusions", "PROBLEM", 142, 163], ["viruses", "OBSERVATION", 42, 49], ["persistent", "OBSERVATION_MODIFIER", 142, 152], ["confusions", "OBSERVATION", 153, 163]]], ["This follows from a fundamental property shared by these two types of infectious agents, i.e., the ability to pass through the pores of bacteriological filters, a character which has led to the definition of \"filterable viruses\" at the end of the nineteenth century [4, 47] .IntroductionWhen, some years later, the bacterial nature of mycoplasmas (as \"PPLO\") was established [88] and the very peculiar characteristics of viruses recognized [62] , the two types of agents were studied in separate ways and different laboratories.", [["infectious agents", "TREATMENT", 70, 87], ["bacteriological filters", "TREATMENT", 136, 159], ["\"filterable viruses", "PROBLEM", 208, 227], ["mycoplasmas", "PROBLEM", 335, 346], ["viruses", "PROBLEM", 421, 428], ["agents", "TREATMENT", 464, 470], ["infectious", "OBSERVATION", 70, 80], ["bacteriological filters", "OBSERVATION", 136, 159], ["filterable viruses", "OBSERVATION", 209, 227], ["viruses", "OBSERVATION", 421, 428]]], ["However, their frequent association continued to raise a number of problems for both virologists and mycoplasmologists.", [["mycoplasmologists", "CANCER", 101, 118], ["mycoplasmologists", "TREATMENT", 101, 118]]], ["The most recent example of such problems is illustrated by mycoplasma studies performed in Europe and the U.S.A. which attempt to clarify the possible role of these organisms in the pathogenesis of AIDS.IntroductionFrom a historical point of view at least four types of definite links between mycoplasmas and viruses have occurred.M ycoplasmas and viruses: a historical perspective\"At the beginning were the filterable viruses\".", [["AIDS", "DISEASE", 198, 202], ["mycoplasmas and viruses", "DISEASE", 293, 316], ["such problems", "PROBLEM", 27, 40], ["mycoplasma studies", "TEST", 59, 77], ["these organisms", "PROBLEM", 159, 174], ["AIDS", "PROBLEM", 198, 202], ["mycoplasmas and viruses", "PROBLEM", 293, 316], ["mycoplasmas", "OBSERVATION", 293, 304], ["viruses", "OBSERVATION", 348, 355], ["viruses", "OBSERVATION", 419, 426]]], ["This biblical-like sentence could eventually serve as an introduction to the historical record of mycoplasmas and viruses as well.", [["mycoplasmas", "PROBLEM", 98, 109], ["viruses", "PROBLEM", 114, 121], ["mycoplasmas", "OBSERVATION", 98, 109]]], ["Indeed, during the 1890's, the first \"true\" virus, the Tobacco mosaic virus, was discovered and isolated [4, 47] from a diseased plant whereas the first mycoplasma, the \"bovine pleuropneumonia agent\" (Mycoplasma myc6ides), was cultured from sick cattle at the Pasteur Institute in Paris by Nocard et al. [72] .", [["Tobacco mosaic virus", "DISEASE", 55, 75], ["mycoplasma", "DISEASE", 153, 163], ["pleuropneumonia", "DISEASE", 177, 192], ["Tobacco mosaic virus", "ORGANISM", 55, 75], ["bovine", "ORGANISM", 170, 176], ["Mycoplasma myc6ides", "ORGANISM", 201, 220], ["cattle", "ORGANISM", 246, 252], ["Tobacco mosaic virus", "SPECIES", 55, 75], ["bovine", "SPECIES", 170, 176], ["Mycoplasma myc6ides", "SPECIES", 201, 220], ["cattle", "SPECIES", 246, 252], ["Tobacco mosaic virus", "SPECIES", 55, 75], ["Mycoplasma myc6ides", "SPECIES", 201, 220], ["cattle", "SPECIES", 246, 252], ["the first \"true\" virus", "PROBLEM", 27, 49], ["the Tobacco mosaic virus", "PROBLEM", 51, 75], ["a diseased plant", "PROBLEM", 118, 134], ["the first mycoplasma", "PROBLEM", 143, 163], ["the \"bovine pleuropneumonia agent", "TREATMENT", 165, 198], ["Tobacco mosaic virus", "OBSERVATION", 55, 75], ["diseased", "OBSERVATION", 120, 128]]], ["These two agents, although quite different in their biological properties, have been then included in the new, emerging group of \"filterable viruses\" [86] together with foot-and-mouth disease [61] and yellow fever viruses [79] .", [["foot-and-mouth disease", "DISEASE", 169, 191], ["yellow fever", "DISEASE", 201, 213], ["foot", "ORGANISM_SUBDIVISION", 169, 173], ["yellow fever viruses", "ORGANISM", 201, 221], ["foot-and-mouth", "SPECIES", 169, 183], ["yellow fever viruses", "SPECIES", 201, 221], ["yellow fever viruses", "SPECIES", 201, 221], ["\"filterable viruses", "PROBLEM", 129, 148], ["foot", "TEST", 169, 173], ["mouth disease", "PROBLEM", 178, 191], ["yellow fever viruses", "PROBLEM", 201, 221], ["foot", "ANATOMY", 169, 173], ["mouth", "ANATOMY", 178, 183]]], ["This was also the case for the \"contagious agalactia agent\" of sheep and goats (M. agalactiae) isolated some years later [8] .", [["agalactia", "DISEASE", 43, 52], ["sheep", "ORGANISM", 63, 68], ["goats", "ORGANISM", 73, 78], ["M. agalactiae", "ORGANISM", 80, 93], ["sheep", "SPECIES", 63, 68], ["goats", "SPECIES", 73, 78], ["M. agalactiae", "SPECIES", 80, 93], ["sheep", "SPECIES", 63, 68], ["goats", "SPECIES", 73, 78], ["M. agalactiae", "SPECIES", 80, 93], ["the \"contagious agalactia agent", "TREATMENT", 27, 58]]], ["However, both the pleuropneumonia and the agalactia agents were visible under the microscope and were readily cultured in serum-enriched media unlike the other filterable viruses.", [["serum", "ANATOMY", 122, 127], ["pleuropneumonia", "DISEASE", 18, 33], ["serum", "ORGANISM_SUBSTANCE", 122, 127], ["the pleuropneumonia", "PROBLEM", 14, 33], ["the agalactia agents", "TREATMENT", 38, 58], ["the microscope", "TEST", 78, 92], ["serum", "TEST", 122, 127], ["the other filterable viruses", "PROBLEM", 150, 178], ["pleuropneumonia", "OBSERVATION", 18, 33], ["filterable viruses", "OBSERVATION", 160, 178]]], ["This led to a durable confusion concerning the actual nature of\"viruses\".", [["confusion", "DISEASE", 22, 31], ["a durable confusion", "PROBLEM", 12, 31], ["\"viruses\"", "PROBLEM", 63, 72]]], ["Many microbiologists spent unsuccessful and time-consuming efforts in order to find artificial media able to support the development of the filterable agents they were working on, and known today as true viruses.M ycoplasmas and viruses: a historical perspectiveDuring the t950's, it was shown that a chronic pneumonia infecting British pigs was distinct from swine influenza and, according to filtration studies, thought to be of probable viral origin [41] .", [["pneumonia", "DISEASE", 309, 318], ["influenza", "DISEASE", 366, 375], ["pigs", "ORGANISM", 337, 341], ["pigs", "SPECIES", 337, 341], ["swine", "SPECIES", 360, 365], ["M ycoplasmas", "SPECIES", 212, 224], ["pigs", "SPECIES", 337, 341], ["swine", "SPECIES", 360, 365], ["artificial media", "TREATMENT", 84, 100], ["the filterable agents", "TREATMENT", 136, 157], ["true viruses", "PROBLEM", 199, 211], ["viruses", "PROBLEM", 229, 236], ["a chronic pneumonia", "PROBLEM", 299, 318], ["swine influenza", "PROBLEM", 360, 375], ["filtration studies", "TEST", 394, 412], ["viral origin", "PROBLEM", 440, 452], ["viruses", "OBSERVATION", 204, 211], ["viruses", "OBSERVATION", 229, 236], ["chronic", "OBSERVATION_MODIFIER", 301, 308], ["pneumonia", "OBSERVATION", 309, 318], ["thought to be", "UNCERTAINTY", 414, 427]]], ["In fact, the aetiological agent of this economically important disease was finally identified as another animal mycoplasma presently known as M. hyopneumoniae [35] .M ycoplasmas and viruses: a historical perspectiveIn human microbiology, when M. pneumoniae was isolated from patients with primary atypical pneumonia, using embryonated hens' eggs (a method suitable for virus isolations), this agent was first considered as a pneumotropic virus [26] although it was recognized as a mycoplasma, 18 years later [12] .", [["mycoplasma", "DISEASE", 112, 122], ["primary atypical pneumonia", "DISEASE", 289, 315], ["mycoplasma", "DISEASE", 481, 491], ["M. hyopneumoniae", "ORGANISM", 142, 158], ["human", "ORGANISM", 218, 223], ["M. pneumoniae", "ORGANISM", 243, 256], ["patients", "ORGANISM", 275, 283], ["hens", "ORGANISM", 335, 339], ["eggs", "DEVELOPING_ANATOMICAL_STRUCTURE", 341, 345], ["M. hyopneumoniae", "SPECIES", 142, 158], ["human", "SPECIES", 218, 223], ["M. pneumoniae", "SPECIES", 243, 256], ["patients", "SPECIES", 275, 283], ["M. hyopneumoniae", "SPECIES", 142, 158], ["M ycoplasmas", "SPECIES", 165, 177], ["human", "SPECIES", 218, 223], ["M. pneumoniae", "SPECIES", 243, 256], ["this economically important disease", "PROBLEM", 35, 70], ["another animal mycoplasma", "PROBLEM", 97, 122], ["M. hyopneumoniae", "PROBLEM", 142, 158], ["viruses", "PROBLEM", 182, 189], ["M. pneumoniae", "PROBLEM", 243, 256], ["primary atypical pneumonia", "PROBLEM", 289, 315], ["embryonated hens' eggs", "TREATMENT", 323, 345], ["a method", "TREATMENT", 347, 355], ["virus isolations", "TREATMENT", 369, 385], ["this agent", "TREATMENT", 388, 398], ["a pneumotropic virus", "PROBLEM", 423, 443], ["a mycoplasma", "PROBLEM", 479, 491], ["viruses", "OBSERVATION", 182, 189], ["atypical", "OBSERVATION_MODIFIER", 297, 305], ["pneumonia", "OBSERVATION", 306, 315]]], ["In comparative pathology, the strange so-called \"suckling mouse cataract agent\" (SMCA) presently known as Spiroplasma mirum has been isolated from ticks using embryonated hens' eggs [15] and considered for a long time as an arbovirus or a slow virus.", [["cataract", "DISEASE", 64, 72], ["mouse", "ORGANISM", 58, 63], ["Spiroplasma mirum", "ORGANISM", 106, 123], ["ticks", "ORGANISM", 147, 152], ["mouse", "SPECIES", 58, 63], ["Spiroplasma mirum", "SPECIES", 106, 123], ["mouse", "SPECIES", 58, 63], ["Spiroplasma mirum", "SPECIES", 106, 123], ["comparative pathology", "TEST", 3, 24], ["Spiroplasma mirum", "PROBLEM", 106, 123], ["embryonated hens' eggs", "TREATMENT", 159, 181], ["an arbovirus", "PROBLEM", 221, 233], ["a slow virus", "PROBLEM", 237, 249], ["arbovirus", "OBSERVATION", 224, 233]]], ["Finally it was recognized as a mycoplasma [3] and more precisely as a helical mycoplasma or spiroplasma [97] .", [["mycoplasma", "DISEASE", 78, 88], ["a mycoplasma", "PROBLEM", 29, 41], ["a helical mycoplasma", "PROBLEM", 68, 88], ["spiroplasma", "PROBLEM", 92, 103]]], ["Plant mycoplasmas were initially thought to be viruses because they were transmitted biologically by sap-sucking insects as is the case for genuine plant viruses as well as for hematophagous arthropod-borne viruses.", [["Plant mycoplasmas", "ORGANISM", 0, 17], ["sap", "ORGANISM_SUBDIVISION", 101, 104], ["hematophagous arthropod-borne viruses", "ORGANISM", 177, 214], ["Plant mycoplasmas", "PROBLEM", 0, 17], ["viruses", "PROBLEM", 47, 54], ["genuine plant viruses", "PROBLEM", 140, 161], ["hematophagous arthropod-borne viruses", "PROBLEM", 177, 214], ["mycoplasmas", "OBSERVATION", 6, 17], ["viruses", "OBSERVATION", 47, 54]]], ["The plant mycoplasmas now known as phytoplasmas were discovered only in 1967 [25] , i.e. 69 years after the cultivation of the first animal mycoplasma [7] .M ycoplasmas and viruses: a historical perspectiveRecently, M. fermentans was isolated from AIDS patients and initially described as a \"virus-like agent\" [54, 55] although its morphology revealed by transmission electron microscopy was obviously that of a mycoplasma.", [["mycoplasma", "DISEASE", 140, 150], ["AIDS", "DISEASE", 248, 252], ["mycoplasma", "DISEASE", 412, 422], ["phytoplasmas", "CANCER", 35, 47], ["M. fermentans", "ORGANISM", 216, 229], ["patients", "ORGANISM", 253, 261], ["M. fermentans", "SPECIES", 216, 229], ["patients", "SPECIES", 253, 261], ["M ycoplasmas", "SPECIES", 156, 168], ["M. fermentans", "SPECIES", 216, 229], ["The plant mycoplasmas", "PROBLEM", 0, 21], ["phytoplasmas", "PROBLEM", 35, 47], ["the cultivation", "TEST", 104, 119], ["viruses", "PROBLEM", 173, 180], ["M. fermentans", "PROBLEM", 216, 229], ["a \"virus", "PROBLEM", 289, 297], ["transmission electron microscopy", "TEST", 355, 387], ["a mycoplasma", "PROBLEM", 410, 422], ["mycoplasmas", "OBSERVATION", 10, 21], ["viruses", "OBSERVATION", 173, 180], ["mycoplasma", "OBSERVATION", 412, 422]]], ["However, this \"new\" agent was soon recognized as a mycoplasma and given the name M. incognitus (sic) [56] before it was properly identified as M. fermentans [89] .M ycoplasmas and viruses: a historical perspectiveThus, the history of viruses and mycoplasmas, mainly before the tissue culture era, was filled with example of confusion between these two types of infectious agents.M ycoplasmas as frequent contaminants of cell cultures: interference with virological studiesFor virologists this represents a more familiar case of mycoplasma/virus association.", [["tissue culture", "ANATOMY", 277, 291], ["cell cultures", "ANATOMY", 420, 433], ["mycoplasma", "DISEASE", 51, 61], ["confusion", "DISEASE", 324, 333], ["mycoplasma/virus", "DISEASE", 528, 544], ["M. incognitus", "ORGANISM", 81, 94], ["M. fermentans", "ORGANISM", 143, 156], ["tissue", "TISSUE", 277, 283], ["cell cultures", "CELL", 420, 433], ["mycoplasma/virus", "ORGANISM", 528, 544], ["cell cultures", "CELL_LINE", 420, 433], ["M. incognitus", "SPECIES", 81, 94], ["M. fermentans", "SPECIES", 143, 156], ["M. incognitus", "SPECIES", 81, 94], ["M. fermentans", "SPECIES", 143, 156], ["a mycoplasma", "PROBLEM", 49, 61], ["viruses", "PROBLEM", 234, 241], ["mycoplasmas", "PROBLEM", 246, 257], ["the tissue culture", "TEST", 273, 291], ["confusion", "PROBLEM", 324, 333], ["infectious agents", "TREATMENT", 361, 378], ["cell cultures", "TEST", 420, 433], ["virological studies", "TEST", 453, 472], ["mycoplasma/virus association", "PROBLEM", 528, 556], ["viruses", "OBSERVATION", 180, 187], ["viruses", "OBSERVATION", 234, 241], ["infectious", "OBSERVATION", 361, 371]]], ["Contamination of cell cultures, mainly continuous lines, has been documented since the 1950's [20, 83] .", [["cell cultures", "ANATOMY", 17, 30], ["cell cultures", "CELL", 17, 30], ["lines", "CELL", 50, 55], ["cell cultures", "CELL_LINE", 17, 30], ["cell cultures", "TEST", 17, 30], ["continuous lines", "TREATMENT", 39, 55], ["cell cultures", "OBSERVATION", 17, 30]]], ["It represents a very serious problem for all those concerned with cell and tissue cultures of any kind.", [["cell", "ANATOMY", 66, 70], ["tissue cultures", "ANATOMY", 75, 90], ["cell", "CELL", 66, 70], ["tissue cultures", "CELL", 75, 90], ["a very serious problem", "PROBLEM", 14, 36], ["cell and tissue cultures", "TEST", 66, 90], ["very", "OBSERVATION_MODIFIER", 16, 20], ["serious", "OBSERVATION", 21, 28]]], ["Several general reviews have discussed this question [2, 84] but detection and decontamination of infected cells proved sometimes difficult, if not impossible.M ycoplasmas as frequent contaminants of cell cultures: interference with virological studiesAseptically obtained cell cultures are generally not contaminated unlike the continuous cell lines which may be infected in 50 to 95 per cent of cases [2] . are also frequently detected [2] .M ycoplasmas as frequent contaminants of cell cultures: interference with virological studiesEffects on cultured cells vary from evident consequences [t0] with the appearance of a non-specific cytopathic effect (abnormal growth, rounded and degenerated cells, acidification of medium) to covert infection with minimal or inapparent cellular damages [84] .", [["cells", "ANATOMY", 107, 112], ["cell cultures", "ANATOMY", 200, 213], ["cell cultures", "ANATOMY", 273, 286], ["cell lines", "ANATOMY", 340, 350], ["cell cultures", "ANATOMY", 484, 497], ["cells", "ANATOMY", 556, 561], ["cells", "ANATOMY", 696, 701], ["cellular", "ANATOMY", 775, 783], ["infection", "DISEASE", 738, 747], ["cells", "CELL", 107, 112], ["cell cultures", "CELL", 200, 213], ["cell cultures", "CELL", 273, 286], ["cell lines", "CELL", 340, 350], ["cell cultures", "CELL", 484, 497], ["cells", "CELL", 556, 561], ["cells", "CELL", 696, 701], ["cellular", "CELL", 775, 783], ["infected cells", "CELL_TYPE", 98, 112], ["cell cultures", "CELL_LINE", 200, 213], ["cell cultures", "CELL_LINE", 273, 286], ["continuous cell lines", "CELL_LINE", 329, 350], ["cell cultures", "CELL_LINE", 484, 497], ["cultured cells", "CELL_LINE", 547, 561], ["rounded and degenerated cells", "CELL_TYPE", 672, 701], ["infected cells", "PROBLEM", 98, 112], ["cell cultures", "TEST", 200, 213], ["virological studies", "TEST", 233, 252], ["cell cultures", "TEST", 273, 286], ["the continuous cell lines", "TREATMENT", 325, 350], ["cell cultures", "TEST", 484, 497], ["virological studies", "TEST", 517, 536], ["cultured cells", "TEST", 547, 561], ["a non-specific cytopathic effect", "PROBLEM", 621, 653], ["abnormal growth", "PROBLEM", 655, 670], ["rounded and degenerated cells", "PROBLEM", 672, 701], ["acidification of medium)", "PROBLEM", 703, 727], ["covert infection", "PROBLEM", 731, 747], ["minimal or inapparent cellular damages", "PROBLEM", 753, 791], ["infected cells", "OBSERVATION", 98, 112], ["cell lines", "OBSERVATION", 340, 350], ["non-specific", "OBSERVATION_MODIFIER", 623, 635], ["cytopathic", "OBSERVATION_MODIFIER", 636, 646], ["abnormal", "OBSERVATION_MODIFIER", 655, 663], ["growth", "OBSERVATION_MODIFIER", 664, 670], ["rounded", "OBSERVATION_MODIFIER", 672, 679], ["degenerated cells", "OBSERVATION", 684, 701], ["infection", "OBSERVATION", 738, 747], ["minimal", "OBSERVATION_MODIFIER", 753, 760], ["inapparent", "OBSERVATION_MODIFIER", 764, 774], ["cellular damages", "OBSERVATION", 775, 791]]], ["Some mycoplasmas such as M. hyorhinis or M. fermentans are efficient cytadsorbing agents.", [["M. hyorhinis", "ORGANISM", 25, 37], ["M. fermentans", "ORGANISM", 41, 54], ["cytadsorbing agents", "SIMPLE_CHEMICAL", 69, 88], ["M. hyorhinis", "SPECIES", 25, 37], ["M. fermentans", "SPECIES", 41, 54], ["M. hyorhinis", "SPECIES", 25, 37], ["M. fermentans", "SPECIES", 41, 54], ["Some mycoplasmas", "PROBLEM", 0, 16], ["M. hyorhinis", "PROBLEM", 25, 37], ["M. fermentans", "PROBLEM", 41, 54], ["cytadsorbing agents", "TREATMENT", 69, 88], ["mycoplasmas", "OBSERVATION", 5, 16]]], ["But in any case, the activities and functions of cells are altered and this may affect the experimental results especially in virus studies, leading to erroneous conclusions, persistent contamination of virus stocks (including reference strains) and virus antibodies.M ycoplasmas as frequent contaminants of cell cultures: interference with virological studiesVirus yield of mycoplasma contaminated cells may be affected or not.", [["cells", "ANATOMY", 49, 54], ["cell cultures", "ANATOMY", 308, 321], ["cells", "ANATOMY", 399, 404], ["cells", "CELL", 49, 54], ["cell cultures", "CELL", 308, 321], ["Virus", "ORGANISM", 360, 365], ["cells", "CELL", 399, 404], ["virus antibodies", "PROTEIN", 250, 266], ["cell cultures", "CELL_LINE", 308, 321], ["mycoplasma contaminated cells", "CELL_TYPE", 375, 404], ["virus studies", "TEST", 126, 139], ["erroneous conclusions", "PROBLEM", 152, 173], ["persistent contamination of virus stocks", "PROBLEM", 175, 215], ["reference strains) and virus antibodies", "PROBLEM", 227, 266], ["cell cultures", "TEST", 308, 321], ["virological studies", "TEST", 341, 360], ["mycoplasma contaminated cells", "PROBLEM", 375, 404], ["persistent", "OBSERVATION_MODIFIER", 175, 185], ["contamination", "OBSERVATION", 186, 199], ["virus stocks", "OBSERVATION", 203, 215], ["mycoplasma contaminated cells", "OBSERVATION", 375, 404]]], ["Some mycoplasmas have no detectable effects on virus growth but other species may depress or even enhance virus replication in infected cells [84] .", [["cells", "ANATOMY", 136, 141], ["cells", "CELL", 136, 141], ["infected cells", "CELL_TYPE", 127, 141], ["Some mycoplasmas", "PROBLEM", 0, 16], ["virus growth", "PROBLEM", 47, 59], ["other species", "PROBLEM", 64, 77], ["enhance virus replication in infected cells", "PROBLEM", 98, 141], ["mycoplasmas", "OBSERVATION", 5, 16], ["virus", "OBSERVATION", 47, 52], ["infected cells", "OBSERVATION", 127, 141]]], ["For instance mycoplasmas can decrease virus yield by depleting the medium of an essential amino acid.", [["amino acid", "CHEMICAL", 90, 100], ["amino acid", "CHEMICAL", 90, 100], ["mycoplasmas", "ORGANISM", 13, 24], ["amino acid", "AMINO_ACID", 90, 100], ["instance mycoplasmas", "PROBLEM", 4, 24], ["an essential amino acid", "TREATMENT", 77, 100], ["amino acid", "OBSERVATION", 90, 100]]], ["Thus, mycoplasma contamination of established lines of human origin, such as KB cells, quickly deplets arginine available in the medium and lowers the plating efficacy of adenovirus type 2 which has an absolute requirement of arginine for growth [85] .", [["lines", "ANATOMY", 46, 51], ["KB cells", "ANATOMY", 77, 85], ["arginine", "CHEMICAL", 103, 111], ["arginine", "CHEMICAL", 226, 234], ["arginine", "CHEMICAL", 103, 111], ["arginine", "CHEMICAL", 226, 234], ["lines", "CELL", 46, 51], ["human", "ORGANISM", 55, 60], ["KB cells", "CELL", 77, 85], ["arginine", "SIMPLE_CHEMICAL", 103, 111], ["adenovirus type 2", "ORGANISM", 171, 188], ["arginine", "SIMPLE_CHEMICAL", 226, 234], ["KB cells", "CELL_LINE", 77, 85], ["human", "SPECIES", 55, 60], ["human", "SPECIES", 55, 60], ["mycoplasma contamination", "PROBLEM", 6, 30], ["KB cells", "PROBLEM", 77, 85], ["adenovirus type 2", "PROBLEM", 171, 188], ["mycoplasma contamination", "OBSERVATION", 6, 30], ["human origin", "OBSERVATION_MODIFIER", 55, 67]]], ["Likewise, in hamster and chick embryo fibroblasts or human amnion cells (FL strain) chronically infected by M.M ycoplasmas as frequent contaminants of cell cultures: interference with virological studiesarginini, an arginine utilizer, there was a decreased yield of vaccinia virus growth 8t4 C. Chastel and this effect might be reverted by addition of arginine to the medium.", [["hamster", "ANATOMY", 13, 20], ["embryo fibroblasts", "ANATOMY", 31, 49], ["amnion cells", "ANATOMY", 59, 71], ["FL strain", "ANATOMY", 73, 82], ["cell cultures", "ANATOMY", 151, 164], ["arginine", "CHEMICAL", 216, 224], ["arginine", "CHEMICAL", 352, 360], ["arginine", "CHEMICAL", 216, 224], ["arginine", "CHEMICAL", 352, 360], ["hamster", "ORGANISM", 13, 20], ["chick", "ORGANISM", 25, 30], ["embryo fibroblasts", "CELL", 31, 49], ["human", "ORGANISM", 53, 58], ["amnion cells", "CELL", 59, 71], ["FL strain", "CELL", 73, 82], ["M.M ycoplasmas", "ORGANISM", 108, 122], ["cell cultures", "CELL", 151, 164], ["studiesarginini", "SIMPLE_CHEMICAL", 196, 211], ["arginine", "AMINO_ACID", 216, 224], ["vaccinia virus", "ORGANISM", 266, 280], ["arginine", "SIMPLE_CHEMICAL", 352, 360], ["chick embryo fibroblasts", "CELL_TYPE", 25, 49], ["human amnion cells", "CELL_TYPE", 53, 71], ["cell cultures", "CELL_LINE", 151, 164], ["hamster", "SPECIES", 13, 20], ["chick", "SPECIES", 25, 30], ["human", "SPECIES", 53, 58], ["hamster", "SPECIES", 13, 20], ["chick", "SPECIES", 25, 30], ["human", "SPECIES", 53, 58], ["M.M ycoplasmas", "SPECIES", 108, 122], ["vaccinia virus", "SPECIES", 266, 280], ["chick embryo fibroblasts", "PROBLEM", 25, 49], ["human amnion cells", "PROBLEM", 53, 71], ["FL strain)", "PROBLEM", 73, 83], ["cell cultures", "TEST", 151, 164], ["virological studiesarginini", "TREATMENT", 184, 211], ["an arginine utilizer", "TREATMENT", 213, 233], ["vaccinia virus growth", "PROBLEM", 266, 287], ["arginine to the medium", "TREATMENT", 352, 374], ["chick embryo fibroblasts", "OBSERVATION", 25, 49], ["human amnion cells", "OBSERVATION", 53, 71], ["vaccinia virus", "OBSERVATION", 266, 280]]], ["This decrease was not observed when chronic cell infection was established with M. hyorhinis, a non-arginine utilizer [94] .", [["cell", "ANATOMY", 44, 48], ["chronic cell infection", "DISEASE", 36, 58], ["non-arginine", "CHEMICAL", 96, 108], ["cell", "CELL", 44, 48], ["M. hyorhinis", "ORGANISM", 80, 92], ["M. hyorhinis", "SPECIES", 80, 92], ["M. hyorhinis", "SPECIES", 80, 92], ["chronic cell infection", "PROBLEM", 36, 58], ["a non-arginine utilizer", "TREATMENT", 94, 117], ["not observed", "UNCERTAINTY", 18, 30], ["infection", "OBSERVATION", 49, 58]]], ["Similar results were observed with another DNA virus, Herpes simplex virus type 1 (HSVt) grown in Veto cells:M ycoplasmas as frequent contaminants of cell cultures: interference with virological studiesM. arginini decreases the yield of HSV 1 and reversion is obtained by supplementing the medium with arginine while Acholeplasma laidlawii, a non-arginine utilizer, has no effect [67] .", [["Veto cells", "ANATOMY", 98, 108], ["cell cultures", "ANATOMY", 150, 163], ["Herpes simplex virus", "DISEASE", 54, 74], ["arginini", "CHEMICAL", 205, 213], ["arginine", "CHEMICAL", 302, 310], ["arginine", "CHEMICAL", 302, 310], ["DNA", "CELLULAR_COMPONENT", 43, 46], ["Herpes simplex virus type 1", "ORGANISM", 54, 81], ["HSVt", "ORGANISM", 83, 87], ["Veto cells", "CELL", 98, 108], ["M ycoplasmas", "CELL", 109, 121], ["cell cultures", "CELL", 150, 163], ["arginini", "SIMPLE_CHEMICAL", 205, 213], ["HSV 1", "ORGANISM", 237, 242], ["arginine", "SIMPLE_CHEMICAL", 302, 310], ["Acholeplasma laidlawii", "ORGANISM", 317, 339], ["Veto cells", "CELL_LINE", 98, 108], ["cell cultures", "CELL_LINE", 150, 163], ["Herpes simplex virus", "SPECIES", 54, 74], ["Acholeplasma laidlawii", "SPECIES", 317, 339], ["Herpes simplex virus type 1", "SPECIES", 54, 81], ["HSVt", "SPECIES", 83, 87], ["arginini", "SPECIES", 205, 213], ["HSV", "SPECIES", 237, 240], ["Acholeplasma laidlawii", "SPECIES", 317, 339], ["another DNA virus", "PROBLEM", 35, 52], ["Herpes simplex virus type", "PROBLEM", 54, 79], ["cell cultures", "TEST", 150, 163], ["virological studiesM", "TEST", 183, 203], ["arginini", "PROBLEM", 205, 213], ["HSV", "PROBLEM", 237, 240], ["arginine while Acholeplasma laidlawii", "TREATMENT", 302, 339], ["a non-arginine utilizer", "TREATMENT", 341, 364], ["Veto cells", "OBSERVATION", 98, 108]]], ["It has been also shown that contamination of chick embryo cells by M. gallisepticum markedly affects the in vitro multiplication of fowlpox virus and modifies the plaque morphology; this mycoplasma also decreases the in vivo infectivity of fowlpox virus for day-old chicks [31] .M ycoplasmas as frequent contaminants of cell cultures: interference with virological studiesConversely, the chronic infection of hamster embryo fibroblasts by M. arginini and M. hyorhinis increased significantly the yield of two arboviruses, vesicular stomatitis (Indiana strain) and Semliki Forest viruses.", [["embryo cells", "ANATOMY", 51, 63], ["plaque", "ANATOMY", 163, 169], ["cell cultures", "ANATOMY", 320, 333], ["embryo fibroblasts", "ANATOMY", 417, 435], ["vesicular", "ANATOMY", 522, 531], ["infection", "DISEASE", 396, 405], ["vesicular stomatitis", "DISEASE", 522, 542], ["chick", "ORGANISM", 45, 50], ["embryo cells", "CELL", 51, 63], ["M. gallisepticum", "ORGANISM", 67, 83], ["fowlpox virus", "ORGANISM", 132, 145], ["plaque", "PATHOLOGICAL_FORMATION", 163, 169], ["fowlpox virus", "ORGANISM", 240, 253], ["cell cultures", "CELL", 320, 333], ["hamster", "ORGANISM", 409, 416], ["embryo fibroblasts", "CELL", 417, 435], ["M. arginini", "ORGANISM", 439, 450], ["M. hyorhinis", "ORGANISM", 455, 467], ["vesicular stomatitis", "ORGANISM", 522, 542], ["Indiana strain", "ORGANISM", 544, 558], ["Semliki Forest viruses", "ORGANISM", 564, 586], ["chick embryo cells", "CELL_TYPE", 45, 63], ["cell cultures", "CELL_LINE", 320, 333], ["hamster embryo fibroblasts", "CELL_TYPE", 409, 435], ["M. gallisepticum", "SPECIES", 67, 83], ["hamster", "SPECIES", 409, 416], ["M. arginini", "SPECIES", 439, 450], ["M. hyorhinis", "SPECIES", 455, 467], ["Semliki", "SPECIES", 564, 571], ["chick", "SPECIES", 45, 50], ["M. gallisepticum", "SPECIES", 67, 83], ["fowlpox virus", "SPECIES", 132, 145], ["fowlpox virus", "SPECIES", 240, 253], ["hamster", "SPECIES", 409, 416], ["M. arginini", "SPECIES", 439, 450], ["M. hyorhinis", "SPECIES", 455, 467], ["Semliki Forest viruses", "SPECIES", 564, 586], ["contamination of chick embryo cells", "PROBLEM", 28, 63], ["M. gallisepticum", "PROBLEM", 67, 83], ["fowlpox virus", "PROBLEM", 132, 145], ["the plaque morphology", "PROBLEM", 159, 180], ["this mycoplasma", "PROBLEM", 182, 197], ["fowlpox virus", "TREATMENT", 240, 253], ["cell cultures", "TEST", 320, 333], ["virological studies", "TEST", 353, 372], ["the chronic infection of hamster embryo fibroblasts", "PROBLEM", 384, 435], ["M. hyorhinis", "PROBLEM", 455, 467], ["two arboviruses", "PROBLEM", 505, 520], ["vesicular stomatitis", "PROBLEM", 522, 542], ["Indiana strain)", "PROBLEM", 544, 559], ["Semliki Forest viruses", "PROBLEM", 564, 586], ["chick embryo cells", "OBSERVATION", 45, 63], ["fowlpox virus", "OBSERVATION", 132, 145], ["plaque", "OBSERVATION", 163, 169], ["chronic", "OBSERVATION_MODIFIER", 388, 395], ["infection", "OBSERVATION", 396, 405], ["hamster embryo fibroblasts", "OBSERVATION", 409, 435], ["vesicular stomatitis", "OBSERVATION", 522, 542], ["Semliki Forest viruses", "OBSERVATION", 564, 586]]], ["This enhancement resulted from a non-arginine dependent depletion of interferon production induced in infected cells by mycoplasmas [92, 93] .M ycoplasmas as frequent contaminants of cell cultures: interference with virological studiesMycoplasma contamination may also have other deleterious effects on the molecular expression of other viruses belonging to the Herpesviridae family.M ycoplasmas as frequent contaminants of cell cultures: interference with virological studiesFor instance some strains of varicella-zoster virus contaminated by M. hyorhinisM ycoplasmas as frequent contaminants of cell cultures: interference with virological studiesshow a greatly reduced immunoreactivity of certain viral glycoproteins possibly by depletion of sugars or interference in glycosylation pathways [42] , and the previously reported immunosuppressive effects of human cytomegalovirus in vitro may in fact be due to the presence of the same swine mycoplasma in virus stocks [91] .Finally, M. orale inhibits the transforming effect of Rous Sarcoma andRous-associated viruses in chick embryo fibroblasts, and other mycoplasmas reduce the number of transformed foci in SV-40 and polyoma-infected cells cultures [84] .", [["cells", "ANATOMY", 111, 116], ["cell cultures", "ANATOMY", 183, 196], ["cell cultures", "ANATOMY", 424, 437], ["cell cultures", "ANATOMY", 597, 610], ["embryo fibroblasts", "ANATOMY", 1078, 1096], ["foci", "ANATOMY", 1153, 1157], ["SV-40", "ANATOMY", 1161, 1166], ["cells", "ANATOMY", 1188, 1193], ["non-arginine", "CHEMICAL", 33, 45], ["Mycoplasma contamination", "DISEASE", 235, 259], ["varicella-zoster virus", "DISEASE", 505, 527], ["cytomegalovirus", "DISEASE", 864, 879], ["Rous Sarcoma", "DISEASE", 1029, 1041], ["SV-40", "CHEMICAL", 1161, 1166], ["non-arginine", "CHEMICAL", 33, 45], ["sugars", "CHEMICAL", 745, 751], ["non-arginine", "SIMPLE_CHEMICAL", 33, 45], ["interferon", "GENE_OR_GENE_PRODUCT", 69, 79], ["cells", "CELL", 111, 116], ["cell cultures", "CELL", 183, 196], ["Mycoplasma", "ORGANISM", 235, 245], ["Herpesviridae", "GENE_OR_GENE_PRODUCT", 362, 375], ["cell cultures", "CELL", 424, 437], ["varicella-zoster virus", "ORGANISM", 505, 527], ["M. hyorhinisM ycoplasmas", "ORGANISM", 544, 568], ["cell cultures", "CELL", 597, 610], ["sugars", "SIMPLE_CHEMICAL", 745, 751], ["human", "ORGANISM", 858, 863], ["cytomegalovirus", "ORGANISM", 864, 879], ["swine mycoplasma", "ORGANISM", 936, 952], ["M. orale", "ORGANISM", 984, 992], ["Rous Sarcoma", "ORGANISM", 1029, 1041], ["Rous-associated viruses", "ORGANISM", 1045, 1068], ["chick", "ORGANISM", 1072, 1077], ["embryo fibroblasts", "CELL", 1078, 1096], ["SV-40", "ORGANISM", 1161, 1166], ["polyoma", "ORGANISM", 1171, 1178], ["cells", "CELL", 1188, 1193], ["interferon", "PROTEIN", 69, 79], ["infected cells", "CELL_TYPE", 102, 116], ["cell cultures", "CELL_LINE", 183, 196], ["Herpesviridae family", "PROTEIN", 362, 382], ["cell cultures", "CELL_LINE", 424, 437], ["cell cultures", "CELL_LINE", 597, 610], ["viral glycoproteins", "PROTEIN", 700, 719], ["chick embryo fibroblasts", "CELL_TYPE", 1072, 1096], ["polyoma-infected cells cultures", "CELL_LINE", 1171, 1202], ["varicella-zoster virus", "SPECIES", 505, 527], ["M. hyorhinisM ycoplasmas", "SPECIES", 544, 568], ["human", "SPECIES", 858, 863], ["swine", "SPECIES", 936, 941], ["M. orale", "SPECIES", 984, 992], ["Rous", "SPECIES", 1029, 1033], ["Rous", "SPECIES", 1045, 1049], ["chick", "SPECIES", 1072, 1077], ["varicella-zoster virus", "SPECIES", 505, 527], ["M. hyorhinisM ycoplasmas", "SPECIES", 544, 568], ["human cytomegalovirus", "SPECIES", 858, 879], ["swine", "SPECIES", 936, 941], ["M. orale", "SPECIES", 984, 992], ["chick", "SPECIES", 1072, 1077], ["SV-40", "SPECIES", 1161, 1166], ["This enhancement", "PROBLEM", 0, 16], ["a non-arginine dependent depletion", "PROBLEM", 31, 65], ["interferon production", "TREATMENT", 69, 90], ["infected cells", "PROBLEM", 102, 116], ["mycoplasmas", "PROBLEM", 120, 131], ["cell cultures", "TEST", 183, 196], ["virological studies", "TEST", 216, 235], ["Mycoplasma contamination", "PROBLEM", 235, 259], ["cell cultures", "TEST", 424, 437], ["virological studies", "TEST", 457, 476], ["varicella", "PROBLEM", 505, 514], ["zoster virus", "PROBLEM", 515, 527], ["cell cultures", "TEST", 597, 610], ["a greatly reduced immunoreactivity", "PROBLEM", 654, 688], ["certain viral glycoproteins", "PROBLEM", 692, 719], ["depletion of sugars", "PROBLEM", 732, 751], ["interference in glycosylation pathways", "PROBLEM", 755, 793], ["human cytomegalovirus", "PROBLEM", 858, 879], ["the same swine mycoplasma", "PROBLEM", 927, 952], ["Rous Sarcoma", "PROBLEM", 1029, 1041], ["Rous-associated viruses", "PROBLEM", 1045, 1068], ["chick embryo fibroblasts", "PROBLEM", 1072, 1096], ["other mycoplasmas", "PROBLEM", 1102, 1119], ["transformed foci", "PROBLEM", 1141, 1157], ["SV", "TEST", 1161, 1163], ["polyoma", "PROBLEM", 1171, 1178], ["infected cells cultures", "TEST", 1179, 1202], ["non-arginine dependent", "OBSERVATION_MODIFIER", 33, 55], ["depletion", "OBSERVATION_MODIFIER", 56, 65], ["interferon production", "OBSERVATION", 69, 90], ["infected cells", "OBSERVATION", 102, 116], ["varicella", "OBSERVATION", 505, 514], ["cytomegalovirus", "OBSERVATION", 864, 879], ["Rous Sarcoma", "OBSERVATION", 1029, 1041], ["viruses", "OBSERVATION", 1061, 1068], ["chick embryo fibroblasts", "OBSERVATION", 1072, 1096], ["transformed", "OBSERVATION_MODIFIER", 1141, 1152], ["foci", "OBSERVATION", 1153, 1157], ["SV", "ANATOMY", 1161, 1163], ["polyoma", "ANATOMY", 1171, 1178], ["infected cells", "OBSERVATION", 1179, 1193]]], ["It is thus clear that mycoplasma contamination of cultured cells and virus stocks may have dileterious effects on many virological studies.", [["cells", "ANATOMY", 59, 64], ["cells", "CELL", 59, 64], ["cultured cells", "CELL_LINE", 50, 64], ["mycoplasma contamination of cultured cells", "PROBLEM", 22, 64], ["virus stocks", "TREATMENT", 69, 81], ["dileterious effects", "PROBLEM", 91, 110], ["many virological studies", "TEST", 114, 138], ["mycoplasma", "OBSERVATION", 22, 32]]], ["From an epidemiological point of view, molecular studies involving the genotyping of obligate intracellular pathogens, including DNA viruses, chlamydias, rickettsias, etc., may lead to erroneous conclusions.", [["intracellular", "ANATOMY", 94, 107], ["rickettsias", "DISEASE", 154, 165], ["intracellular", "IMMATERIAL_ANATOMICAL_ENTITY", 94, 107], ["DNA", "CELLULAR_COMPONENT", 129, 132], ["molecular studies", "TEST", 39, 56], ["obligate intracellular pathogens", "PROBLEM", 85, 117], ["DNA viruses", "PROBLEM", 129, 140], ["chlamydias", "PROBLEM", 142, 152], ["rickettsias", "PROBLEM", 154, 165], ["erroneous conclusions", "PROBLEM", 185, 206], ["intracellular pathogens", "OBSERVATION", 94, 117]]], ["Mycoplasmas as a whole are a true \"plague\" for virologists and other biologists, and only frequent testing of cell cultures can avoid this type of problem.Infection of mycoplasmas by viruses (bacteriophages) is well documentedAlthough mycoplasmas (Class Mollicutes) are the smallest and simplest prokaryotes with a genome size of 600-2500 Kbp they have been found to be infected by a number of viruses.", [["cell cultures", "ANATOMY", 110, 123], ["Mycoplasmas", "CHEMICAL", 0, 11], ["cell cultures", "CELL", 110, 123], ["mycoplasmas", "ORGANISM", 168, 179], ["cell cultures", "CELL_LINE", 110, 123], ["Mycoplasmas", "PROBLEM", 0, 11], ["cell cultures", "TEST", 110, 123], ["problem", "PROBLEM", 147, 154], ["Infection of mycoplasmas", "PROBLEM", 155, 179], ["viruses (bacteriophages", "PROBLEM", 183, 206], ["mycoplasmas", "PROBLEM", 235, 246], ["Kbp", "TEST", 339, 342], ["mycoplasmas", "OBSERVATION", 168, 179], ["size", "OBSERVATION_MODIFIER", 322, 326], ["found to be", "UNCERTAINTY", 358, 369], ["infected", "OBSERVATION", 370, 378], ["viruses", "OBSERVATION", 394, 401]]], ["Moreover, these specific bacteriophages have been described from different species of mycoplasmas belonging to at least three genera: Acholeplasma, Spiroplasma and Mycoplasma.", [["mycoplasmas", "ORGANISM", 86, 97], ["Acholeplasma", "ORGANISM", 134, 146], ["Spiroplasma", "ORGANISM", 148, 159], ["Mycoplasma", "ORGANISM", 164, 174], ["these specific bacteriophages", "PROBLEM", 10, 39], ["mycoplasmas", "PROBLEM", 86, 97], ["Acholeplasma", "PROBLEM", 134, 146], ["Spiroplasma", "PROBLEM", 148, 159], ["Mycoplasma", "PROBLEM", 164, 174], ["bacteriophages", "OBSERVATION", 25, 39], ["Acholeplasma", "ANATOMY", 134, 146]]], ["Their basic properties, structure and classification have been reviewed in detail by Cole [18, 19] , Maniloff et al. [64] , Razin [78] , Maniloff [65, 66] and Renaudin and Bov~ [81] .Infection of mycoplasmas by viruses (bacteriophages) is well documentedThe first known mycoplasma virus, strain M V-L1, was described some 25 years ago by Gourlay in England [38] from Acholeplasma laidlawii.", [["Renaudin", "SIMPLE_CHEMICAL", 159, 167], ["mycoplasmas", "ORGANISM", 196, 207], ["mycoplasma virus", "ORGANISM", 270, 286], ["Acholeplasma laidlawii", "ORGANISM", 367, 389], ["Acholeplasma laidlawii", "SPECIES", 367, 389], ["mycoplasma virus", "SPECIES", 270, 286], ["M V-L1", "SPECIES", 295, 301], ["Acholeplasma laidlawii", "SPECIES", 367, 389], ["Renaudin", "TREATMENT", 159, 167], ["Infection of mycoplasmas", "PROBLEM", 183, 207], ["viruses (bacteriophages", "PROBLEM", 211, 234], ["The first known mycoplasma virus", "PROBLEM", 254, 286], ["Acholeplasma laidlawii", "TREATMENT", 367, 389], ["mycoplasmas", "OBSERVATION", 196, 207], ["mycoplasma virus", "OBSERVATION", 270, 286], ["L1", "ANATOMY", 299, 301]]], ["Soon thereafter the same author described a second mycoplasma virus, strain MV-L2, and then a third, strain MV-L3, always from A. laidlawii [32, 39] .Infection of mycoplasmas by viruses (bacteriophages) is well documentedThree spiroplasma viruses, known as SpV1, SpV2 and SpV3, have been characterized from Spiroplasma cirri, the aetiological agent of\"stubborn\" disease of Citrus, an important economical problem worldwide [18] , and a fourth spiroplasma virus, SpV4, has been isolated from Spiroplasma melliferum, a bee pathogen [80] .", [["mycoplasma virus", "DISEASE", 51, 67], ["Spiroplasma cirri", "DISEASE", 307, 324], ["stubborn\" disease", "DISEASE", 352, 369], ["SpV4", "CHEMICAL", 462, 466], ["Spiroplasma melliferum", "DISEASE", 491, 513], ["mycoplasma virus", "ORGANISM", 51, 67], ["A. laidlawii", "ORGANISM", 127, 139], ["mycoplasmas", "ORGANISM", 163, 174], ["spiroplasma viruses", "ORGANISM", 227, 246], ["SpV1", "GENE_OR_GENE_PRODUCT", 257, 261], ["SpV2", "GENE_OR_GENE_PRODUCT", 263, 267], ["SpV3", "GENE_OR_GENE_PRODUCT", 272, 276], ["Spiroplasma cirri", "ORGANISM", 307, 324], ["spiroplasma virus", "ORGANISM", 443, 460], ["SpV4", "GENE_OR_GENE_PRODUCT", 462, 466], ["Spiroplasma melliferum", "ORGANISM", 491, 513], ["SpV3", "PROTEIN", 272, 276], ["A. laidlawii", "SPECIES", 127, 139], ["Spiroplasma cirri", "SPECIES", 307, 324], ["Spiroplasma melliferum", "SPECIES", 491, 513], ["MV-L2", "SPECIES", 76, 81], ["MV-L3", "SPECIES", 108, 113], ["A. laidlawii", "SPECIES", 127, 139], ["Spiroplasma cirri", "SPECIES", 307, 324], ["spiroplasma virus", "SPECIES", 443, 460], ["Spiroplasma melliferum", "SPECIES", 491, 513], ["a second mycoplasma virus", "PROBLEM", 42, 67], ["Infection of mycoplasmas", "PROBLEM", 150, 174], ["viruses (bacteriophages", "PROBLEM", 178, 201], ["Three spiroplasma viruses", "PROBLEM", 221, 246], ["SpV1", "TEST", 257, 261], ["SpV2 and SpV3", "PROBLEM", 263, 276], ["Spiroplasma cirri", "PROBLEM", 307, 324], ["\"stubborn\" disease of Citrus", "PROBLEM", 351, 379], ["a fourth spiroplasma virus", "PROBLEM", 434, 460], ["Spiroplasma melliferum", "PROBLEM", 491, 513], ["a bee pathogen", "PROBLEM", 515, 529], ["L2", "ANATOMY", 79, 81], ["L3", "ANATOMY", 111, 113], ["mycoplasmas", "OBSERVATION", 163, 174], ["Spiroplasma cirri", "OBSERVATION", 307, 324], ["spiroplasma virus", "OBSERVATION", 443, 460], ["Spiroplasma melliferum", "OBSERVATION", 491, 513]]], ["Other mycoplasma viruses present in different species of the Mycoplasma genus (see below) remain to be better characterized [78] .Infection of mycoplasmas by viruses (bacteriophages) is well documentedMany mycoplasma viruses resemble classical bacteriophages previously described from wall-covered bacteria but some others, with an enveloped spherial shape and devoid of internal structure, such as MV-L2 or L172 strains from A. laidlawii, resemble animal viruses [78] .", [["mycoplasma viruses", "DISEASE", 6, 24], ["mycoplasma viruses", "DISEASE", 206, 224], ["mycoplasma viruses", "ORGANISM", 6, 24], ["Mycoplasma genus", "ORGANISM", 61, 77], ["mycoplasmas", "ORGANISM", 143, 154], ["mycoplasma viruses", "ORGANISM", 206, 224], ["MV-L2", "ORGANISM", 399, 404], ["L172 strains", "ORGANISM", 408, 420], ["A. laidlawii", "ORGANISM", 426, 438], ["A. laidlawii", "SPECIES", 426, 438], ["MV-L2", "SPECIES", 399, 404], ["A. laidlawii", "SPECIES", 426, 438], ["Other mycoplasma viruses", "PROBLEM", 0, 24], ["the Mycoplasma genus", "PROBLEM", 57, 77], ["Infection of mycoplasmas", "PROBLEM", 130, 154], ["viruses (bacteriophages", "PROBLEM", 158, 181], ["Many mycoplasma viruses", "PROBLEM", 201, 224], ["classical bacteriophages", "PROBLEM", 234, 258], ["wall-covered bacteria", "PROBLEM", 285, 306], ["an enveloped spherial shape", "PROBLEM", 329, 356], ["internal structure", "PROBLEM", 371, 389], ["MV", "TEST", 399, 401], ["L172 strains", "PROBLEM", 408, 420], ["A. laidlawii", "TREATMENT", 426, 438], ["animal viruses", "PROBLEM", 449, 463], ["mycoplasma viruses", "OBSERVATION", 6, 24], ["different species", "OBSERVATION_MODIFIER", 36, 53], ["Mycoplasma genus", "OBSERVATION", 61, 77], ["mycoplasmas", "OBSERVATION", 143, 154], ["mycoplasma viruses", "OBSERVATION", 206, 224], ["bacteria", "OBSERVATION", 298, 306], ["enveloped", "OBSERVATION_MODIFIER", 332, 341], ["spherial shape", "OBSERVATION", 342, 356], ["internal structure", "OBSERVATION", 371, 389], ["L2", "ANATOMY", 402, 404]]], ["Moreover, they are released from infected cells by budding from the plasma membrane [78] , an impossible process for viruses released from rigid, wall-covered cells, such as eubacteria or fungi.", [["cells", "ANATOMY", 42, 47], ["plasma membrane", "ANATOMY", 68, 83], ["wall", "ANATOMY", 146, 150], ["cells", "ANATOMY", 159, 164], ["cells", "CELL", 42, 47], ["plasma membrane", "CELLULAR_COMPONENT", 68, 83], ["cells", "CELL", 159, 164], ["infected cells", "CELL_TYPE", 33, 47], ["rigid, wall-covered cells", "CELL_TYPE", 139, 164], ["infected cells", "PROBLEM", 33, 47], ["the plasma membrane", "TEST", 64, 83], ["viruses", "PROBLEM", 117, 124], ["rigid, wall-covered cells", "PROBLEM", 139, 164], ["eubacteria", "PROBLEM", 174, 184], ["fungi", "PROBLEM", 188, 193], ["infected cells", "OBSERVATION", 33, 47], ["viruses", "OBSERVATION", 117, 124], ["fungi", "OBSERVATION", 188, 193]]], ["Spiroplasma virus SpV1 resembles E. coli virus M 13 not only because the two viruses are rod shaped and have double stranded, circular DNA genome, but also because they are lytic and their morphogenesis occurs when the DNA moves through the cell envelope [81] .Infection of mycoplasmas by viruses (bacteriophages) is well documentedMycoplasma viruses, like other bacteriophages, can persist in two types of carrier states: lysogeny and persistent infection [78] .Infection of mycoplasmas by viruses (bacteriophages) is well documentedThe old classification of Cole [19] was essentially morphological and listed viruses in four groups: a) Rod-shaped viruses (group L1) with MV-L1 strain as prototype, b) Spherieal enveloped viruses (group L2) with MV-L2 strain as prototype, c) Short-tailed polyhedral viruses (group L3) with MV-L3 strain as prototype, and d) Long-tailed polyhedral viruses (group L2) with S. cirri virus SpV2, as prototype.", [["cell", "ANATOMY", 241, 245], ["Mycoplasma viruses", "DISEASE", 332, 350], ["infection", "DISEASE", 447, 456], ["Spiroplasma virus SpV1", "ORGANISM", 0, 22], ["E. coli virus M 13", "ORGANISM", 33, 51], ["DNA", "CELLULAR_COMPONENT", 135, 138], ["DNA", "CELLULAR_COMPONENT", 219, 222], ["cell", "CELL", 241, 245], ["mycoplasmas", "ORGANISM", 274, 285], ["Mycoplasma viruses", "ORGANISM", 332, 350], ["mycoplasmas", "ORGANISM", 476, 487], ["Spherieal enveloped viruses", "ORGANISM", 703, 730], ["S. cirri virus", "ORGANISM", 906, 920], ["SpV2", "ORGANISM", 921, 925], ["circular DNA genome", "DNA", 126, 145], ["Spiroplasma virus", "SPECIES", 0, 17], ["E. coli virus", "SPECIES", 33, 46], ["S. cirri virus", "SPECIES", 906, 920], ["Spiroplasma virus", "SPECIES", 0, 17], ["E. coli", "SPECIES", 33, 40], ["Mycoplasma viruses", "SPECIES", 332, 350], ["MV", "SPECIES", 673, 675], ["MV", "SPECIES", 747, 749], ["MV", "SPECIES", 825, 827], ["Long-tailed polyhedral viruses", "SPECIES", 859, 889], ["S. cirri virus", "SPECIES", 906, 920], ["Spiroplasma virus SpV1", "PROBLEM", 0, 22], ["E. coli virus M", "PROBLEM", 33, 48], ["the two viruses", "PROBLEM", 69, 84], ["double stranded, circular DNA genome", "PROBLEM", 109, 145], ["Infection of mycoplasmas", "PROBLEM", 261, 285], ["viruses (bacteriophages", "PROBLEM", 289, 312], ["Mycoplasma viruses", "PROBLEM", 332, 350], ["persistent infection", "PROBLEM", 436, 456], ["Infection of mycoplasmas", "PROBLEM", 463, 487], ["viruses (bacteriophages", "PROBLEM", 491, 514], ["essentially morphological", "PROBLEM", 574, 599], ["a) Rod-shaped viruses", "PROBLEM", 635, 656], ["MV", "TEST", 673, 675], ["L1 strain", "PROBLEM", 676, 685], ["Spherieal enveloped viruses", "PROBLEM", 703, 730], ["MV", "TEST", 747, 749], ["L2 strain", "PROBLEM", 750, 759], ["Short-tailed polyhedral viruses", "PROBLEM", 777, 808], ["MV", "TEST", 825, 827], ["L3 strain", "PROBLEM", 828, 837], ["Long-tailed polyhedral viruses (group L2", "TREATMENT", 859, 899], ["S. cirri virus SpV2", "PROBLEM", 906, 925], ["coli virus", "OBSERVATION", 36, 46], ["viruses", "OBSERVATION", 77, 84], ["rod shaped", "OBSERVATION", 89, 99], ["double stranded", "OBSERVATION_MODIFIER", 109, 124], ["circular", "OBSERVATION_MODIFIER", 126, 134], ["DNA genome", "OBSERVATION", 135, 145], ["lytic", "OBSERVATION", 173, 178], ["mycoplasmas", "OBSERVATION", 274, 285], ["Mycoplasma viruses", "OBSERVATION", 332, 350], ["persistent", "OBSERVATION_MODIFIER", 436, 446], ["infection", "OBSERVATION", 447, 456], ["mycoplasmas", "OBSERVATION", 476, 487], ["viruses", "OBSERVATION", 649, 656], ["viruses", "OBSERVATION", 723, 730], ["polyhedral viruses", "OBSERVATION", 790, 808], ["L3", "ANATOMY", 828, 830], ["polyhedral viruses", "OBSERVATION", 871, 889]]], ["It should be noted, however, that for some of these groups the \"prototype\" strain is the only known isolate.Infection of mycoplasmas by viruses (bacteriophages) is well documentedThe most recent, modern classifications [64] [65] [66] of mycoplasma viruses take into account the biophysical and biochemical properties of these viruses.", [["mycoplasmas", "ORGANISM", 121, 132], ["mycoplasma viruses", "ORGANISM", 237, 255], ["Infection of mycoplasmas", "PROBLEM", 108, 132], ["viruses (bacteriophages", "PROBLEM", 136, 159], ["mycoplasma viruses", "PROBLEM", 237, 255], ["mycoplasmas", "OBSERVATION", 121, 132], ["viruses", "OBSERVATION", 326, 333]]], ["Our present knowledge of some well characterized mycoplasma viruses is summarized in Table 1 .Infection of mycoplasmas by viruses (bacteriophages) is well documentedAn important question in connection with mycoplasma viruses is whether or not the virus infection may eventually affect the pathogenicity of the infected mycoplasmas [78] .", [["mycoplasma viruses", "DISEASE", 49, 67], ["mycoplasma viruses", "DISEASE", 206, 224], ["infection", "DISEASE", 253, 262], ["mycoplasmas", "ORGANISM", 107, 118], ["mycoplasma viruses", "ORGANISM", 206, 224], ["some well characterized mycoplasma viruses", "PROBLEM", 25, 67], ["Infection of mycoplasmas", "PROBLEM", 94, 118], ["viruses (bacteriophages", "PROBLEM", 122, 145], ["mycoplasma viruses", "PROBLEM", 206, 224], ["the virus infection", "PROBLEM", 243, 262], ["the infected mycoplasmas", "PROBLEM", 306, 330], ["mycoplasma viruses", "OBSERVATION", 49, 67], ["mycoplasmas", "OBSERVATION", 107, 118], ["infected", "OBSERVATION_MODIFIER", 310, 318]]], ["The most convincing evidence of such an effect came from spiroplasmas.", [["spiroplasmas", "SIMPLE_CHEMICAL", 57, 69], ["spiroplasmas", "PROBLEM", 57, 69], ["most convincing evidence of", "UNCERTAINTY", 4, 31], ["effect", "OBSERVATION", 40, 46]]], ["It was shown that transmission of S. cirri infected by virus strain ai to periwinkle plants (Catharantus reseus) already infected with a highly pathogenic S. cirri resulted in suppression of symptoms and reduction in the [66] bAccording to Francki et al. [29] and Renaudin and Bov6 [81] number of viable spiroplasmas [1] .", [["spiroplasmas", "ANATOMY", 304, 316], ["cirri", "CHEMICAL", 158, 163], ["S. cirri", "ORGANISM", 34, 42], ["periwinkle plants", "ORGANISM", 74, 91], ["Catharantus reseus", "ORGANISM", 93, 111], ["S. cirri", "ORGANISM", 155, 163], ["Renaudin", "SIMPLE_CHEMICAL", 264, 272], ["S. cirri", "SPECIES", 34, 42], ["Catharantus reseus", "SPECIES", 93, 111], ["S. cirri", "SPECIES", 155, 163], ["S. cirri", "SPECIES", 34, 42], ["Catharantus reseus", "SPECIES", 93, 111], ["S. cirri", "SPECIES", 155, 163], ["S. cirri infected", "PROBLEM", 34, 51], ["symptoms", "PROBLEM", 191, 199], ["Francki et al.", "TEST", 240, 254], ["Renaudin", "TEST", 264, 272], ["reduction", "OBSERVATION_MODIFIER", 204, 213]]], ["However, the use of this competitive effect to control \"stubborn\" disease of Citrus [82] has never been seriously considered.Infection of mycoplasmas by viruses (bacteriophages) is well documentedAnother example of modified spiroplasma pathogenicity as a consequence of virus infection concerns the sex ratio organism (spiroplasma) responsible for male lethality in Drosophila.", [["Citrus [82]", "CHEMICAL", 77, 88], ["infection", "DISEASE", 276, 285], ["mycoplasmas", "ORGANISM", 138, 149], ["spiroplasma", "CANCER", 224, 235], ["spiroplasma", "ORGANISM_SUBDIVISION", 319, 330], ["Drosophila", "ORGANISM", 366, 376], ["Drosophila", "SPECIES", 366, 376], ["Drosophila", "SPECIES", 366, 376], ["\"stubborn\" disease of Citrus", "PROBLEM", 55, 83], ["Infection of mycoplasmas", "PROBLEM", 125, 149], ["viruses (bacteriophages", "PROBLEM", 153, 176], ["modified spiroplasma pathogenicity", "PROBLEM", 215, 249], ["virus infection", "PROBLEM", 270, 285], ["the sex ratio organism (spiroplasma", "PROBLEM", 295, 330], ["male lethality in Drosophila", "PROBLEM", 348, 376], ["mycoplasmas", "OBSERVATION", 138, 149], ["spiroplasma pathogenicity", "OBSERVATION", 224, 249], ["lethality", "OBSERVATION", 353, 362]]], ["Virus infection of this SRO spiroplasma by SRO viruses resulted in lysis of the microorganism and the infection to be cured [ 10t] .Infection of mycoplasmas by viruses (bacteriophages) is well documentedIt is probable that other bacteriophages may affect the pathogenic power of mycoplasmas either by inducing variations in surface antigens, secretion of toxins, or more simply by killing the mycoplasma in situ [78] .Animal diseasesInfectious diseases of multiple aetiology are frequent in veterinary medicine.", [["surface", "ANATOMY", 324, 331], ["Virus infection", "DISEASE", 0, 15], ["infection", "DISEASE", 102, 111], ["mycoplasma", "DISEASE", 393, 403], ["Infectious diseases of multiple aetiology", "DISEASE", 433, 474], ["Virus", "ORGANISM", 0, 5], ["SRO spiroplasma", "ORGANISM", 24, 39], ["SRO viruses", "ORGANISM", 43, 54], ["mycoplasmas", "ORGANISM", 145, 156], ["mycoplasmas", "ORGANISM", 279, 290], ["surface antigens", "GENE_OR_GENE_PRODUCT", 324, 340], ["surface antigens", "PROTEIN", 324, 340], ["Virus infection", "PROBLEM", 0, 15], ["this SRO spiroplasma", "PROBLEM", 19, 39], ["SRO viruses", "PROBLEM", 43, 54], ["lysis", "TREATMENT", 67, 72], ["the microorganism", "PROBLEM", 76, 93], ["the infection", "PROBLEM", 98, 111], ["Infection of mycoplasmas", "PROBLEM", 132, 156], ["viruses (bacteriophages", "PROBLEM", 160, 183], ["other bacteriophages", "PROBLEM", 223, 243], ["mycoplasmas", "PROBLEM", 279, 290], ["inducing variations in surface antigens", "PROBLEM", 301, 340], ["secretion of toxins", "PROBLEM", 342, 361], ["Animal diseasesInfectious diseases of multiple aetiology", "PROBLEM", 418, 474], ["lysis", "OBSERVATION", 67, 72], ["infection", "OBSERVATION", 102, 111], ["mycoplasmas", "OBSERVATION", 145, 156], ["probable", "UNCERTAINTY", 209, 217], ["bacteriophages", "OBSERVATION", 229, 243], ["mycoplasmas", "OBSERVATION", 279, 290], ["mycoplasma", "OBSERVATION", 393, 403], ["diseases", "OBSERVATION", 425, 433], ["multiple", "OBSERVATION_MODIFIER", 456, 464]]], ["Those which associate mycoplasmas and viruses pose difficult problems because it is very hard if not impossible to assess the actual role played by each agent acting as a part of the \"pathogenic complex\": interference, indifference, facilitation, synergy or, more simply, addition of the damaging effects of individual pathogens.Animal diseasesIn this respect, the muddled aetiology of the \"avian respiratory disease complex\", reviewed by Jordan [48] , represents a paradigm.", [["respiratory", "ANATOMY", 397, 408], ["avian respiratory disease", "DISEASE", 391, 416], ["mycoplasmas", "PROBLEM", 22, 33], ["difficult problems", "PROBLEM", 51, 69], ["individual pathogens", "PROBLEM", 308, 328], ["Animal diseases", "PROBLEM", 329, 344], ["the \"avian respiratory disease complex", "PROBLEM", 386, 424], ["mycoplasmas", "OBSERVATION", 22, 33], ["diseases", "OBSERVATION", 336, 344], ["respiratory disease", "OBSERVATION", 397, 416]]], ["At least four different pathogens could be involved, either alone or in combination: Newcastle disease (ND) virus, a paramyxovirus, infectious bronchitis (IB) virus, a coronavirus, infectious laryngotracheitis (ILT) virus, a herpesvirus, M. gallisepticum and, eventually, other mycoplasmas, avian reoviruses and adenoviruses.", [["Newcastle disease (ND) virus", "DISEASE", 85, 113], ["paramyxovirus", "DISEASE", 117, 130], ["infectious bronchitis (IB) virus", "DISEASE", 132, 164], ["coronavirus", "DISEASE", 168, 179], ["infectious laryngotracheitis", "DISEASE", 181, 209], ["herpesvirus", "DISEASE", 225, 236], ["avian reoviruses", "DISEASE", 291, 307], ["Newcastle disease (ND) virus", "ORGANISM", 85, 113], ["infectious bronchitis", "ORGANISM", 132, 153], ["infectious laryngotracheitis (ILT) virus", "ORGANISM", 181, 221], ["herpesvirus", "ORGANISM", 225, 236], ["M. gallisepticum", "ORGANISM", 238, 254], ["avian reoviruses", "ORGANISM", 291, 307], ["adenoviruses", "ORGANISM", 312, 324], ["coronavirus", "SPECIES", 168, 179], ["M. gallisepticum", "SPECIES", 238, 254], ["avian", "SPECIES", 291, 296], ["Newcastle disease (ND) virus", "SPECIES", 85, 113], ["infectious bronchitis (IB) virus", "SPECIES", 132, 164], ["infectious laryngotracheitis (ILT) virus", "SPECIES", 181, 221], ["M. gallisepticum", "SPECIES", 238, 254], ["Newcastle disease (ND) virus", "PROBLEM", 85, 113], ["a paramyxovirus", "PROBLEM", 115, 130], ["infectious bronchitis (IB) virus", "PROBLEM", 132, 164], ["a coronavirus", "PROBLEM", 166, 179], ["infectious laryngotracheitis (ILT) virus", "PROBLEM", 181, 221], ["a herpesvirus, M. gallisepticum", "PROBLEM", 223, 254], ["other mycoplasmas, avian reoviruses", "PROBLEM", 272, 307], ["adenoviruses", "PROBLEM", 312, 324], ["four different", "OBSERVATION_MODIFIER", 9, 23], ["pathogens", "OBSERVATION", 24, 33], ["infectious", "OBSERVATION_MODIFIER", 132, 142], ["bronchitis", "OBSERVATION", 143, 153], ["infectious", "OBSERVATION_MODIFIER", 181, 191]]], ["All the listed viruses, mainly ND virus, may express considerable variation in virulence, from highly pathogenic devastating strains, to very mild ones inducing asymtomatic infections [48] .Animal diseasesFrom epidemiological data and a number of experimental results [21, 51] , it clearly appears that association of respiratory viruses and M. gallisepticum (or other bacteria) results in more severe or prolonged disease for poultry, especially turkeys and broilers.", [["infections", "DISEASE", 173, 183], ["respiratory viruses", "DISEASE", 318, 337], ["ND virus", "ORGANISM", 31, 39], ["M. gallisepticum", "ORGANISM", 342, 358], ["turkeys", "ORGANISM", 447, 454], ["broilers", "ORGANISM_SUBDIVISION", 459, 467], ["M. gallisepticum", "SPECIES", 342, 358], ["turkeys", "SPECIES", 447, 454], ["broilers", "SPECIES", 459, 467], ["ND virus", "SPECIES", 31, 39], ["M. gallisepticum", "SPECIES", 342, 358], ["poultry", "SPECIES", 427, 434], ["turkeys", "SPECIES", 447, 454], ["broilers", "SPECIES", 459, 467], ["mainly ND virus", "PROBLEM", 24, 39], ["virulence", "PROBLEM", 79, 88], ["highly pathogenic devastating strains", "PROBLEM", 95, 132], ["very mild ones inducing asymtomatic infections", "PROBLEM", 137, 183], ["Animal diseases", "PROBLEM", 190, 205], ["epidemiological data", "TEST", 210, 230], ["respiratory viruses", "PROBLEM", 318, 337], ["M. gallisepticum", "PROBLEM", 342, 358], ["other bacteria", "PROBLEM", 363, 377], ["prolonged disease", "PROBLEM", 405, 422], ["viruses", "OBSERVATION", 15, 22], ["diseases", "OBSERVATION", 197, 205], ["respiratory viruses", "OBSERVATION", 318, 337], ["more severe", "OBSERVATION_MODIFIER", 390, 401], ["prolonged", "OBSERVATION_MODIFIER", 405, 414], ["disease", "OBSERVATION", 415, 422]]], ["Thus, viral damage of the tracheal epithelium induced by ND virus enhances the multiplication of M. gallisepticum in the trachea of experimentally infected chickens [21] .", [["tracheal epithelium", "ANATOMY", 26, 45], ["trachea", "ANATOMY", 121, 128], ["tracheal epithelium", "TISSUE", 26, 45], ["ND virus", "ORGANISM", 57, 65], ["M. gallisepticum", "ORGANISM", 97, 113], ["trachea", "ORGAN", 121, 128], ["chickens", "ORGANISM", 156, 164], ["M. gallisepticum", "SPECIES", 97, 113], ["chickens", "SPECIES", 156, 164], ["ND virus", "SPECIES", 57, 65], ["M. gallisepticum", "SPECIES", 97, 113], ["chickens", "SPECIES", 156, 164], ["viral damage of the tracheal epithelium", "PROBLEM", 6, 45], ["ND virus", "PROBLEM", 57, 65], ["M. gallisepticum", "PROBLEM", 97, 113], ["viral damage", "OBSERVATION", 6, 18], ["tracheal epithelium", "ANATOMY", 26, 45], ["M. gallisepticum", "OBSERVATION", 97, 113], ["trachea", "ANATOMY", 121, 128], ["experimentally", "OBSERVATION_MODIFIER", 132, 146], ["infected", "OBSERVATION_MODIFIER", 147, 155]]], ["Likewise, production of prolonged corysa and rales was observed in adult poultry exposed to 1B virus 31 days after infection with M. gallisepticum.", [["infection", "DISEASE", 115, 124], ["1B virus", "ORGANISM", 92, 100], ["M. gallisepticum", "ORGANISM", 130, 146], ["M. gallisepticum", "SPECIES", 130, 146], ["M. gallisepticum", "SPECIES", 130, 146], ["prolonged corysa", "PROBLEM", 24, 40], ["rales", "PROBLEM", 45, 50], ["infection", "PROBLEM", 115, 124], ["M. gallisepticum", "PROBLEM", 130, 146], ["prolonged", "OBSERVATION_MODIFIER", 24, 33], ["gallisepticum", "OBSERVATION", 133, 146]]], ["However, interactions between ILT virus and \"PPLO\" were influence on the course of gallisepticum 24 h previously. hens with M. gallisepticum not documented, and avian reoviruses exerted no the disease in young chickens infected by M. On the contrary, the combined infection of laying and avian adenoviruses caused a fall in egg production greater than that induced by viruses alone, suggesting a synergistic effect [6] .", [["reoviruses", "ANATOMY", 167, 177], ["egg", "ANATOMY", 324, 327], ["infection", "DISEASE", 264, 273], ["ILT virus", "ORGANISM", 30, 39], ["PPLO", "GENE_OR_GENE_PRODUCT", 45, 49], ["M. gallisepticum", "ORGANISM", 124, 140], ["avian reoviruses", "ORGANISM", 161, 177], ["chickens", "ORGANISM", 210, 218], ["avian", "ORGANISM", 288, 293], ["adenoviruses", "ORGANISM", 294, 306], ["egg", "ORGANISM_SUBSTANCE", 324, 327], ["M. gallisepticum", "SPECIES", 124, 140], ["chickens", "SPECIES", 210, 218], ["avian", "SPECIES", 288, 293], ["gallisepticum", "SPECIES", 83, 96], ["M. gallisepticum", "SPECIES", 124, 140], ["chickens", "SPECIES", 210, 218], ["ILT virus", "PROBLEM", 30, 39], ["M. gallisepticum", "PROBLEM", 124, 140], ["the disease", "PROBLEM", 189, 200], ["the combined infection", "PROBLEM", 251, 273], ["avian adenoviruses", "TREATMENT", 288, 306], ["a fall in egg production", "PROBLEM", 314, 338], ["disease", "OBSERVATION", 193, 200], ["infection", "OBSERVATION", 264, 273], ["fall", "OBSERVATION", 316, 320], ["viruses", "OBSERVATION", 368, 375]]], ["Consequences of an eventual decrease in interferon synthesis or a possible immunosuppressive effect of mycoplasma infection on the course of viral diseases of poultry were not considered in the Jordan's review [48] .C. ChastelMore recently, according to a large serological survey which included 71 California meat-turkey flocks, it was demonstrated that flocks where antibodies to ND virus and/or Mycoplasma meleagridis were detected, had an increased risk of outbreak of fowl cholera [11] .C. ChastelConcerning the \"endemic calf pneumonia\", an enzootic pneumonia with high mortality occurring primarily in housed dairy calves, it was established that infections with bovine respiratory syncytial virus and parainfluenza type 3 virus are followed by secondary, sometimes fatal, invasion of the lungs by mycoplasmas.", [["lungs", "ANATOMY", 795, 800], ["mycoplasma infection", "DISEASE", 103, 123], ["viral diseases", "DISEASE", 141, 155], ["fowl cholera", "DISEASE", 473, 485], ["pneumonia", "DISEASE", 531, 540], ["pneumonia", "DISEASE", 555, 564], ["infections", "DISEASE", 653, 663], ["bovine respiratory syncytial virus", "DISEASE", 669, 703], ["parainfluenza type 3 virus", "DISEASE", 708, 734], ["invasion of the lungs", "DISEASE", 779, 800], ["interferon", "GENE_OR_GENE_PRODUCT", 40, 50], ["meat", "ORGANISM_SUBDIVISION", 310, 314], ["ND virus", "ORGANISM", 382, 390], ["Mycoplasma meleagridis", "ORGANISM", 398, 420], ["fowl cholera", "ORGANISM", 473, 485], ["calf", "ORGANISM_SUBDIVISION", 526, 530], ["calves", "ORGANISM", 621, 627], ["bovine", "ORGANISM", 669, 675], ["respiratory syncytial virus", "ORGANISM", 676, 703], ["parainfluenza type 3 virus", "ORGANISM", 708, 734], ["lungs", "ORGAN", 795, 800], ["interferon", "PROTEIN", 40, 50], ["antibodies", "PROTEIN", 368, 378], ["meat-turkey", "SPECIES", 310, 321], ["Mycoplasma meleagridis", "SPECIES", 398, 420], ["fowl cholera", "SPECIES", 473, 485], ["calf", "SPECIES", 526, 530], ["calves", "SPECIES", 621, 627], ["bovine", "SPECIES", 669, 675], ["respiratory syncytial virus", "SPECIES", 676, 703], ["parainfluenza type 3 virus", "SPECIES", 708, 734], ["ND virus", "SPECIES", 382, 390], ["Mycoplasma meleagridis", "SPECIES", 398, 420], ["fowl cholera", "SPECIES", 473, 485], ["bovine respiratory syncytial virus", "SPECIES", 669, 703], ["parainfluenza type 3 virus", "SPECIES", 708, 734], ["an eventual decrease", "PROBLEM", 16, 36], ["interferon synthesis", "TREATMENT", 40, 60], ["mycoplasma infection", "PROBLEM", 103, 123], ["viral diseases of poultry", "PROBLEM", 141, 166], ["a large serological survey", "TEST", 254, 280], ["antibodies", "PROBLEM", 368, 378], ["ND virus", "PROBLEM", 382, 390], ["Mycoplasma meleagridis", "PROBLEM", 398, 420], ["the \"endemic calf pneumonia", "PROBLEM", 513, 540], ["an enzootic pneumonia", "PROBLEM", 543, 564], ["high mortality", "PROBLEM", 570, 584], ["infections", "PROBLEM", 653, 663], ["bovine respiratory syncytial virus", "PROBLEM", 669, 703], ["parainfluenza type 3 virus", "PROBLEM", 708, 734], ["invasion of the lungs", "PROBLEM", 779, 800], ["mycoplasmas", "PROBLEM", 804, 815], ["decrease", "OBSERVATION_MODIFIER", 28, 36], ["interferon synthesis", "OBSERVATION", 40, 60], ["mycoplasma", "OBSERVATION_MODIFIER", 103, 113], ["infection", "OBSERVATION", 114, 123], ["increased", "OBSERVATION_MODIFIER", 443, 452], ["endemic", "OBSERVATION_MODIFIER", 518, 525], ["calf", "ANATOMY", 526, 530], ["pneumonia", "OBSERVATION", 531, 540], ["enzootic", "OBSERVATION_MODIFIER", 546, 554], ["pneumonia", "OBSERVATION", 555, 564], ["high mortality", "OBSERVATION_MODIFIER", 570, 584], ["respiratory syncytial virus", "OBSERVATION", 676, 703], ["lungs", "ANATOMY", 795, 800], ["mycoplasmas", "OBSERVATION", 804, 815]]], ["However, pneumotropic species of mycoplasmas isolated from calves i.e., M. boris, M. dispar and Ureaplasma dispar, can be pathogenic for calves in the absence of viruses or other bacteria [9] .", [["Ureaplasma dispar", "DISEASE", 96, 113], ["mycoplasmas", "ORGANISM", 33, 44], ["calves", "ORGANISM", 59, 65], ["M. boris", "ORGANISM", 72, 80], ["M. dispar", "ORGANISM", 82, 91], ["Ureaplasma dispar", "ORGANISM", 96, 113], ["calves", "ORGANISM", 137, 143], ["calves", "SPECIES", 59, 65], ["M. boris", "SPECIES", 72, 80], ["M. dispar", "SPECIES", 82, 91], ["Ureaplasma dispar", "SPECIES", 96, 113], ["calves", "SPECIES", 137, 143], ["M. boris", "SPECIES", 72, 80], ["M. dispar", "SPECIES", 82, 91], ["Ureaplasma dispar", "SPECIES", 96, 113], ["pneumotropic species", "PROBLEM", 9, 29], ["mycoplasmas", "PROBLEM", 33, 44], ["Ureaplasma dispar", "PROBLEM", 96, 113], ["calves", "PROBLEM", 137, 143], ["viruses", "PROBLEM", 162, 169], ["other bacteria", "PROBLEM", 173, 187], ["mycoplasmas isolated", "OBSERVATION", 33, 53]]], ["Thus, in this bovine disease the role of respiratory mycoplasmas and other bacteria (PasteurelIa, Haemophilus) seems limited to a secondary aggravation of the viral pathology.C. ChastelLikewise, \"Enzootic pneumonia of swine\" occurs worldwide with a high morbidity (30 to 80}/o) but a near zero mortality in slaughter pigs.", [["respiratory mycoplasmas", "DISEASE", 41, 64], ["pneumonia", "DISEASE", 205, 214], ["bovine", "ORGANISM", 14, 20], ["respiratory mycoplasmas", "ORGANISM", 41, 64], ["pigs", "ORGANISM", 317, 321], ["bovine", "SPECIES", 14, 20], ["swine", "SPECIES", 218, 223], ["pigs", "SPECIES", 317, 321], ["swine", "SPECIES", 218, 223], ["this bovine disease", "PROBLEM", 9, 28], ["respiratory mycoplasmas", "PROBLEM", 41, 64], ["other bacteria (PasteurelIa", "PROBLEM", 69, 96], ["Haemophilus", "PROBLEM", 98, 109], ["the viral pathology", "PROBLEM", 155, 174], ["Enzootic pneumonia of swine\"", "PROBLEM", 196, 224], ["a high morbidity", "PROBLEM", 247, 263], ["respiratory mycoplasmas", "OBSERVATION", 41, 64], ["viral pathology", "OBSERVATION", 159, 174], ["Enzootic", "OBSERVATION_MODIFIER", 196, 204], ["pneumonia", "OBSERVATION", 205, 214]]], ["The primary aetiological agent, M. hyopneumoniae (formerly M. suipneumoniae) was not described until 1967 [36] .", [["M. hyopneumoniae", "ORGANISM", 32, 48], ["M. suipneumoniae", "ORGANISM", 59, 75], ["M. hyopneumoniae", "SPECIES", 32, 48], ["M. suipneumoniae", "SPECIES", 59, 75], ["M. hyopneumoniae", "SPECIES", 32, 48], ["M. suipneumoniae", "SPECIES", 59, 75], ["M. hyopneumoniae", "PROBLEM", 32, 48], ["hyopneumoniae", "OBSERVATION", 35, 48]]], ["The disease is frequently complicated by viral or bacterial infections which can exacerbate the generally mild symptoms due to the mycoplasma.C. ChastelAnother example of complex interrelations between mycoplasmas and viruses in animal pathology concerns the massive death in seals (pinnipeds) recently observed in Europe, Asia and the USA.", [["viral or bacterial infections", "DISEASE", 41, 70], ["mycoplasma", "DISEASE", 131, 141], ["mycoplasmas and viruses", "DISEASE", 202, 225], ["death", "DISEASE", 267, 272], ["C. Chastel", "SPECIES", 142, 152], ["The disease", "PROBLEM", 0, 11], ["viral or bacterial infections", "PROBLEM", 41, 70], ["the generally mild symptoms", "PROBLEM", 92, 119], ["the mycoplasma", "PROBLEM", 127, 141], ["complex interrelations", "PROBLEM", 171, 193], ["mycoplasmas", "PROBLEM", 202, 213], ["viruses", "PROBLEM", 218, 225], ["the massive death in seals", "PROBLEM", 255, 281], ["disease", "OBSERVATION", 4, 11], ["viral", "OBSERVATION", 41, 46], ["bacterial", "OBSERVATION_MODIFIER", 50, 59], ["infections", "OBSERVATION", 60, 70], ["mild", "OBSERVATION_MODIFIER", 106, 110], ["mycoplasma", "OBSERVATION", 131, 141], ["complex", "OBSERVATION_MODIFIER", 171, 178], ["mycoplasmas", "OBSERVATION", 202, 213], ["viruses", "OBSERVATION_MODIFIER", 218, 225], ["massive", "OBSERVATION_MODIFIER", 259, 266], ["death", "OBSERVATION", 267, 272], ["seals", "OBSERVATION_MODIFIER", 276, 281]]], ["During the summer of 1988, about 18000 harbor seals (Phoca vitulina) died of pneumonia during an epizootic occurring in the North sea and Baltic sea [23, 24] .", [["pneumonia", "DISEASE", 77, 86], ["Phoca vitulina", "ORGANISM", 53, 67], ["Phoca vitulina", "SPECIES", 53, 67], ["Phoca vitulina", "SPECIES", 53, 67], ["pneumonia", "PROBLEM", 77, 86], ["pneumonia", "OBSERVATION", 77, 86], ["epizootic", "OBSERVATION_MODIFIER", 97, 106]]], ["The cause of the disease was a \"new\" morbillivirus closely related to canine distemper virus, called phocine distemper virus (PDV) [74] .", [["canine distemper virus", "DISEASE", 70, 92], ["canine distemper virus", "ORGANISM", 70, 92], ["phocine distemper virus", "ORGANISM", 101, 124], ["canine distemper virus", "SPECIES", 70, 92], ["phocine distemper virus", "SPECIES", 101, 124], ["canine distemper virus", "SPECIES", 70, 92], ["phocine distemper virus", "SPECIES", 101, 124], ["PDV", "SPECIES", 126, 129], ["the disease", "PROBLEM", 13, 24], ["a \"new\" morbillivirus", "PROBLEM", 29, 50], ["canine distemper virus", "PROBLEM", 70, 92], ["disease", "OBSERVATION", 17, 24]]], ["PDV was also found infecting grey seals (Halichoerus grypus).", [["PDV", "ORGANISM", 0, 3], ["Halichoerus grypus", "ORGANISM", 41, 59], ["Halichoerus grypus", "SPECIES", 41, 59], ["PDV", "SPECIES", 0, 3], ["grey seals", "SPECIES", 29, 39], ["Halichoerus grypus", "SPECIES", 41, 59], ["infecting", "OBSERVATION_MODIFIER", 19, 28], ["grey seals", "OBSERVATION", 29, 39]]], ["Interestingly, in the former U.S.S.R., another mass death related to a morbillivirus has been previously reported from Lake Baikal seals (Phoca sibirica) in 1987 [40] .", [["death", "DISEASE", 52, 57], ["morbillivirus", "CHEMICAL", 71, 84], ["morbillivirus", "CANCER", 71, 84], ["Phoca sibirica", "ORGANISM", 138, 152], ["Phoca sibirica", "SPECIES", 138, 152], ["Baikal seals", "SPECIES", 124, 136], ["Phoca sibirica", "SPECIES", 138, 152], ["another mass death", "PROBLEM", 39, 57], ["a morbillivirus", "PROBLEM", 69, 84], ["mass", "OBSERVATION", 47, 51], ["morbillivirus", "OBSERVATION", 71, 84]]], ["Since serological surveys have shown that canine distemper virus antibody was prevalent in crabeater seals (Labodon carcinophagus) in the Antartic [5] , the viral aetiology of these massive epizootics was largely accepted.", [["epizootics", "DISEASE", 190, 200], ["canine distemper virus", "ORGANISM", 42, 64], ["crabeater seals", "ORGANISM", 91, 106], ["Labodon carcinophagus", "ORGANISM", 108, 129], ["canine distemper virus", "SPECIES", 42, 64], ["Labodon carcinophagus", "SPECIES", 108, 129], ["canine distemper virus", "SPECIES", 42, 64], ["crabeater seals", "SPECIES", 91, 106], ["Labodon carcinophagus", "SPECIES", 108, 129], ["serological surveys", "TEST", 6, 25], ["canine distemper virus antibody", "TEST", 42, 73], ["these massive epizootics", "PROBLEM", 176, 200], ["distemper virus", "OBSERVATION", 49, 64], ["massive", "OBSERVATION_MODIFIER", 182, 189], ["epizootics", "OBSERVATION", 190, 200]]], ["This appeared particularly founded because, in 1979 and 1980, an epizootic of pneumonia has killed at least 445 harbor seals along the New England seabord, in northeastern USA, during which an influenza virus (A/Seat/Mass/i/80) has been isolated from the lungs of deceased seals [33] .C. ChastelThis conclusion, however, may have to be revised.", [["lungs", "ANATOMY", 255, 260], ["pneumonia", "DISEASE", 78, 87], ["influenza virus", "ORGANISM", 193, 208], ["Mass/i/80", "ORGANISM", 217, 226], ["lungs", "ORGAN", 255, 260], ["A/Seat/Mass/i/80", "SPECIES", 210, 226], ["pneumonia", "PROBLEM", 78, 87], ["an influenza virus", "PROBLEM", 190, 208], ["Mass", "PROBLEM", 217, 221], ["epizootic", "OBSERVATION_MODIFIER", 65, 74], ["pneumonia", "OBSERVATION", 78, 87], ["New", "OBSERVATION_MODIFIER", 135, 138], ["lungs", "ANATOMY", 255, 260]]], ["Several seal herpesviruses were also isolated from pneumonic harbor seals during the 1988 epizootic in northern Europe [30, 73] together with a large number of mycoplasma strains [50] .", [["herpesviruses", "ORGANISM", 13, 26], ["Several seal herpesviruses", "PROBLEM", 0, 26], ["pneumonic harbor seals", "PROBLEM", 51, 73], ["mycoplasma strains", "PROBLEM", 160, 178], ["seal", "OBSERVATION_MODIFIER", 8, 12], ["herpesviruses", "OBSERVATION", 13, 26], ["large", "OBSERVATION_MODIFIER", 144, 149], ["mycoplasma strains", "OBSERVATION", 160, 178]]], ["These mycoplasmas were believed to be responsible for increasing the death rate among seals [50] and soon afterwards they were recognized as two new species named M. phocarhinis and M. phocacerebrale [34] .", [["death", "DISEASE", 69, 74], ["mycoplasmas", "ORGANISM", 6, 17], ["M. phocarhinis", "ORGANISM", 163, 177], ["M. phocacerebrale", "ORGANISM", 182, 199], ["M. phocarhinis", "SPECIES", 163, 177], ["M. phocacerebrale", "SPECIES", 182, 199], ["M. phocarhinis", "SPECIES", 163, 177], ["M. phocacerebrale", "SPECIES", 182, 199], ["These mycoplasmas", "PROBLEM", 0, 17], ["increasing the death rate", "PROBLEM", 54, 79]]], ["Moreover, by a remarkable coincidence, another new species of mycoplasma, M. phocidae, unrelated to the European ones, was isolated from sick harbor seals during the 1979-1980 north-American epizootic [87] .", [["mycoplasma", "DISEASE", 62, 72], ["M. phocidae", "DISEASE", 74, 85], ["M. phocidae", "ORGANISM", 74, 85], ["M. phocidae", "SPECIES", 74, 85], ["M. phocidae", "SPECIES", 74, 85], ["mycoplasma", "PROBLEM", 62, 72]]], ["Howeover, the actual role of M. phocidae in the seal disease remains to be established; it is likely to be minimal [87] .AIDSProbably much more important for the understanding of mycoplasma/virus interactions, at the molecular level, is the hypothesis recently developed in the USA [60] and France [68] concerning an eventual role of human mycoplasmas in the pathogenesis of AIDS.", [["AIDS", "DISEASE", 375, 379], ["M. phocidae", "ORGANISM", 29, 40], ["mycoplasma/virus", "ORGANISM", 179, 195], ["human", "ORGANISM", 334, 339], ["M. phocidae", "SPECIES", 29, 40], ["human", "SPECIES", 334, 339], ["M. phocidae", "SPECIES", 29, 40], ["human", "SPECIES", 334, 339], ["the seal disease", "PROBLEM", 44, 60], ["mycoplasma/virus interactions", "PROBLEM", 179, 208], ["human mycoplasmas", "PROBLEM", 334, 351], ["AIDS", "PROBLEM", 375, 379], ["seal", "ANATOMY", 48, 52], ["disease", "OBSERVATION", 53, 60], ["likely to be", "UNCERTAINTY", 94, 106], ["minimal", "OBSERVATION_MODIFIER", 107, 114]]], ["Indeed, this is not a theoretical debate since it was considered that AIDS is not only a viral disease due to HIV-1 and HIV-2 but essentially a multifactorial infection with multiple overlapping phases and this concept may have important repercussion in therapy [28] .", [["AIDS", "DISEASE", 70, 74], ["viral disease", "DISEASE", 89, 102], ["infection", "DISEASE", 159, 168], ["HIV-1", "ORGANISM", 110, 115], ["HIV-2", "ORGANISM", 120, 125], ["HIV-1", "SPECIES", 110, 115], ["HIV-", "SPECIES", 120, 124], ["HIV-1", "SPECIES", 110, 115], ["HIV-2", "SPECIES", 120, 125], ["AIDS", "PROBLEM", 70, 74], ["a viral disease", "PROBLEM", 87, 102], ["HIV", "PROBLEM", 110, 113], ["HIV", "PROBLEM", 120, 123], ["a multifactorial infection", "PROBLEM", 142, 168], ["viral", "OBSERVATION", 89, 94], ["multifactorial", "OBSERVATION_MODIFIER", 144, 158], ["infection", "OBSERVATION", 159, 168]]], ["Mycoptasmas, as several other bacteria and viruses, could represent certain factors or co-factors operating at different stages of the natural history of the disease [70, 76] .AIDSA number of mycoplasma species such as M. fermentans (incognitus strain), M. penetrans, M. pirum or M. genitalium have been repeatedly detected in or isolated from AIDS and also non-AIDS patients [17, 22, 43, 49, 54, 56, 57, 59] .", [["Mycoptasmas", "DISEASE", 0, 11], ["AIDS", "DISEASE", 344, 348], ["non-AIDS", "DISEASE", 358, 366], ["M. fermentans", "ORGANISM", 219, 232], ["incognitus strain", "ORGANISM", 234, 251], ["M. penetrans", "ORGANISM", 254, 266], ["M. pirum", "ORGANISM", 268, 276], ["M. genitalium", "ORGANISM", 280, 293], ["patients", "ORGANISM", 367, 375], ["M. fermentans", "SPECIES", 219, 232], ["M. penetrans", "SPECIES", 254, 266], ["M. pirum", "SPECIES", 268, 276], ["M. genitalium", "SPECIES", 280, 293], ["patients", "SPECIES", 367, 375], ["M. fermentans", "SPECIES", 219, 232], ["M. penetrans", "SPECIES", 254, 266], ["M. pirum", "SPECIES", 268, 276], ["M. genitalium", "SPECIES", 280, 293], ["Mycoptasmas", "TEST", 0, 11], ["several other bacteria and viruses", "PROBLEM", 16, 50], ["the disease", "PROBLEM", 154, 165], ["mycoplasma species", "PROBLEM", 192, 210], ["M. fermentans", "PROBLEM", 219, 232], ["incognitus strain)", "PROBLEM", 234, 252], ["M. penetrans", "PROBLEM", 254, 266], ["M. genitalium", "PROBLEM", 280, 293], ["viruses", "OBSERVATION", 43, 50], ["mycoplasma species", "OBSERVATION", 192, 210]]], ["Antibodies to M. fermentans were detected with a high frequency in HIVinfected patients [99] .", [["M. fermentans", "ORGANISM", 14, 27], ["patients", "ORGANISM", 79, 87], ["M. fermentans", "SPECIES", 14, 27], ["patients", "SPECIES", 79, 87], ["M. fermentans", "SPECIES", 14, 27], ["Antibodies to M. fermentans", "PROBLEM", 0, 27]]], ["Basically, the metabolism of these mycoplasmas apparently does not differ from that of other, more fully characterized species.", [["these mycoplasmas", "PROBLEM", 29, 46], ["mycoplasmas", "OBSERVATION", 35, 46]]], ["Pollack et al. recently [77] noted that they lack cytochromes, the tricarboxylic acid cycle and portions of the hexose mono-phosphate shunt.", [["tricarboxylic acid", "CHEMICAL", 67, 85], ["mono-phosphate", "CHEMICAL", 119, 133], ["tricarboxylic acid", "CHEMICAL", 67, 85], ["hexose mono-phosphate", "CHEMICAL", 112, 133], ["cytochromes", "GENE_OR_GENE_PRODUCT", 50, 61], ["tricarboxylic acid", "SIMPLE_CHEMICAL", 67, 85], ["hexose mono-phosphate", "SIMPLE_CHEMICAL", 112, 133], ["the tricarboxylic acid cycle", "TEST", 63, 91], ["the hexose mono-phosphate shunt", "TREATMENT", 108, 139], ["mono-phosphate shunt", "OBSERVATION", 119, 139]]], ["Their pathogenic potential might proceed from the generation of toxic oxygenated products that could damage the host cell membrane [77] .", [["cell membrane", "ANATOMY", 117, 130], ["cell membrane", "CELLULAR_COMPONENT", 117, 130], ["toxic oxygenated products", "TREATMENT", 64, 89], ["toxic", "OBSERVATION_MODIFIER", 64, 69], ["oxygenated products", "OBSERVATION", 70, 89], ["host cell membrane", "OBSERVATION", 112, 130]]], ["The question may thus be asked: What is the role of mycoplasmas in AIDS; are they only a part of many opportunistic infectious agents isolated from immunocompromised AIDS patients or synergistic, precipitating co-factors?AIDSFrom a clinical point of view, it was sometimes found that there was a steady link between HIV infection and the presence of M. fermentans or M. pirum in urine [22, 70] or blood [43] of patients, but in other surveys it was observed that M. fermentans occurred in similar proportion among HIV sero-positive and HIV sero-negative patients [49] .", [["urine", "ANATOMY", 379, 384], ["blood", "ANATOMY", 397, 402], ["AIDS", "DISEASE", 67, 71], ["AIDS", "DISEASE", 166, 170], ["HIV infection", "DISEASE", 316, 329], ["patients", "ORGANISM", 171, 179], ["HIV", "ORGANISM", 316, 319], ["M. fermentans", "ORGANISM", 350, 363], ["M. pirum", "ORGANISM", 367, 375], ["urine", "ORGANISM_SUBSTANCE", 379, 384], ["blood", "ORGANISM_SUBSTANCE", 397, 402], ["patients", "ORGANISM", 411, 419], ["M. fermentans", "ORGANISM", 463, 476], ["HIV", "ORGANISM", 514, 517], ["HIV", "ORGANISM", 536, 539], ["patients", "ORGANISM", 554, 562], ["patients", "SPECIES", 171, 179], ["HIV", "SPECIES", 316, 319], ["M. fermentans", "SPECIES", 350, 363], ["M. pirum", "SPECIES", 367, 375], ["patients", "SPECIES", 411, 419], ["M. fermentans", "SPECIES", 463, 476], ["HIV", "SPECIES", 514, 517], ["HIV", "SPECIES", 536, 539], ["patients", "SPECIES", 554, 562], ["HIV", "SPECIES", 316, 319], ["M. fermentans", "SPECIES", 350, 363], ["M. pirum", "SPECIES", 367, 375], ["M. fermentans", "SPECIES", 463, 476], ["HIV", "SPECIES", 514, 517], ["HIV", "SPECIES", 536, 539], ["mycoplasmas", "PROBLEM", 52, 63], ["opportunistic infectious agents", "TREATMENT", 102, 133], ["synergistic", "PROBLEM", 183, 194], ["HIV infection", "PROBLEM", 316, 329], ["M. fermentans", "PROBLEM", 350, 363], ["M. pirum in urine", "TEST", 367, 384], ["blood", "TEST", 397, 402], ["M. fermentans", "PROBLEM", 463, 476], ["HIV sero", "TEST", 536, 544], ["opportunistic", "OBSERVATION_MODIFIER", 102, 115], ["infectious", "OBSERVATION", 116, 126], ["infection", "OBSERVATION", 320, 329]]], ["Moreover, no association was observed between the infection by M. fermentans and the stage of the disease, CD4 count or HIV-load [49] .", [["infection", "DISEASE", 50, 59], ["M. fermentans", "ORGANISM", 63, 76], ["CD4", "GENE_OR_GENE_PRODUCT", 107, 110], ["CD4", "PROTEIN", 107, 110], ["M. fermentans", "SPECIES", 63, 76], ["M. fermentans", "SPECIES", 63, 76], ["the infection", "PROBLEM", 46, 59], ["the disease", "PROBLEM", 94, 105], ["CD4 count", "TEST", 107, 116], ["HIV", "PROBLEM", 120, 123], ["infection", "OBSERVATION", 50, 59], ["disease", "OBSERVATION", 98, 105]]], ["Other authors also find no correlation between M. fermentans infection and HIV clinical stages [43] , an argument against an action of the mycoplasma at a particular stage of the disease.AIDSHowever, the fact [99] that a higher frequency of antibodies to M. fermentans was found in sera from HIV-l-infected patients with AIDS (40~o) than in sera from HIV-l-negative controls (1~o) argues for a possible role of mycoplasmas in the progression of AIDS, a theory advanced as early as 1989 by Lo et al. [54] and developed since 1990 by Montagnier et al. [68, 69] .AIDSIn addition, M. fermentans causes a fatal systemic disease in non-human primates [55] and M. penetrans appears as a possible pathogen since it exhibits a tip-like structure which allows it to attach to and penetrate in human and animal cells [57, 59] .", [["sera", "ANATOMY", 282, 286], ["sera", "ANATOMY", 341, 345], ["cells", "ANATOMY", 800, 805], ["fermentans infection", "DISEASE", 50, 70], ["mycoplasma", "DISEASE", 139, 149], ["HIV-l-infected", "DISEASE", 292, 306], ["AIDS", "DISEASE", 321, 325], ["AIDS", "DISEASE", 445, 449], ["systemic disease", "DISEASE", 606, 622], ["M. fermentans", "ORGANISM", 47, 60], ["M. fermentans", "ORGANISM", 255, 268], ["sera", "ORGANISM_SUBSTANCE", 282, 286], ["HIV-l", "ORGANISM", 292, 297], ["patients", "ORGANISM", 307, 315], ["sera", "ORGANISM_SUBSTANCE", 341, 345], ["HIV-l", "ORGANISM", 351, 356], ["M. fermentans", "ORGANISM", 577, 590], ["non-human", "ORGANISM", 626, 635], ["primates", "ORGANISM", 636, 644], ["M. penetrans", "ORGANISM", 654, 666], ["human", "ORGANISM", 783, 788], ["cells", "CELL", 800, 805], ["antibodies", "PROTEIN", 241, 251], ["human and animal cells", "CELL_TYPE", 783, 805], ["M. fermentans", "SPECIES", 47, 60], ["HIV", "SPECIES", 75, 78], ["M. fermentans", "SPECIES", 255, 268], ["HIV-", "SPECIES", 292, 296], ["patients", "SPECIES", 307, 315], ["HIV", "SPECIES", 351, 354], ["M. fermentans", "SPECIES", 577, 590], ["M. penetrans", "SPECIES", 654, 666], ["human", "SPECIES", 783, 788], ["M. fermentans", "SPECIES", 47, 60], ["HIV", "SPECIES", 75, 78], ["M. fermentans", "SPECIES", 255, 268], ["HIV", "SPECIES", 292, 295], ["HIV", "SPECIES", 351, 354], ["M. fermentans", "SPECIES", 577, 590], ["M. penetrans", "SPECIES", 654, 666], ["human", "SPECIES", 783, 788], ["M. fermentans infection", "PROBLEM", 47, 70], ["HIV clinical stages", "PROBLEM", 75, 94], ["the mycoplasma", "PROBLEM", 135, 149], ["the disease", "PROBLEM", 175, 186], ["a higher frequency of antibodies to M. fermentans", "PROBLEM", 219, 268], ["sera", "TEST", 282, 286], ["HIV", "TEST", 292, 295], ["AIDS", "PROBLEM", 321, 325], ["sera", "TEST", 341, 345], ["HIV", "TEST", 351, 354], ["mycoplasmas", "PROBLEM", 411, 422], ["AIDS", "PROBLEM", 445, 449], ["a fatal systemic disease", "PROBLEM", 598, 622], ["pathogen", "PROBLEM", 689, 697], ["a tip-like structure", "PROBLEM", 716, 736], ["mycoplasma", "OBSERVATION", 139, 149], ["disease", "OBSERVATION", 179, 186], ["mycoplasmas", "OBSERVATION", 411, 422], ["fatal", "OBSERVATION_MODIFIER", 600, 605], ["systemic disease", "OBSERVATION", 606, 622], ["tip", "OBSERVATION_MODIFIER", 718, 721]]], ["Furthermore, M. penetrans is apparently actively transmitted among homosexual males and epidemiologically linked with Kaposi's sarcoma in homosexual men with AIDS, a correlation not observed with another species, M. 9enitalium [100] .AIDSAt the cellular level, it was shown that M. hyorhinis contamination of lymphocyte cultures suppressed the HIV-1 reverse transcriptase (RT) activity [98] whereas the treatment of HIV-1 infected CEM cells with antimycoplasmal tetracyclines resulted in increased RT activity of HIV-1 [52] .", [["Kaposi's sarcoma", "ANATOMY", 118, 134], ["cellular", "ANATOMY", 245, 253], ["lymphocyte cultures", "ANATOMY", 309, 328], ["CEM cells", "ANATOMY", 431, 440], ["Kaposi's sarcoma", "DISEASE", 118, 134], ["AIDS", "DISEASE", 158, 162], ["tetracyclines", "CHEMICAL", 462, 475], ["tetracyclines", "CHEMICAL", 462, 475], ["M. penetrans", "ORGANISM", 13, 25], ["Kaposi's sarcoma", "CANCER", 118, 134], ["men", "ORGANISM", 149, 152], ["cellular", "CELL", 245, 253], ["M. hyorhinis", "ORGANISM", 279, 291], ["lymphocyte cultures", "CELL", 309, 328], ["HIV-1 reverse transcriptase", "GENE_OR_GENE_PRODUCT", 344, 371], ["HIV-1", "ORGANISM", 416, 421], ["CEM cells", "CELL", 431, 440], ["antimycoplasmal tetracyclines", "SIMPLE_CHEMICAL", 446, 475], ["HIV-1", "ORGANISM", 513, 518], ["lymphocyte cultures", "CELL_LINE", 309, 328], ["HIV-1 reverse transcriptase", "PROTEIN", 344, 371], ["CEM cells", "CELL_LINE", 431, 440], ["M. penetrans", "SPECIES", 13, 25], ["men", "SPECIES", 149, 152], ["M. 9enitalium", "SPECIES", 213, 226], ["M. hyorhinis", "SPECIES", 279, 291], ["HIV-1", "SPECIES", 344, 349], ["HIV-1", "SPECIES", 416, 421], ["HIV-1", "SPECIES", 513, 518], ["M. penetrans", "SPECIES", 13, 25], ["M. 9enitalium", "SPECIES", 213, 226], ["M. hyorhinis", "SPECIES", 279, 291], ["HIV-1", "SPECIES", 344, 349], ["HIV-1", "SPECIES", 416, 421], ["HIV-1", "SPECIES", 513, 518], ["Kaposi's sarcoma", "PROBLEM", 118, 134], ["AIDS", "PROBLEM", 158, 162], ["M. hyorhinis contamination", "PROBLEM", 279, 305], ["lymphocyte cultures", "TEST", 309, 328], ["the HIV", "PROBLEM", 340, 347], ["HIV", "PROBLEM", 416, 419], ["infected CEM cells", "PROBLEM", 422, 440], ["antimycoplasmal tetracyclines", "TREATMENT", 446, 475], ["increased RT activity of HIV", "PROBLEM", 488, 516], ["sarcoma", "OBSERVATION", 127, 134], ["infected CEM cells", "OBSERVATION", 422, 440], ["increased", "OBSERVATION_MODIFIER", 488, 497], ["RT activity", "OBSERVATION_MODIFIER", 498, 509]]], ["In fact, it was recently shown that the drastic inhibition of HIV-1 RT as a consequence of mycoplasma contamination was due to a soluble protein with a molecular mass about 70 Kda, present in the particle-free supernatants of contaminated cultures.", [["supernatants", "ANATOMY", 210, 222], ["cultures", "ANATOMY", 239, 247], ["mycoplasma contamination", "DISEASE", 91, 115], ["HIV-1 RT", "ORGANISM", 62, 70], ["mycoplasma", "ORGANISM", 91, 101], ["Kda", "GENE_OR_GENE_PRODUCT", 176, 179], ["soluble protein", "PROTEIN", 129, 144], ["contaminated cultures", "CELL_LINE", 226, 247], ["HIV-1", "SPECIES", 62, 67], ["HIV-1", "SPECIES", 62, 67], ["the drastic inhibition of HIV", "PROBLEM", 36, 65], ["mycoplasma contamination", "PROBLEM", 91, 115], ["a soluble protein", "PROBLEM", 127, 144], ["a molecular mass", "PROBLEM", 150, 166], ["70 Kda", "PROBLEM", 173, 179], ["contaminated cultures", "TEST", 226, 247], ["mass", "OBSERVATION", 162, 166], ["70 Kda", "OBSERVATION_MODIFIER", 173, 179]]], ["This RT-inhibitor had a strong DNase activity on both linear and circular DNas [27] .", [["DNase", "GENE_OR_GENE_PRODUCT", 31, 36], ["DNase", "PROTEIN", 31, 36], ["This RT-inhibitor", "TREATMENT", 0, 17]]], ["Such nuclease activity has been already postulated to explain RT depression observed in mycoplasma contaminated murine hybridoma cell lines producing types A and C retroviral particles [63] .", [["hybridoma cell lines", "ANATOMY", 119, 139], ["depression", "DISEASE", 65, 75], ["murine", "ORGANISM", 112, 118], ["hybridoma cell lines", "CELL", 119, 139], ["nuclease", "PROTEIN", 5, 13], ["mycoplasma contaminated murine hybridoma cell lines", "CELL_LINE", 88, 139], ["murine", "SPECIES", 112, 118], ["Such nuclease activity", "PROBLEM", 0, 22], ["RT depression", "PROBLEM", 62, 75], ["mycoplasma contaminated murine hybridoma cell lines", "TREATMENT", 88, 139], ["types A and C retroviral particles", "PROBLEM", 150, 184], ["hybridoma cell lines", "OBSERVATION", 119, 139]]], ["On the other hand, antibody directed against the binding site of M. 9enitalium inhibited or reduced the infectivity of HIV-1 and HIV-2 in the same cells [69] and an unidentified mycoplasma significantly reduced the CD4 expression, with a consequent inhibition of gp 120 binding and HIV infection in CEM cells [75] .AIDSHowever, mixed infection of A3.01 cells by both M. fermentans and HIV-1 resulted in the disappearence of syncytia but an increased cytocidal effect, despite little or no RT activity and the apparent normal assembly of VIH virions [58] .", [["cells", "ANATOMY", 147, 152], ["CEM cells", "ANATOMY", 299, 308], ["A3.01 cells", "ANATOMY", 347, 358], ["syncytia", "ANATOMY", 424, 432], ["HIV infection", "DISEASE", 282, 295], ["infection", "DISEASE", 334, 343], ["syncytia", "DISEASE", 424, 432], ["M. 9enitalium", "ORGANISM", 65, 78], ["HIV-1", "ORGANISM", 119, 124], ["HIV-2", "ORGANISM", 129, 134], ["cells", "CELL", 147, 152], ["mycoplasma", "ORGANISM", 178, 188], ["CD4", "GENE_OR_GENE_PRODUCT", 215, 218], ["gp 120", "GENE_OR_GENE_PRODUCT", 263, 269], ["HIV", "ORGANISM", 282, 285], ["CEM cells", "CELL", 299, 308], ["A3.01 cells", "CELL", 347, 358], ["M. fermentans", "ORGANISM", 367, 380], ["HIV-1", "ORGANISM", 385, 390], ["syncytia", "CELL", 424, 432], ["VIH", "GENE_OR_GENE_PRODUCT", 537, 540], ["CD4", "PROTEIN", 215, 218], ["gp 120", "PROTEIN", 263, 269], ["CEM cells", "CELL_LINE", 299, 308], ["A3.01 cells", "CELL_LINE", 347, 358], ["M. 9enitalium", "SPECIES", 65, 78], ["HIV-1", "SPECIES", 119, 124], ["HIV-2", "SPECIES", 129, 134], ["M. fermentans", "SPECIES", 367, 380], ["HIV-1", "SPECIES", 385, 390], ["M. 9enitalium", "SPECIES", 65, 78], ["HIV-1", "SPECIES", 119, 124], ["HIV-2", "SPECIES", 129, 134], ["HIV", "SPECIES", 282, 285], ["M. fermentans", "SPECIES", 367, 380], ["HIV-1", "SPECIES", 385, 390], ["antibody", "TREATMENT", 19, 27], ["HIV", "TEST", 119, 122], ["HIV", "TEST", 129, 132], ["an unidentified mycoplasma", "PROBLEM", 162, 188], ["a consequent inhibition of gp 120 binding", "PROBLEM", 236, 277], ["HIV infection in CEM cells", "PROBLEM", 282, 308], ["mixed infection of A3.01 cells", "PROBLEM", 328, 358], ["M. fermentans", "TEST", 367, 380], ["HIV", "PROBLEM", 385, 388], ["syncytia", "PROBLEM", 424, 432], ["an increased cytocidal effect", "PROBLEM", 437, 466], ["RT activity", "PROBLEM", 489, 500], ["mycoplasma", "OBSERVATION", 178, 188], ["CD4 expression", "OBSERVATION", 215, 229], ["mixed", "OBSERVATION_MODIFIER", 328, 333], ["infection", "OBSERVATION", 334, 343], ["syncytia", "OBSERVATION", 424, 432], ["increased", "OBSERVATION_MODIFIER", 440, 449], ["cytocidal effect", "OBSERVATION", 450, 466]]], ["A synergy in cell killing was also observed in U937 cells doubly infected with M. fermentans and HIV-t or HIV-2 [53] .", [["cell", "ANATOMY", 13, 17], ["U937 cells", "ANATOMY", 47, 57], ["cell", "CELL", 13, 17], ["U937 cells", "CELL", 47, 57], ["M. fermentans", "ORGANISM", 79, 92], ["HIV-t", "ORGANISM", 97, 102], ["HIV-2", "ORGANISM", 106, 111], ["U937 cells", "CELL_LINE", 47, 57], ["M. fermentans", "SPECIES", 79, 92], ["HIV", "SPECIES", 97, 100], ["HIV", "SPECIES", 106, 109], ["M. fermentans", "SPECIES", 79, 92], ["HIV", "SPECIES", 97, 100], ["HIV-2", "SPECIES", 106, 111], ["A synergy in cell killing", "PROBLEM", 0, 25], ["HIV", "PROBLEM", 97, 100], ["HIV", "PROBLEM", 106, 109], ["cell killing", "OBSERVATION", 13, 25]]], ["Cell lysates of M. fermentans, M. 9enitalium and M. pneumoniae stimulate the HIV-1 replication through selective activation of CD4+ T lymphocytes [90] .AIDSFrom these different in vitro studies it is clear that several mycoplasma species could interfere, though along different pathways, with the replicative cycle of human immunodeficiency viruses.", [["Cell lysates", "ANATOMY", 0, 12], ["CD4+ T lymphocytes", "ANATOMY", 127, 145], ["human immunodeficiency viruses", "DISEASE", 318, 348], ["Cell lysates", "ORGANISM_SUBSTANCE", 0, 12], ["M. fermentans", "ORGANISM", 16, 29], ["M. 9enitalium", "ORGANISM", 31, 44], ["M. pneumoniae", "ORGANISM", 49, 62], ["HIV-1", "ORGANISM", 77, 82], ["CD4", "GENE_OR_GENE_PRODUCT", 127, 130], ["human immunodeficiency viruses", "ORGANISM", 318, 348], ["CD4", "PROTEIN", 127, 130], ["T lymphocytes", "CELL_TYPE", 132, 145], ["M. fermentans", "SPECIES", 16, 29], ["M. 9enitalium", "SPECIES", 31, 44], ["M. pneumoniae", "SPECIES", 49, 62], ["HIV-1", "SPECIES", 77, 82], ["human", "SPECIES", 318, 323], ["M. fermentans", "SPECIES", 16, 29], ["M. 9enitalium", "SPECIES", 31, 44], ["M. pneumoniae", "SPECIES", 49, 62], ["HIV-1", "SPECIES", 77, 82], ["human immunodeficiency viruses", "SPECIES", 318, 348], ["Cell lysates", "TEST", 0, 12], ["M. fermentans", "PROBLEM", 16, 29], ["M. pneumoniae", "PROBLEM", 49, 62], ["the HIV", "TEST", 73, 80], ["vitro studies", "TEST", 180, 193], ["several mycoplasma species", "PROBLEM", 211, 237], ["human immunodeficiency viruses", "PROBLEM", 318, 348], ["different", "OBSERVATION_MODIFIER", 167, 176], ["several", "OBSERVATION_MODIFIER", 211, 218], ["mycoplasma species", "OBSERVATION", 219, 237], ["immunodeficiency viruses", "OBSERVATION", 324, 348]]], ["Nevertheless, the actual effects of mycoplasmas on the natural history of HIV infection and AIDS remains to be clarified [70] .", [["HIV infection", "DISEASE", 74, 87], ["AIDS", "DISEASE", 92, 96], ["HIV", "ORGANISM", 74, 77], ["HIV", "SPECIES", 74, 77], ["HIV", "SPECIES", 74, 77], ["mycoplasmas", "PROBLEM", 36, 47], ["HIV infection", "PROBLEM", 74, 87], ["AIDS", "PROBLEM", 92, 96], ["infection", "OBSERVATION", 78, 87]]], ["It is not impossible that progression of the disease may result from more subtle interactions of these organisms (and others) with the immune system of the host rather than from the direct cytopathic effect of the HIV lentiviruses.AIDSFor instance, mycoplasmas could act on the immune system by means of their antigens or superantigens, inducing a programmed cell death or apoptosis in activated infected or non infected TH cells [37] .", [["immune system", "ANATOMY", 135, 148], ["immune system", "ANATOMY", 278, 291], ["cell", "ANATOMY", 359, 363], ["TH cells", "ANATOMY", 421, 429], ["death", "DISEASE", 364, 369], ["HIV lentiviruses", "ORGANISM", 214, 230], ["immune system", "ANATOMICAL_SYSTEM", 278, 291], ["cell", "CELL", 359, 363], ["TH cells", "CELL", 421, 429], ["antigens", "PROTEIN", 310, 318], ["superantigens", "PROTEIN", 322, 335], ["TH cells", "CELL_TYPE", 421, 429], ["HIV", "SPECIES", 214, 217], ["HIV", "SPECIES", 214, 217], ["the disease", "PROBLEM", 41, 52], ["these organisms", "PROBLEM", 97, 112], ["the direct cytopathic effect", "PROBLEM", 178, 206], ["the HIV lentiviruses", "PROBLEM", 210, 230], ["mycoplasmas", "PROBLEM", 249, 260], ["superantigens", "PROBLEM", 322, 335], ["a programmed cell death", "PROBLEM", 346, 369], ["apoptosis", "PROBLEM", 373, 382], ["non infected TH cells", "PROBLEM", 408, 429], ["not impossible", "UNCERTAINTY", 6, 20], ["progression", "OBSERVATION_MODIFIER", 26, 37], ["disease", "OBSERVATION", 45, 52], ["cytopathic", "OBSERVATION_MODIFIER", 189, 199], ["HIV lentiviruses", "OBSERVATION", 214, 230], ["infected", "OBSERVATION_MODIFIER", 396, 404]]], ["These antigenic stimuli could also induce a chronic activation of the immune system and a deep de-regulation of the complex interrelation of cytokines, especially TNF-0~ and IL 2 or IL 6 interleukines [-16, 28, 71] .", [["immune system", "ANATOMY", 70, 83], ["TNF-0", "GENE_OR_GENE_PRODUCT", 163, 168], ["IL 2", "GENE_OR_GENE_PRODUCT", 174, 178], ["IL 6", "GENE_OR_GENE_PRODUCT", 182, 186], ["cytokines", "PROTEIN", 141, 150], ["TNF", "PROTEIN", 163, 166], ["These antigenic stimuli", "TEST", 0, 23], ["a chronic activation of the immune system", "PROBLEM", 42, 83], ["cytokines", "PROBLEM", 141, 150], ["TNF", "TEST", 163, 166], ["chronic", "OBSERVATION_MODIFIER", 44, 51], ["deep", "OBSERVATION_MODIFIER", 90, 94], ["cytokines", "OBSERVATION", 141, 150]]], ["It is noteworthy that mycoplasmas provoke the production of TNF-cz and other cytokines in lymphocytes and macrophages, thus enhancing the in vitro HIV replication [16] .AIDSSuch pathogenicity studies in AIDS seem more realistic than experiments conducted only in vitro which account essentially for the effect of mycoplasmal infections on the replicative cycle of HIV-1 or HIV-2 in a peculiar type of lymphocyte cells line.Concluding remarksIf one takes into account the various data mentioned above as well as the fact that infection of a mosquito by a spiroplasma may reduce its vector competence for Eastern equine encephalitis virus [95] or that another mosquito spiroplasma, S. taiwanense may be used as a biological control agent against dangerous mosquito-borne viral diseases [ 13, [44] [45] [46] , it becomes clear that the associations between mycoplasmas and viruses appear multiple and sometimes extremely complex.Concluding remarksFrom a historical point of view, these associations have evolved from persistent confusions in the past sometimes still present today, to genuine interactions, since mycoplasmas are now implicated as possible co-factors in AIDS.Concluding remarksViral diseases of cattle and poultry, especially those affecting the respiratory tract, are frequenly aggravated by concurrent or subsequent mycoplasmal infections.", [["lymphocytes", "ANATOMY", 90, 101], ["macrophages", "ANATOMY", 106, 117], ["lymphocyte cells line", "ANATOMY", 401, 422], ["spiroplasma", "ANATOMY", 554, 565], ["respiratory tract", "ANATOMY", 1259, 1276], ["AIDS", "DISEASE", 203, 207], ["mycoplasmal infections", "DISEASE", 313, 335], ["infection", "DISEASE", 525, 534], ["spiroplasma", "CHEMICAL", 554, 565], ["encephalitis", "DISEASE", 618, 630], ["viral diseases", "DISEASE", 769, 783], ["AIDS", "DISEASE", 1167, 1171], ["Viral diseases of cattle and poultry", "DISEASE", 1190, 1226], ["mycoplasmal infections", "DISEASE", 1331, 1353], ["mycoplasmas", "ORGANISM", 22, 33], ["TNF-cz", "GENE_OR_GENE_PRODUCT", 60, 66], ["lymphocytes", "CELL", 90, 101], ["macrophages", "CELL", 106, 117], ["HIV", "ORGANISM", 147, 150], ["HIV-1", "ORGANISM", 364, 369], ["HIV-2", "ORGANISM", 373, 378], ["lymphocyte cells line", "CELL", 401, 422], ["mosquito", "ORGANISM", 540, 548], ["spiroplasma", "ORGANISM", 554, 565], ["Eastern equine encephalitis virus", "ORGANISM", 603, 636], ["mosquito spiroplasma", "ORGANISM", 658, 678], ["S. taiwanense", "ORGANISM", 680, 693], ["cattle", "ORGANISM", 1208, 1214], ["respiratory tract", "ORGANISM_SUBDIVISION", 1259, 1276], ["TNF", "PROTEIN", 60, 63], ["cz", "PROTEIN", 64, 66], ["cytokines", "PROTEIN", 77, 86], ["lymphocytes", "CELL_TYPE", 90, 101], ["macrophages", "CELL_TYPE", 106, 117], ["lymphocyte cells line", "CELL_LINE", 401, 422], ["HIV-1", "SPECIES", 364, 369], ["HIV-2", "SPECIES", 373, 378], ["equine encephalitis virus", "SPECIES", 611, 636], ["S. taiwanense", "SPECIES", 680, 693], ["cattle", "SPECIES", 1208, 1214], ["poultry", "SPECIES", 1219, 1226], ["HIV", "SPECIES", 147, 150], ["HIV-1", "SPECIES", 364, 369], ["HIV-2", "SPECIES", 373, 378], ["Eastern equine encephalitis virus", "SPECIES", 603, 636], ["S. taiwanense", "SPECIES", 680, 693], ["cattle", "SPECIES", 1208, 1214], ["mycoplasmas", "PROBLEM", 22, 33], ["TNF", "PROBLEM", 60, 63], ["cz", "PROBLEM", 64, 66], ["other cytokines in lymphocytes", "PROBLEM", 71, 101], ["macrophages", "PROBLEM", 106, 117], ["enhancing the in vitro HIV replication", "TREATMENT", 124, 162], ["AIDSSuch pathogenicity studies in AIDS", "PROBLEM", 169, 207], ["mycoplasmal infections", "PROBLEM", 313, 335], ["HIV", "PROBLEM", 364, 367], ["HIV", "PROBLEM", 373, 376], ["lymphocyte cells line", "TREATMENT", 401, 422], ["infection", "PROBLEM", 525, 534], ["a spiroplasma", "PROBLEM", 552, 565], ["Eastern equine encephalitis virus", "PROBLEM", 603, 636], ["another mosquito spiroplasma", "PROBLEM", 650, 678], ["a biological control agent", "TREATMENT", 709, 735], ["dangerous mosquito-borne viral diseases", "PROBLEM", 744, 783], ["mycoplasmas and viruses", "PROBLEM", 854, 877], ["persistent confusions", "PROBLEM", 1014, 1035], ["mycoplasmas", "PROBLEM", 1110, 1121], ["Viral diseases of cattle and poultry", "PROBLEM", 1190, 1226], ["subsequent mycoplasmal infections", "PROBLEM", 1320, 1353], ["mycoplasmas", "OBSERVATION", 22, 33], ["lymphocytes", "ANATOMY", 90, 101], ["macrophages", "ANATOMY", 106, 117], ["mycoplasmal", "OBSERVATION_MODIFIER", 313, 324], ["infections", "OBSERVATION", 325, 335], ["lymphocyte cells line", "OBSERVATION", 401, 422], ["infection", "OBSERVATION", 525, 534], ["viruses", "OBSERVATION", 870, 877], ["persistent", "OBSERVATION_MODIFIER", 1014, 1024], ["confusions", "OBSERVATION", 1025, 1035], ["diseases", "OBSERVATION", 1196, 1204], ["poultry", "OBSERVATION_MODIFIER", 1219, 1226], ["respiratory tract", "ANATOMY", 1259, 1276], ["mycoplasmal", "OBSERVATION_MODIFIER", 1331, 1342], ["infections", "OBSERVATION", 1343, 1353]]], ["On the contrary, the eventual role of mycoplasmas in the natural history and progression of AIDS appears fundamentally distinct because the human disease is multifactorial (but not multi-aetiological) in nature and that the mycoplasmas could exert their deleterious effects directly within the immune system, already assaulted by a T lymphotropic lentivirus.Concluding remarksThus, it is not unreasonable to think that the studies presently performed on the pathogenesis of this terrifying disease could result in a better understanding of mycoplasma-virus interactions in other hosts, including lower invertebrates, plants and insects as well.", [["immune system", "ANATOMY", 294, 307], ["AIDS", "DISEASE", 92, 96], ["human", "ORGANISM", 140, 145], ["mycoplasmas", "ORGANISM", 224, 235], ["immune system", "ANATOMICAL_SYSTEM", 294, 307], ["T lymphotropic lentivirus", "ORGANISM", 332, 357], ["mycoplasma-virus", "ORGANISM", 540, 556], ["human", "SPECIES", 140, 145], ["human", "SPECIES", 140, 145], ["T lymphotropic lentivirus", "SPECIES", 332, 357], ["mycoplasmas", "PROBLEM", 38, 49], ["AIDS", "PROBLEM", 92, 96], ["fundamentally distinct", "PROBLEM", 105, 127], ["the human disease", "PROBLEM", 136, 153], ["the mycoplasmas", "PROBLEM", 220, 235], ["a T lymphotropic lentivirus", "TREATMENT", 330, 357], ["the studies", "TEST", 419, 430], ["this terrifying disease", "PROBLEM", 474, 497], ["mycoplasma-virus interactions", "PROBLEM", 540, 569], ["mycoplasmas", "OBSERVATION", 38, 49], ["human disease", "OBSERVATION", 140, 153], ["deleterious", "OBSERVATION", 254, 265], ["lymphotropic lentivirus", "OBSERVATION", 334, 357]]]], "4b2d0758977fdb35bbec866239d5e483e1ebe64c": [["IntroductionSystemic lupus erythematosus (SLE) is a complex connective tissue disorder, which has the propensity to cause multi organ involvement.", [["connective tissue", "ANATOMY", 60, 77], ["organ", "ANATOMY", 128, 133], ["IntroductionSystemic lupus erythematosus", "DISEASE", 0, 40], ["SLE", "DISEASE", 42, 45], ["connective tissue disorder", "DISEASE", 60, 86], ["connective tissue", "TISSUE", 60, 77], ["organ", "ORGAN", 128, 133], ["IntroductionSystemic lupus erythematosus", "PROBLEM", 0, 40], ["SLE", "PROBLEM", 42, 45], ["a complex connective tissue disorder", "PROBLEM", 50, 86], ["multi organ involvement", "PROBLEM", 122, 145], ["lupus erythematosus", "OBSERVATION", 21, 40], ["complex", "OBSERVATION_MODIFIER", 52, 59], ["connective tissue", "OBSERVATION_MODIFIER", 60, 77], ["disorder", "OBSERVATION", 78, 86], ["organ", "ANATOMY", 128, 133], ["involvement", "OBSERVATION", 134, 145]]], ["Neurological manifestations in SLE are numerous and varied, of which central nervous system (CNS) manifestations tend to be diverse and often have major prognostic consequences.", [["Neurological", "ANATOMY", 0, 12], ["central nervous system", "ANATOMY", 69, 91], ["CNS", "ANATOMY", 93, 96], ["SLE", "DISEASE", 31, 34], ["central nervous system (CNS) manifestations", "DISEASE", 69, 112], ["SLE", "CANCER", 31, 34], ["central nervous system", "ANATOMICAL_SYSTEM", 69, 91], ["CNS", "ANATOMICAL_SYSTEM", 93, 96], ["Neurological manifestations in SLE", "PROBLEM", 0, 34], ["central", "ANATOMY_MODIFIER", 69, 76], ["nervous system", "ANATOMY", 77, 91]]], ["Seizures in SLE are well noted, and develop in approximately 10 to 20% of patients [1] [2] [3] , either as the preliminary manifestation of the disease or occurring later.IntroductionThe cardiac spectrum of presentation in SLE is broad as almost every anatomic component of the heart is involved.", [["cardiac", "ANATOMY", 187, 194], ["heart", "ANATOMY", 278, 283], ["Seizures", "DISEASE", 0, 8], ["SLE", "DISEASE", 12, 15], ["SLE", "DISEASE", 223, 226], ["SLE", "CANCER", 12, 15], ["patients", "ORGANISM", 74, 82], ["cardiac", "ORGAN", 187, 194], ["heart", "ORGAN", 278, 283], ["patients", "SPECIES", 74, 82], ["Seizures in SLE", "PROBLEM", 0, 15], ["the disease", "PROBLEM", 140, 151], ["disease", "OBSERVATION", 144, 151], ["cardiac", "ANATOMY", 187, 194], ["heart", "ANATOMY", 278, 283]]], ["That being said, myocarditis happens to be an uncommon manifestation in SLE, with a noted prevalence being as low as 3%, though contradictory reports suggest that to be as high as 25% [4] [5] [6] [7] .", [["myocarditis", "DISEASE", 17, 28], ["SLE", "DISEASE", 72, 75], ["SLE", "CANCER", 72, 75], ["[4] [5] [6] [7]", "SIMPLE_CHEMICAL", 184, 199], ["myocarditis", "PROBLEM", 17, 28], ["SLE", "PROBLEM", 72, 75], ["myocarditis", "OBSERVATION", 17, 28]]], ["Myocarditis complicated with acute heart failure as an early manifestation of SLE is rarely reported in the literature.IntroductionIn this case vignette, we present a young female who presented with both status epilepticus and subsequently acute myocarditis complicated with heart failure as an early and atypical presentation of SLE.", [["heart", "ANATOMY", 35, 40], ["heart", "ANATOMY", 275, 280], ["Myocarditis", "DISEASE", 0, 11], ["acute heart failure", "DISEASE", 29, 48], ["SLE", "DISEASE", 78, 81], ["status epilepticus", "DISEASE", 204, 222], ["myocarditis", "DISEASE", 246, 257], ["heart failure", "DISEASE", 275, 288], ["SLE", "DISEASE", 330, 333], ["heart", "ORGAN", 35, 40], ["female", "ORGANISM", 173, 179], ["heart", "ORGAN", 275, 280], ["SLE", "CANCER", 330, 333], ["Myocarditis", "PROBLEM", 0, 11], ["acute heart failure", "PROBLEM", 29, 48], ["SLE", "PROBLEM", 78, 81], ["status epilepticus", "PROBLEM", 204, 222], ["acute myocarditis", "PROBLEM", 240, 257], ["heart failure", "PROBLEM", 275, 288], ["SLE", "PROBLEM", 330, 333], ["acute", "OBSERVATION_MODIFIER", 29, 34], ["heart", "ANATOMY", 35, 40], ["failure", "OBSERVATION", 41, 48], ["early", "OBSERVATION_MODIFIER", 55, 60], ["SLE", "OBSERVATION", 78, 81], ["acute", "OBSERVATION_MODIFIER", 240, 245], ["myocarditis", "OBSERVATION", 246, 257], ["heart", "ANATOMY", 275, 280], ["failure", "OBSERVATION", 281, 288], ["atypical", "OBSERVATION_MODIFIER", 305, 313]]], ["We discuss similar cases reported in literature and emphasize the importance of screening for autoimmune etiology in young females who present with seizures or myocarditis without other risk factors as most of such cases were diagnosed as SLE after the acute episode.Case descriptionA 15-year-old previously healthy South Asian, Sri Lankan female presented with three episodes of generalized tonic clonic seizures over a 24-h period, which progressed to status epilepticus within 2 h of admission.", [["autoimmune etiology", "DISEASE", 94, 113], ["seizures", "DISEASE", 148, 156], ["myocarditis", "DISEASE", 160, 171], ["SLE", "DISEASE", 239, 242], ["tonic clonic seizures", "DISEASE", 392, 413], ["status epilepticus", "DISEASE", 454, 472], ["Sri Lankan female", "ORGANISM", 329, 346], ["seizures", "PROBLEM", 148, 156], ["myocarditis", "PROBLEM", 160, 171], ["other risk factors", "PROBLEM", 180, 198], ["SLE", "PROBLEM", 239, 242], ["the acute episode", "PROBLEM", 249, 266], ["generalized tonic clonic seizures", "PROBLEM", 380, 413], ["status epilepticus", "PROBLEM", 454, 472], ["myocarditis", "OBSERVATION", 160, 171], ["acute", "OBSERVATION_MODIFIER", 253, 258]]], ["A targeted history from observer and family member revealed that she had developed an erythematous painless rash over both legs that had progressed over the preceding 2 weeks prior to the presentation.", [["legs", "ANATOMY", 123, 127], ["rash", "DISEASE", 108, 112], ["legs", "ORGANISM_SUBDIVISION", 123, 127], ["an erythematous painless rash over both legs", "PROBLEM", 83, 127], ["erythematous", "OBSERVATION_MODIFIER", 86, 98], ["painless", "OBSERVATION_MODIFIER", 99, 107], ["rash", "OBSERVATION", 108, 112], ["both", "ANATOMY_MODIFIER", 118, 122], ["legs", "ANATOMY", 123, 127]]], ["Furthermore, she also had a headache for 2 days, which had been diffuse in nature without features favoring meningism, discernible systemic symptoms, or fever to suggest an association or etiology.", [["headache", "DISEASE", 28, 36], ["meningism", "DISEASE", 108, 117], ["fever", "DISEASE", 153, 158], ["a headache", "PROBLEM", 26, 36], ["meningism", "PROBLEM", 108, 117], ["discernible systemic symptoms", "PROBLEM", 119, 148], ["fever", "PROBLEM", 153, 158], ["headache", "OBSERVATION", 28, 36], ["diffuse", "OBSERVATION_MODIFIER", 64, 71], ["systemic", "OBSERVATION_MODIFIER", 131, 139], ["symptoms", "OBSERVATION", 140, 148]]], ["There was no background history of autoimmune diseases.", [["autoimmune diseases", "DISEASE", 35, 54], ["autoimmune diseases", "PROBLEM", 35, 54], ["no", "UNCERTAINTY", 10, 12], ["autoimmune diseases", "OBSERVATION", 35, 54]]], ["The patient and family failed to recognize the clinical significance and did not seek medical intervention when these symptoms had occurred.Case descriptionOn examination, she was afebrile.", [["patient", "ORGANISM", 4, 11], ["patient", "SPECIES", 4, 11], ["medical intervention", "TREATMENT", 86, 106], ["these symptoms", "PROBLEM", 112, 126], ["Case descriptionOn examination", "TEST", 140, 170], ["afebrile", "PROBLEM", 180, 188]]], ["She had mild periorbital edema and a resolving purpuric rash was noted on both her ankles.", [["periorbital edema", "ANATOMY", 13, 30], ["purpuric", "ANATOMY", 47, 55], ["ankles", "ANATOMY", 83, 89], ["periorbital edema", "DISEASE", 13, 30], ["rash", "DISEASE", 56, 60], ["periorbital edema", "PATHOLOGICAL_FORMATION", 13, 30], ["ankles", "ORGANISM_SUBDIVISION", 83, 89], ["mild periorbital edema", "PROBLEM", 8, 30], ["a resolving purpuric rash", "PROBLEM", 35, 60], ["mild", "OBSERVATION_MODIFIER", 8, 12], ["periorbital", "ANATOMY", 13, 24], ["edema", "OBSERVATION", 25, 30], ["resolving", "OBSERVATION_MODIFIER", 37, 46], ["purpuric", "OBSERVATION_MODIFIER", 47, 55], ["rash", "OBSERVATION", 56, 60], ["ankles", "ANATOMY", 83, 89]]], ["Despite a detailed neurological examination, no focal neurological signs were demonstrable.", [["neurological", "ANATOMY", 54, 66], ["a detailed neurological examination", "TEST", 8, 43], ["focal neurological signs", "PROBLEM", 48, 72], ["no", "UNCERTAINTY", 45, 47], ["focal", "OBSERVATION_MODIFIER", 48, 53]]], ["The fundi were also normal with no papilledema.", [["papilledema", "DISEASE", 35, 46], ["fundi", "CANCER", 4, 9], ["papilledema", "PROBLEM", 35, 46], ["fundi", "ANATOMY", 4, 9], ["normal", "OBSERVATION", 20, 26], ["no", "UNCERTAINTY", 32, 34], ["papilledema", "OBSERVATION", 35, 46]]], ["Examination of her cardiovascular system revealed her blood pressure to be within reference range; however, a tachycardia was noted, though it was regular in rhythm.", [["cardiovascular", "ANATOMY", 19, 33], ["blood", "ANATOMY", 54, 59], ["tachycardia", "DISEASE", 110, 121], ["blood", "ORGANISM_SUBSTANCE", 54, 59], ["Examination of her cardiovascular system", "TEST", 0, 40], ["her blood pressure", "TEST", 50, 68], ["a tachycardia", "PROBLEM", 108, 121]]], ["The jugular venous pressure was however elevated.", [["jugular venous", "ANATOMY", 4, 18], ["jugular venous", "MULTI-TISSUE_STRUCTURE", 4, 18], ["The jugular venous pressure", "TEST", 0, 27], ["elevated", "PROBLEM", 40, 48], ["jugular venous", "ANATOMY", 4, 18], ["pressure", "OBSERVATION_MODIFIER", 19, 27], ["elevated", "OBSERVATION", 40, 48]]], ["Auscultation revealed a grade 2 pan-systolic murmur at the apex, favoring a mitral regurgitation, but the apex was not shifted.", [["mitral", "ANATOMY", 76, 82], ["mitral regurgitation", "DISEASE", 76, 96], ["mitral", "PATHOLOGICAL_FORMATION", 76, 82], ["Auscultation", "TEST", 0, 12], ["a grade 2 pan-systolic murmur at the apex", "PROBLEM", 22, 63], ["a mitral regurgitation", "PROBLEM", 74, 96], ["pan-systolic", "OBSERVATION_MODIFIER", 32, 44], ["murmur", "OBSERVATION", 45, 51], ["apex", "ANATOMY_MODIFIER", 59, 63], ["mitral", "ANATOMY", 76, 82], ["regurgitation", "OBSERVATION", 83, 96], ["apex", "ANATOMY_MODIFIER", 106, 110], ["shifted", "OBSERVATION", 119, 126]]], ["Respiratory system examination revealed tachypnea and presence of bibasal lung crepitations, in the absence of other features.", [["lung", "ANATOMY", 74, 78], ["tachypnea", "DISEASE", 40, 49], ["lung", "ORGAN", 74, 78], ["Respiratory system examination", "TEST", 0, 30], ["tachypnea", "PROBLEM", 40, 49], ["bibasal lung crepitations", "PROBLEM", 66, 91], ["tachypnea", "OBSERVATION", 40, 49], ["bibasal", "ANATOMY_MODIFIER", 66, 73], ["lung", "ANATOMY", 74, 78], ["crepitations", "OBSERVATION", 79, 91]]], ["Abdominal examination failed to reveal clinically significant findings.Case descriptionIn view of her seizures and status epilepticus, she was treated with intravenous diazepam 10 mg followed by intravenous phenytoin 18 mg/kg bolus along with oral sodium valproate via a nasogastric tube, which failed to control seizures.", [["Abdominal", "ANATOMY", 0, 9], ["intravenous", "ANATOMY", 156, 167], ["intravenous", "ANATOMY", 195, 206], ["oral", "ANATOMY", 243, 247], ["nasogastric tube", "ANATOMY", 271, 287], ["seizures", "DISEASE", 102, 110], ["status epilepticus", "DISEASE", 115, 133], ["diazepam", "CHEMICAL", 168, 176], ["phenytoin", "CHEMICAL", 207, 216], ["sodium valproate", "CHEMICAL", 248, 264], ["seizures", "DISEASE", 313, 321], ["diazepam", "CHEMICAL", 168, 176], ["phenytoin", "CHEMICAL", 207, 216], ["sodium valproate", "CHEMICAL", 248, 264], ["intravenous", "IMMATERIAL_ANATOMICAL_ENTITY", 156, 167], ["diazepam", "SIMPLE_CHEMICAL", 168, 176], ["intravenous", "IMMATERIAL_ANATOMICAL_ENTITY", 195, 206], ["phenytoin", "SIMPLE_CHEMICAL", 207, 216], ["oral", "ORGANISM_SUBDIVISION", 243, 247], ["sodium", "SIMPLE_CHEMICAL", 248, 254], ["valproate", "SIMPLE_CHEMICAL", 255, 264], ["nasogastric tube", "MULTI-TISSUE_STRUCTURE", 271, 287], ["Abdominal examination", "TEST", 0, 21], ["clinically significant findings", "PROBLEM", 39, 70], ["her seizures", "PROBLEM", 98, 110], ["status epilepticus", "PROBLEM", 115, 133], ["intravenous diazepam", "TREATMENT", 156, 176], ["intravenous phenytoin", "TREATMENT", 195, 216], ["oral sodium valproate", "TREATMENT", 243, 264], ["a nasogastric tube", "TREATMENT", 269, 287], ["seizures", "PROBLEM", 313, 321], ["nasogastric tube", "OBSERVATION", 271, 287]]], ["She was therefore electively intubated and ventilated while inducing paralysis and was started on intravenous midazolam followed by thiopentone sodium.Case descriptionCapillary blood sugar values and serum electrolytes were within normal reference range.", [["intravenous", "ANATOMY", 98, 109], ["blood", "ANATOMY", 177, 182], ["serum", "ANATOMY", 200, 205], ["paralysis", "DISEASE", 69, 78], ["midazolam", "CHEMICAL", 110, 119], ["thiopentone sodium", "CHEMICAL", 132, 150], ["midazolam", "CHEMICAL", 110, 119], ["thiopentone sodium", "CHEMICAL", 132, 150], ["sugar", "CHEMICAL", 183, 188], ["She", "ORGANISM", 0, 3], ["intravenous", "IMMATERIAL_ANATOMICAL_ENTITY", 98, 109], ["midazolam", "SIMPLE_CHEMICAL", 110, 119], ["thiopentone sodium", "SIMPLE_CHEMICAL", 132, 150], ["blood", "ORGANISM_SUBSTANCE", 177, 182], ["sugar", "SIMPLE_CHEMICAL", 183, 188], ["serum", "ORGANISM_SUBSTANCE", 200, 205], ["electrolytes", "ORGANISM_SUBSTANCE", 206, 218], ["ventilated", "TREATMENT", 43, 53], ["paralysis", "PROBLEM", 69, 78], ["intravenous midazolam", "TREATMENT", 98, 119], ["thiopentone sodium", "TREATMENT", 132, 150], ["Case descriptionCapillary blood sugar values", "TEST", 151, 195], ["serum electrolytes", "TEST", 200, 218], ["paralysis", "OBSERVATION", 69, 78]]], ["All basic investigations including blood counts, biochemistry, and cultures were done along with a lumbar puncture.", [["blood", "ANATOMY", 35, 40], ["lumbar", "ANATOMY", 99, 105], ["blood", "ORGANISM_SUBSTANCE", 35, 40], ["All basic investigations", "TEST", 0, 24], ["blood counts", "TEST", 35, 47], ["biochemistry", "TEST", 49, 61], ["cultures", "TEST", 67, 75], ["a lumbar puncture", "TEST", 97, 114], ["lumbar", "ANATOMY", 99, 105]]], ["Erring on the side of caution, she was empirically treated with intravenous ceftriaxone and intravenous acyclovir along with intravenous dexamethasone to cover the possible spectrum of meningoencephalitis.Case descriptionWhile on treatment for possible meningoencephalitis, her clinical picture deteriorated; her tachycardia worsened and desaturated on atmospheric oxygen.", [["intravenous", "ANATOMY", 64, 75], ["intravenous", "ANATOMY", 92, 103], ["intravenous", "ANATOMY", 125, 136], ["ceftriaxone", "CHEMICAL", 76, 87], ["acyclovir", "CHEMICAL", 104, 113], ["dexamethasone", "CHEMICAL", 137, 150], ["meningoencephalitis", "DISEASE", 185, 204], ["meningoencephalitis", "DISEASE", 253, 272], ["tachycardia", "DISEASE", 313, 324], ["oxygen", "CHEMICAL", 365, 371], ["ceftriaxone", "CHEMICAL", 76, 87], ["acyclovir", "CHEMICAL", 104, 113], ["dexamethasone", "CHEMICAL", 137, 150], ["oxygen", "CHEMICAL", 365, 371], ["intravenous", "IMMATERIAL_ANATOMICAL_ENTITY", 64, 75], ["ceftriaxone", "SIMPLE_CHEMICAL", 76, 87], ["intravenous", "IMMATERIAL_ANATOMICAL_ENTITY", 92, 103], ["acyclovir", "SIMPLE_CHEMICAL", 104, 113], ["intravenous", "IMMATERIAL_ANATOMICAL_ENTITY", 125, 136], ["dexamethasone", "SIMPLE_CHEMICAL", 137, 150], ["oxygen", "SIMPLE_CHEMICAL", 365, 371], ["intravenous ceftriaxone", "TREATMENT", 64, 87], ["intravenous acyclovir", "TREATMENT", 92, 113], ["intravenous dexamethasone", "TREATMENT", 125, 150], ["meningoencephalitis", "PROBLEM", 185, 204], ["treatment", "TREATMENT", 230, 239], ["meningoencephalitis", "PROBLEM", 253, 272], ["her clinical picture", "PROBLEM", 274, 294], ["her tachycardia", "PROBLEM", 309, 324], ["atmospheric oxygen", "TREATMENT", 353, 371], ["meningoencephalitis", "OBSERVATION", 185, 204], ["possible", "UNCERTAINTY", 244, 252], ["meningoencephalitis", "OBSERVATION", 253, 272]]], ["Worsening signs of heart failure alerted us to the possibility of myocarditis.", [["heart", "ANATOMY", 19, 24], ["heart failure", "DISEASE", 19, 32], ["myocarditis", "DISEASE", 66, 77], ["heart", "ORGAN", 19, 24], ["heart failure", "PROBLEM", 19, 32], ["myocarditis", "PROBLEM", 66, 77], ["heart", "ANATOMY", 19, 24], ["failure", "OBSERVATION", 25, 32], ["myocarditis", "OBSERVATION", 66, 77]]], ["Electrocardiogram showed sinus tachycardia with T wave inversions in chest leads V2 to V6.", [["sinus", "ANATOMY", 25, 30], ["chest", "ANATOMY", 69, 74], ["sinus tachycardia", "DISEASE", 25, 42], ["chest", "ORGANISM_SUBDIVISION", 69, 74], ["Electrocardiogram", "TEST", 0, 17], ["sinus tachycardia", "PROBLEM", 25, 42], ["T wave inversions in chest leads V2 to V6", "PROBLEM", 48, 89], ["sinus", "ANATOMY", 25, 30], ["tachycardia", "OBSERVATION", 31, 42], ["wave inversions", "OBSERVATION", 50, 65], ["chest", "ANATOMY", 69, 74]]], ["Despite this, her cardiac enzyme assay (Troponin T and I, CK-MB) was negative.", [["cardiac", "ANATOMY", 18, 25], ["Troponin T", "GENE_OR_GENE_PRODUCT", 40, 50], ["CK-MB", "GENE_OR_GENE_PRODUCT", 58, 63], ["CK", "PROTEIN", 58, 60], ["her cardiac enzyme assay", "TEST", 14, 38], ["Troponin T", "TEST", 40, 50], ["I", "TEST", 55, 56], ["CK-MB", "TEST", 58, 63]]], ["Her chest x-ray revealed relative cardiomegaly.", [["cardiomegaly", "DISEASE", 34, 46], ["Her chest x-ray", "TEST", 0, 15], ["relative cardiomegaly", "PROBLEM", 25, 46], ["chest", "ANATOMY", 4, 9], ["relative", "OBSERVATION_MODIFIER", 25, 33], ["cardiomegaly", "OBSERVATION", 34, 46]]], ["Transthoracic 2D-echocardiohraphy (Phillips EQIP CVx, made in Germany) revealed moderate left ventricular systolic dysfunction with an ejection fraction of 40% with left ventricular global hypokinesia, along with a grade 2 severity mitral regurgitation, grade 1 severity aortic regurgitation; a clinically insignificant thin rim of pericardial effusion with no right atrial or ventricular collapse was noted.", [["left ventricular", "ANATOMY", 89, 105], ["left ventricular", "ANATOMY", 165, 181], ["mitral", "ANATOMY", 232, 238], ["aortic", "ANATOMY", 271, 277], ["pericardial", "ANATOMY", 332, 343], ["right atrial", "ANATOMY", 361, 373], ["ventricular", "ANATOMY", 377, 388], ["left ventricular systolic dysfunction", "DISEASE", 89, 126], ["left ventricular global hypokinesia", "DISEASE", 165, 200], ["mitral regurgitation", "DISEASE", 232, 252], ["aortic regurgitation", "DISEASE", 271, 291], ["pericardial effusion", "DISEASE", 332, 352], ["right atrial or ventricular collapse", "DISEASE", 361, 397], ["ventricular", "MULTI-TISSUE_STRUCTURE", 94, 105], ["ventricular", "MULTI-TISSUE_STRUCTURE", 170, 181], ["mitral", "PATHOLOGICAL_FORMATION", 232, 238], ["aortic", "MULTI-TISSUE_STRUCTURE", 271, 277], ["pericardial", "ORGAN", 332, 343], ["atrial", "MULTI-TISSUE_STRUCTURE", 367, 373], ["ventricular", "MULTI-TISSUE_STRUCTURE", 377, 388], ["Transthoracic 2D-echocardiohraphy", "TEST", 0, 33], ["moderate left ventricular systolic dysfunction", "PROBLEM", 80, 126], ["an ejection fraction", "TEST", 132, 152], ["left ventricular global hypokinesia", "PROBLEM", 165, 200], ["a grade 2 severity mitral regurgitation", "PROBLEM", 213, 252], ["grade 1 severity aortic regurgitation", "PROBLEM", 254, 291], ["a clinically insignificant thin rim of pericardial effusion", "PROBLEM", 293, 352], ["right atrial or ventricular collapse", "PROBLEM", 361, 397], ["moderate", "OBSERVATION_MODIFIER", 80, 88], ["left ventricular", "ANATOMY", 89, 105], ["systolic dysfunction", "OBSERVATION", 106, 126], ["ejection fraction", "OBSERVATION", 135, 152], ["left ventricular", "ANATOMY", 165, 181], ["global hypokinesia", "OBSERVATION", 182, 200], ["severity", "OBSERVATION_MODIFIER", 223, 231], ["mitral regurgitation", "OBSERVATION", 232, 252], ["severity", "OBSERVATION_MODIFIER", 262, 270], ["aortic", "ANATOMY", 271, 277], ["regurgitation", "OBSERVATION", 278, 291], ["insignificant", "OBSERVATION_MODIFIER", 306, 319], ["thin", "OBSERVATION_MODIFIER", 320, 324], ["rim", "OBSERVATION_MODIFIER", 325, 328], ["pericardial", "ANATOMY", 332, 343], ["effusion", "OBSERVATION", 344, 352], ["no", "UNCERTAINTY", 358, 360], ["right", "ANATOMY_MODIFIER", 361, 366], ["atrial", "ANATOMY", 367, 373], ["ventricular", "ANATOMY", 377, 388], ["collapse", "OBSERVATION", 389, 397]]], ["Following a cardiac consult, a clinical decision was taken to manage her medically with diuretics and fluid restriction.", [["cardiac", "ANATOMY", 12, 19], ["cardiac", "ORGAN", 12, 19], ["diuretics", "TREATMENT", 88, 97], ["fluid restriction", "TREATMENT", 102, 119]]], ["Upon stabilization, she was started on bisoprolol 2.5 mg bd and ivabradine 2.5 mg daily for control of heart rate along with a low dose enalapril of 2.5 mg daily.Case descriptionUpon clinical recovery from status epilepticus and cardiomyopathy, while still under investigation, we noted a trend toward reduction in cell counts in her whole blood analysis.", [["heart", "ANATOMY", 103, 108], ["cell", "ANATOMY", 315, 319], ["blood", "ANATOMY", 340, 345], ["bisoprolol", "CHEMICAL", 39, 49], ["ivabradine", "CHEMICAL", 64, 74], ["enalapril", "CHEMICAL", 136, 145], ["status epilepticus", "DISEASE", 206, 224], ["cardiomyopathy", "DISEASE", 229, 243], ["bisoprolol", "CHEMICAL", 39, 49], ["bd", "CHEMICAL", 57, 59], ["ivabradine", "CHEMICAL", 64, 74], ["enalapril", "CHEMICAL", 136, 145], ["bisoprolol", "SIMPLE_CHEMICAL", 39, 49], ["bd", "SIMPLE_CHEMICAL", 57, 59], ["ivabradine", "SIMPLE_CHEMICAL", 64, 74], ["heart", "ORGAN", 103, 108], ["enalapril", "SIMPLE_CHEMICAL", 136, 145], ["cell", "CELL", 315, 319], ["blood", "ORGANISM_SUBSTANCE", 340, 345], ["bisoprolol", "TREATMENT", 39, 49], ["ivabradine", "TREATMENT", 64, 74], ["heart rate", "TEST", 103, 113], ["a low dose enalapril", "TREATMENT", 125, 145], ["status epilepticus", "PROBLEM", 206, 224], ["cardiomyopathy", "PROBLEM", 229, 243], ["cell counts", "TEST", 315, 326], ["her whole blood analysis", "TEST", 330, 354], ["heart", "ANATOMY", 103, 108], ["cardiomyopathy", "OBSERVATION", 229, 243], ["cell counts", "OBSERVATION", 315, 326]]], ["Pancytopenia was seen on day 14 of her presentation.", [["Pancytopenia", "DISEASE", 0, 12], ["Pancytopenia", "PROBLEM", 0, 12]]], ["Hemoglobin dropped from 12.4 to 8.2 g/dL, while the total white blood cell count (WBC) was noted to have reduced to 3.5 \u00d7 10 9 /L (4-10) with a differential count suggestive of neutropenia (2.8 \u00d7 10 9 /L) and a lymphocyte count of 0.35 \u00d7 10 9 /L. Thrombocytopenia was also noted.", [["white blood cell", "ANATOMY", 58, 74], ["WBC", "ANATOMY", 82, 85], ["lymphocyte", "ANATOMY", 211, 221], ["neutropenia", "DISEASE", 177, 188], ["Thrombocytopenia", "DISEASE", 247, 263], ["Hemoglobin", "GENE_OR_GENE_PRODUCT", 0, 10], ["white blood cell", "CELL", 58, 74], ["WBC", "CELL", 82, 85], ["lymphocyte", "CELL", 211, 221], ["Hemoglobin", "PROTEIN", 0, 10], ["Hemoglobin", "TEST", 0, 10], ["the total white blood cell count", "TEST", 48, 80], ["WBC", "TEST", 82, 85], ["a differential count", "TEST", 142, 162], ["neutropenia", "PROBLEM", 177, 188], ["a lymphocyte count", "TEST", 209, 227], ["Thrombocytopenia", "PROBLEM", 247, 263], ["suggestive of", "UNCERTAINTY", 163, 176], ["neutropenia", "OBSERVATION", 177, 188], ["Thrombocytopenia", "OBSERVATION", 247, 263]]], ["Blood picture revealed few fragmented red blood cells (RBC) with the lactate dehydrogenase elevated at 851 U/L (225-450).", [["Blood", "ANATOMY", 0, 5], ["red blood cells", "ANATOMY", 38, 53], ["RBC", "ANATOMY", 55, 58], ["lactate", "CHEMICAL", 69, 76], ["lactate", "CHEMICAL", 69, 76], ["Blood", "ORGANISM_SUBSTANCE", 0, 5], ["red blood cells", "CELL", 38, 53], ["RBC", "CELL", 55, 58], ["lactate dehydrogenase", "GENE_OR_GENE_PRODUCT", 69, 90], ["red blood cells", "CELL_TYPE", 38, 53], ["RBC", "CELL_TYPE", 55, 58], ["lactate dehydrogenase", "PROTEIN", 69, 90], ["Blood picture", "TEST", 0, 13], ["few fragmented red blood cells", "PROBLEM", 23, 53], ["RBC", "TEST", 55, 58], ["the lactate dehydrogenase", "TEST", 65, 90], ["few", "OBSERVATION_MODIFIER", 23, 26], ["fragmented", "OBSERVATION_MODIFIER", 27, 37], ["blood cells", "OBSERVATION", 42, 53]]], ["Coomb's test was negative.Case descriptionOngoing inflammation was appreciated, as the Creactive protein was initially elevated at 60 mg/l (< 5), which then decreased to 8 mg/l (< 5).", [["inflammation", "DISEASE", 50, 62], ["Creactive protein", "PROTEIN", 87, 104], ["Coomb's test", "TEST", 0, 12], ["Case descriptionOngoing inflammation", "PROBLEM", 26, 62], ["the Creactive protein", "TEST", 83, 104], ["elevated", "PROBLEM", 119, 127], ["inflammation", "OBSERVATION", 50, 62]]], ["The erythrocyte sedimentation rate (ESR) also rose from 22 mm in the first hour, to reach 50 mm later in the second week of her presentation.", [["erythrocyte", "ANATOMY", 4, 15], ["erythrocyte", "CELL", 4, 15], ["The erythrocyte sedimentation rate", "TEST", 0, 34], ["ESR", "TEST", 36, 39], ["erythrocyte sedimentation", "OBSERVATION", 4, 29], ["22 mm", "OBSERVATION_MODIFIER", 56, 61]]], ["Her coagulation profile (prothrombin time/international normalized ratio, activated partial thromboplastin time and plasma fibrinogen, renal and thyroid function tests, and liver profile) were all normal (Table 1) .Case descriptionIn suspecting a multisystem disease, three urinalysis reports done within the first 2 weeks repeatedly showed moderately field full RBC in a high power field with 40% dysmorphic RBC, red cell casts, and WBC (25-30 cells/ per high power field).", [["plasma", "ANATOMY", 116, 122], ["renal", "ANATOMY", 135, 140], ["thyroid", "ANATOMY", 145, 152], ["liver", "ANATOMY", 173, 178], ["RBC", "ANATOMY", 363, 366], ["RBC", "ANATOMY", 409, 412], ["red cell", "ANATOMY", 414, 422], ["WBC", "ANATOMY", 434, 437], ["cells", "ANATOMY", 445, 450], ["multisystem disease", "DISEASE", 247, 266], ["prothrombin", "GENE_OR_GENE_PRODUCT", 25, 36], ["thromboplastin", "GENE_OR_GENE_PRODUCT", 92, 106], ["plasma", "ORGANISM_SUBSTANCE", 116, 122], ["fibrinogen", "GENE_OR_GENE_PRODUCT", 123, 133], ["renal", "MULTI-TISSUE_STRUCTURE", 135, 140], ["thyroid", "ORGAN", 145, 152], ["liver", "ORGAN", 173, 178], ["RBC", "CELL", 363, 366], ["RBC", "CELL", 409, 412], ["red cell", "CELL", 414, 422], ["cells", "CELL", 445, 450], ["plasma fibrinogen", "PROTEIN", 116, 133], ["RBC", "CELL_TYPE", 363, 366], ["dysmorphic RBC", "CELL_TYPE", 398, 412], ["WBC", "CELL_TYPE", 434, 437], ["Her coagulation profile", "TEST", 0, 23], ["prothrombin time", "TEST", 25, 41], ["international normalized ratio", "TEST", 42, 72], ["activated partial thromboplastin time", "TEST", 74, 111], ["plasma fibrinogen", "TEST", 116, 133], ["renal and thyroid function tests", "TEST", 135, 167], ["liver profile", "TEST", 173, 186], ["a multisystem disease", "PROBLEM", 245, 266], ["three urinalysis", "TEST", 268, 284], ["moderately field full RBC", "PROBLEM", 341, 366], ["40% dysmorphic RBC", "PROBLEM", 394, 412], ["red cell casts", "TEST", 414, 428], ["WBC", "TEST", 434, 437], ["cells", "TEST", 445, 450], ["renal", "ANATOMY", 135, 140], ["thyroid", "ANATOMY", 145, 152], ["liver", "ANATOMY", 173, 178], ["multisystem", "OBSERVATION_MODIFIER", 247, 258], ["disease", "OBSERVATION", 259, 266], ["moderately", "OBSERVATION_MODIFIER", 341, 351], ["dysmorphic RBC", "OBSERVATION", 398, 412], ["red cell casts", "OBSERVATION", 414, 428]]], ["Despite this, her urine culture was sterile.", [["urine", "ANATOMY", 18, 23], ["urine", "ORGANISM_SUBSTANCE", 18, 23], ["her urine culture", "TEST", 14, 31]]], ["She also had a sub-nephrotic proteinuria (600 mg of protein for 24 h).", [["nephrotic proteinuria", "DISEASE", 19, 40], ["a sub-nephrotic proteinuria", "PROBLEM", 13, 40], ["protein", "TEST", 52, 59], ["sub", "OBSERVATION_MODIFIER", 15, 18], ["nephrotic", "OBSERVATION_MODIFIER", 19, 28], ["proteinuria", "OBSERVATION", 29, 40]]], ["Ionized calcium and serum magnesium were repeatedly marginally below the reference value with normal urinary excretion of calcium and magnesium.", [["serum", "ANATOMY", 20, 25], ["urinary", "ANATOMY", 101, 108], ["calcium", "CHEMICAL", 8, 15], ["magnesium", "CHEMICAL", 26, 35], ["calcium", "CHEMICAL", 122, 129], ["magnesium", "CHEMICAL", 134, 143], ["calcium", "CHEMICAL", 8, 15], ["magnesium", "CHEMICAL", 26, 35], ["calcium", "CHEMICAL", 122, 129], ["magnesium", "CHEMICAL", 134, 143], ["calcium", "SIMPLE_CHEMICAL", 8, 15], ["serum", "ORGANISM_SUBSTANCE", 20, 25], ["magnesium", "SIMPLE_CHEMICAL", 26, 35], ["urinary", "ORGANISM_SUBSTANCE", 101, 108], ["calcium", "SIMPLE_CHEMICAL", 122, 129], ["magnesium", "SIMPLE_CHEMICAL", 134, 143], ["Ionized calcium", "TEST", 0, 15], ["serum magnesium", "TEST", 20, 35], ["calcium", "TEST", 122, 129], ["magnesium", "TREATMENT", 134, 143], ["urinary", "ANATOMY", 101, 108]]], ["Serum parathyroid hormone level was also normal ( Table 1) .Vitamin B 12 levels were normal at 273 pmol/L (140-650).Case descriptionExtensive neurological investigations were carried out.", [["Serum", "ANATOMY", 0, 5], ["Vitamin B", "CHEMICAL", 60, 69], ["Vitamin B 12", "CHEMICAL", 60, 72], ["Serum", "ORGANISM_SUBSTANCE", 0, 5], ["parathyroid hormone", "GENE_OR_GENE_PRODUCT", 6, 25], ["Vitamin B 12", "GENE_OR_GENE_PRODUCT", 60, 72], ["Serum parathyroid hormone level", "TEST", 0, 31], ["Vitamin B 12 levels", "TEST", 60, 79], ["Case descriptionExtensive neurological investigations", "TEST", 116, 169]]], ["Non-contrast CT brain was suggestive of mild cerebral edema.", [["brain", "ANATOMY", 16, 21], ["cerebral", "ANATOMY", 45, 53], ["cerebral edema", "DISEASE", 45, 59], ["brain", "ORGAN", 16, 21], ["cerebral edema", "PATHOLOGICAL_FORMATION", 45, 59], ["Non-contrast CT brain", "TEST", 0, 21], ["mild cerebral edema", "PROBLEM", 40, 59], ["brain", "ANATOMY", 16, 21], ["suggestive of", "UNCERTAINTY", 26, 39], ["mild", "OBSERVATION_MODIFIER", 40, 44], ["cerebral", "ANATOMY", 45, 53], ["edema", "OBSERVATION", 54, 59]]], ["Magnetic resonance imaging with T2 flair image showed very subtle altered signal intensity in bilateral parietal and occipital regions, suggesting acute parenchymal inflammatory changes favoring encephalitis.", [["bilateral parietal", "ANATOMY", 94, 112], ["occipital regions", "ANATOMY", 117, 134], ["parenchymal", "ANATOMY", 153, 164], ["encephalitis", "DISEASE", 195, 207], ["parietal", "MULTI-TISSUE_STRUCTURE", 104, 112], ["Magnetic resonance imaging", "TEST", 0, 26], ["T2 flair image", "TEST", 32, 46], ["very subtle altered signal intensity in bilateral parietal and occipital regions", "PROBLEM", 54, 134], ["acute parenchymal inflammatory changes", "PROBLEM", 147, 185], ["encephalitis", "PROBLEM", 195, 207], ["very", "OBSERVATION_MODIFIER", 54, 58], ["subtle", "OBSERVATION_MODIFIER", 59, 65], ["altered", "OBSERVATION_MODIFIER", 66, 73], ["signal intensity", "OBSERVATION", 74, 90], ["bilateral", "ANATOMY_MODIFIER", 94, 103], ["parietal", "ANATOMY_MODIFIER", 104, 112], ["occipital", "ANATOMY_MODIFIER", 117, 126], ["regions", "ANATOMY_MODIFIER", 127, 134], ["suggesting", "UNCERTAINTY", 136, 146], ["acute", "OBSERVATION_MODIFIER", 147, 152], ["parenchymal", "ANATOMY_MODIFIER", 153, 164], ["inflammatory", "OBSERVATION", 165, 177], ["encephalitis", "OBSERVATION", 195, 207]]], ["The cerebrospinal fluid (CSF) analysis showed isolated high levels of protein (387 mg/dL) in the absence of leucocytes and red blood cells.", [["cerebrospinal fluid", "ANATOMY", 4, 23], ["leucocytes", "ANATOMY", 108, 118], ["red blood cells", "ANATOMY", 123, 138], ["cerebrospinal fluid", "ORGANISM_SUBSTANCE", 4, 23], ["CSF", "ORGANISM_SUBSTANCE", 25, 28], ["leucocytes", "CELL", 108, 118], ["red blood cells", "CELL", 123, 138], ["leucocytes", "CELL_TYPE", 108, 118], ["red blood cells", "CELL_TYPE", 123, 138], ["The cerebrospinal fluid (CSF) analysis", "TEST", 0, 38], ["isolated high levels of protein", "PROBLEM", 46, 77], ["leucocytes", "TEST", 108, 118], ["red blood cells", "TEST", 123, 138], ["cerebrospinal", "ANATOMY", 4, 17], ["fluid", "OBSERVATION", 18, 23], ["leucocytes", "ANATOMY", 108, 118], ["red blood cells", "OBSERVATION", 123, 138]]], ["CSF for gram stain, culture, Ziehl-Neelsen stain, polymerase chain reaction (PCR) for mycobacterium tuberculosis, tuberculosis culture, herpes simplex virus 1 PCR, Japanese encephalitis IgM antibodies, anti-NMDA (N-methyl D-aspartate) and receptor antibodies were all negative.", [["mycobacterium tuberculosis", "DISEASE", 86, 112], ["tuberculosis", "DISEASE", 114, 126], ["herpes simplex virus", "DISEASE", 136, 156], ["encephalitis", "DISEASE", 173, 185], ["NMDA", "CHEMICAL", 207, 211], ["N-methyl D-aspartate", "CHEMICAL", 213, 233], ["NMDA", "CHEMICAL", 207, 211], ["N-methyl D-aspartate", "CHEMICAL", 213, 233], ["CSF", "GENE_OR_GENE_PRODUCT", 0, 3], ["herpes simplex virus 1", "ORGANISM", 136, 158], ["anti-", "SIMPLE_CHEMICAL", 202, 207], ["NMDA", "SIMPLE_CHEMICAL", 207, 211], ["N-methyl D-aspartate", "SIMPLE_CHEMICAL", 213, 233], ["CSF", "PROTEIN", 0, 3], ["Japanese encephalitis IgM antibodies", "PROTEIN", 164, 200], ["receptor antibodies", "PROTEIN", 239, 258], ["mycobacterium tuberculosis", "SPECIES", 86, 112], ["herpes simplex virus", "SPECIES", 136, 156], ["mycobacterium tuberculosis", "SPECIES", 86, 112], ["herpes simplex virus 1", "SPECIES", 136, 158], ["Japanese encephalitis", "SPECIES", 164, 185], ["CSF", "TEST", 0, 3], ["gram stain", "TEST", 8, 18], ["culture", "TEST", 20, 27], ["Ziehl", "TEST", 29, 34], ["Neelsen stain", "TEST", 35, 48], ["polymerase chain reaction", "TEST", 50, 75], ["PCR", "TEST", 77, 80], ["mycobacterium tuberculosis", "PROBLEM", 86, 112], ["tuberculosis culture", "TEST", 114, 134], ["herpes simplex virus 1 PCR", "TEST", 136, 162], ["Japanese encephalitis", "TEST", 164, 185], ["IgM antibodies", "TEST", 186, 200], ["anti-NMDA", "TEST", 202, 211], ["methyl D-aspartate)", "TEST", 215, 234], ["receptor antibodies", "TEST", 239, 258], ["mycobacterium tuberculosis", "OBSERVATION", 86, 112]]], ["Electroencephalogram revealed only diffuse slow waves.Case descriptionCultures of blood, endotracheal secretions, and urine were sterile.", [["blood", "ANATOMY", 82, 87], ["endotracheal secretions", "ANATOMY", 89, 112], ["urine", "ANATOMY", 118, 123], ["blood", "ORGANISM_SUBSTANCE", 82, 87], ["endotracheal secretions", "MULTI-TISSUE_STRUCTURE", 89, 112], ["urine", "ORGANISM_SUBSTANCE", 118, 123], ["Electroencephalogram", "TEST", 0, 20], ["diffuse slow waves", "PROBLEM", 35, 53], ["blood", "TEST", 82, 87], ["endotracheal secretions", "TEST", 89, 112], ["diffuse", "OBSERVATION_MODIFIER", 35, 42], ["slow waves", "OBSERVATION", 43, 53], ["blood", "ANATOMY", 82, 87], ["endotracheal", "ANATOMY", 89, 101]]], ["Leptospirosis serology (microscopic agglutination test for leptospirosis), Rickettsia serology, viral studies for HIV (human immunodeficiency virus antigen and antibody), JE (Japanese encephalitis antibodies IgG and Ig M), EBV (Epstein-Barr virus monospot and antibody test), CMV (Cytomegalovirus IgG, IgM, and PCR), and dengue were all negative.Case descriptionOn suspicion of connective tissue disease, anti nuclear antibodies (ANA) were done and was found to be weakly positive (1: 40) (Method used: indirect immunofluorescence assay, Substrate used HEp 2 cells).", [["connective tissue", "ANATOMY", 378, 395], ["HEp 2 cells", "ANATOMY", 553, 564], ["Leptospirosis", "DISEASE", 0, 13], ["leptospirosis", "DISEASE", 59, 72], ["HIV (human immunodeficiency virus antigen", "DISEASE", 114, 155], ["JE", "DISEASE", 171, 173], ["encephalitis", "DISEASE", 184, 196], ["dengue", "DISEASE", 321, 327], ["connective tissue disease", "DISEASE", 378, 403], ["HIV", "ORGANISM", 114, 117], ["human immunodeficiency virus antigen", "ORGANISM", 119, 155], ["Japanese encephalitis antibodies", "ORGANISM", 175, 207], ["IgG", "GENE_OR_GENE_PRODUCT", 208, 211], ["Ig M", "GENE_OR_GENE_PRODUCT", 216, 220], ["EBV", "ORGANISM", 223, 226], ["Epstein-Barr virus", "ORGANISM", 228, 246], ["monospot", "ORGANISM", 247, 255], ["CMV", "ORGANISM", 276, 279], ["Cytomegalovirus", "ORGANISM", 281, 296], ["IgG", "GENE_OR_GENE_PRODUCT", 297, 300], ["IgM", "GENE_OR_GENE_PRODUCT", 302, 305], ["connective tissue", "TISSUE", 378, 395], ["anti nuclear antibodies", "GENE_OR_GENE_PRODUCT", 405, 428], ["HEp 2 cells", "CELL", 553, 564], ["human immunodeficiency virus antigen", "PROTEIN", 119, 155], ["antibody", "PROTEIN", 160, 168], ["JE", "PROTEIN", 171, 173], ["Japanese encephalitis antibodies IgG", "PROTEIN", 175, 211], ["Ig M", "PROTEIN", 216, 220], ["Cytomegalovirus IgG", "PROTEIN", 281, 300], ["IgM", "PROTEIN", 302, 305], ["anti nuclear antibodies", "PROTEIN", 405, 428], ["ANA", "PROTEIN", 430, 433], ["HIV", "SPECIES", 114, 117], ["human", "SPECIES", 119, 124], ["immunodeficiency virus", "SPECIES", 125, 147], ["HIV", "SPECIES", 114, 117], ["human immunodeficiency virus", "SPECIES", 119, 147], ["EBV", "SPECIES", 223, 226], ["Epstein-Barr virus", "SPECIES", 228, 246], ["CMV", "SPECIES", 276, 279], ["Cytomegalovirus", "SPECIES", 281, 296], ["dengue", "SPECIES", 321, 327], ["Leptospirosis serology", "TEST", 0, 22], ["microscopic agglutination test", "TEST", 24, 54], ["leptospirosis", "PROBLEM", 59, 72], ["Rickettsia serology", "TEST", 75, 94], ["viral studies", "TEST", 96, 109], ["HIV", "PROBLEM", 114, 117], ["human immunodeficiency virus antigen", "TEST", 119, 155], ["antibody", "TEST", 160, 168], ["JE (Japanese encephalitis antibodies", "TEST", 171, 207], ["IgG", "TEST", 208, 211], ["Ig M", "TEST", 216, 220], ["EBV", "TEST", 223, 226], ["Epstein", "TEST", 228, 235], ["Barr virus monospot", "TEST", 236, 255], ["antibody test", "TEST", 260, 273], ["CMV", "TEST", 276, 279], ["Cytomegalovirus IgG", "TEST", 281, 300], ["IgM", "TEST", 302, 305], ["PCR", "TEST", 311, 314], ["dengue", "PROBLEM", 321, 327], ["connective tissue disease", "PROBLEM", 378, 403], ["anti nuclear antibodies", "TEST", 405, 428], ["weakly positive", "PROBLEM", 465, 480], ["indirect immunofluorescence assay", "TEST", 503, 536], ["HEp 2 cells", "TREATMENT", 553, 564], ["suspicion of", "UNCERTAINTY", 365, 377], ["connective tissue disease", "OBSERVATION", 378, 403]]], ["Anti dsDNA showed positivity with very high titers of > 150 IU/mL.", [["Anti dsDNA", "TEST", 0, 10], ["positivity", "PROBLEM", 18, 28], ["very high titers", "PROBLEM", 34, 50]]], ["(Positive if > 46.1 in method used ELISA, confirmed by IFA).", [["ELISA", "TEST", 35, 40]]], ["Human complement 3 (C3) and human complement 4 (C4) were both low: C3 = 41 mg/dL (83-177), C4 = 03 mg/dL .", [["Human", "ORGANISM", 0, 5], ["complement 3", "GENE_OR_GENE_PRODUCT", 6, 18], ["C3", "GENE_OR_GENE_PRODUCT", 20, 22], ["human", "ORGANISM", 28, 33], ["complement 4", "GENE_OR_GENE_PRODUCT", 34, 46], ["C4", "GENE_OR_GENE_PRODUCT", 48, 50], ["Human complement 3", "PROTEIN", 0, 18], ["C3", "PROTEIN", 20, 22], ["human complement 4", "PROTEIN", 28, 46], ["C4", "PROTEIN", 48, 50], ["Human", "SPECIES", 0, 5], ["human", "SPECIES", 28, 33], ["human", "SPECIES", 28, 33], ["Human complement", "TEST", 0, 16], ["human complement", "TEST", 28, 44], ["C3", "TEST", 67, 69], ["dL", "TEST", 78, 80], ["C4", "TEST", 91, 93]]], ["Anti cardiolipin antibody, antibeta 2 glycoprotein antibody, and lupus anticoagulant were negative.Case descriptionIntravenous antibiotics and antivirals were ceased with negative cultures and a working diagnosis of SLE was made.", [["SLE", "DISEASE", 216, 219], ["cardiolipin", "CHEMICAL", 5, 16], ["cardiolipin antibody", "GENE_OR_GENE_PRODUCT", 5, 25], ["antibeta 2 glycoprotein", "GENE_OR_GENE_PRODUCT", 27, 50], ["SLE", "CANCER", 216, 219], ["Anti cardiolipin antibody", "PROTEIN", 0, 25], ["antibeta 2 glycoprotein antibody", "PROTEIN", 27, 59], ["Anti cardiolipin antibody", "TEST", 0, 25], ["antibeta", "TEST", 27, 35], ["glycoprotein antibody", "TEST", 38, 59], ["lupus anticoagulant", "TREATMENT", 65, 84], ["Intravenous antibiotics", "TREATMENT", 115, 138], ["antivirals", "TREATMENT", 143, 153], ["SLE", "PROBLEM", 216, 219], ["cardiolipin antibody", "OBSERVATION", 5, 25], ["lupus anticoagulant", "OBSERVATION", 65, 84]]], ["Heart failure treatment was continued till she showed clinical and echocardiographic recovery.", [["Heart", "ANATOMY", 0, 5], ["Heart failure", "DISEASE", 0, 13], ["Heart", "ORGAN", 0, 5], ["Heart failure treatment", "TREATMENT", 0, 23], ["failure", "OBSERVATION", 6, 13]]], ["Sodium valproate was continued at a dose of 200 mg tds while phenytoin infusion was tailed off gradually.", [["Sodium valproate", "CHEMICAL", 0, 16], ["phenytoin", "CHEMICAL", 61, 70], ["Sodium valproate", "CHEMICAL", 0, 16], ["phenytoin", "CHEMICAL", 61, 70], ["Sodium", "SIMPLE_CHEMICAL", 0, 6], ["valproate", "SIMPLE_CHEMICAL", 7, 16], ["phenytoin", "SIMPLE_CHEMICAL", 61, 70], ["Sodium valproate", "TREATMENT", 0, 16], ["phenytoin infusion", "TREATMENT", 61, 79]]], ["By day 14, she had recovered back to her premorbid state with complete recovery from both her neurological and cardiac conditions.", [["neurological", "ANATOMY", 94, 106], ["cardiac", "ANATOMY", 111, 118], ["neurological and cardiac conditions", "DISEASE", 94, 129], ["cardiac", "ORGAN", 111, 118], ["cardiac", "ANATOMY", 111, 118]]], ["Serial ECHOs were done and by day 14 the left ventricular ejection fraction had improved back to 60% with no regional wall motion abnormalities.", [["left ventricular", "ANATOMY", 41, 57], ["wall", "ANATOMY", 118, 122], ["left ventricular", "MULTI-TISSUE_STRUCTURE", 41, 57], ["wall", "MULTI-TISSUE_STRUCTURE", 118, 122], ["Serial ECHOs", "TEST", 0, 12], ["the left ventricular ejection fraction", "TEST", 37, 75], ["regional wall motion abnormalities", "PROBLEM", 109, 143], ["left ventricular", "ANATOMY", 41, 57], ["ejection fraction", "OBSERVATION", 58, 75], ["no", "UNCERTAINTY", 106, 108], ["regional", "ANATOMY_MODIFIER", 109, 117], ["wall", "ANATOMY_MODIFIER", 118, 122], ["motion abnormalities", "OBSERVATION", 123, 143]]], ["She was discharged on day 21, on sodium valproate and folic acid with a follow up review planned by the multidisciplinary team.", [["sodium valproate", "CHEMICAL", 33, 49], ["folic acid", "CHEMICAL", 54, 64], ["sodium valproate", "CHEMICAL", 33, 49], ["folic acid", "CHEMICAL", 54, 64], ["sodium", "SIMPLE_CHEMICAL", 33, 39], ["valproate", "SIMPLE_CHEMICAL", 40, 49], ["folic acid", "SIMPLE_CHEMICAL", 54, 64], ["sodium valproate", "TREATMENT", 33, 49], ["folic acid", "TREATMENT", 54, 64]]], ["A repeated urinalysis on the day 21 only showed few RBC and WBC.", [["RBC", "ANATOMY", 52, 55], ["WBC", "ANATOMY", 60, 63], ["RBC", "CELL", 52, 55], ["WBC", "CELL", 60, 63], ["RBC", "CELL_TYPE", 52, 55], ["WBC", "CELL_TYPE", 60, 63], ["A repeated urinalysis", "TEST", 0, 21], ["few RBC", "PROBLEM", 48, 55], ["WBC", "TEST", 60, 63]]], ["The urine protein creatinine ratio was marginally elevated at 0.5 (< 0.4).", [["urine", "ANATOMY", 4, 9], ["creatinine", "CHEMICAL", 18, 28], ["creatinine", "CHEMICAL", 18, 28], ["urine", "ORGANISM_SUBSTANCE", 4, 9], ["creatinine", "GENE_OR_GENE_PRODUCT", 18, 28], ["The urine protein creatinine ratio", "TEST", 0, 34], ["marginally elevated", "PROBLEM", 39, 58], ["elevated", "OBSERVATION_MODIFIER", 50, 58]]], ["Because of the resolving microscopic hematuria and proteinuria, renal biopsy was not done during the current admission.", [["renal", "ANATOMY", 64, 69], ["hematuria", "DISEASE", 37, 46], ["proteinuria", "DISEASE", 51, 62], ["renal biopsy", "MULTI-TISSUE_STRUCTURE", 64, 76], ["the resolving microscopic hematuria", "PROBLEM", 11, 46], ["proteinuria", "PROBLEM", 51, 62], ["renal biopsy", "TEST", 64, 76], ["resolving", "OBSERVATION_MODIFIER", 15, 24], ["microscopic", "OBSERVATION_MODIFIER", 25, 36], ["hematuria", "OBSERVATION", 37, 46], ["proteinuria", "OBSERVATION", 51, 62], ["renal", "ANATOMY", 64, 69], ["biopsy", "OBSERVATION", 70, 76]]], ["A repeated ANA done on day 28 was high (1/320) and the dsDNA too was elevated at 81.7 IU/mL.Discussion and evaluationThe diagnosis of SLE was made using the American College of Rheumatology criteria and Systemic Lupus International Collaborating Clinics criteria.", [["SLE", "DISEASE", 134, 137], ["dsDNA", "CELLULAR_COMPONENT", 55, 60], ["SLE", "CANCER", 134, 137], ["ANA", "PROTEIN", 11, 14], ["A repeated ANA", "TEST", 0, 14], ["the dsDNA", "TEST", 51, 60], ["elevated", "PROBLEM", 69, 77], ["evaluation", "TEST", 107, 117], ["SLE", "PROBLEM", 134, 137], ["SLE", "OBSERVATION", 134, 137]]], ["Our patient had renal involvement with proteinuria and positive urinary sediments, a neurologic disorder with seizures in the absence of an alternate cause, and hematologic disorder with pancytopenia making up the clinical criteria.", [["renal", "ANATOMY", 16, 21], ["urinary sediments", "ANATOMY", 64, 81], ["neurologic", "ANATOMY", 85, 95], ["proteinuria", "DISEASE", 39, 50], ["urinary sediments", "DISEASE", 64, 81], ["neurologic disorder", "DISEASE", 85, 104], ["seizures", "DISEASE", 110, 118], ["hematologic disorder", "DISEASE", 161, 181], ["pancytopenia", "DISEASE", 187, 199], ["patient", "ORGANISM", 4, 11], ["renal", "ORGAN", 16, 21], ["urinary", "ORGANISM_SUBSTANCE", 64, 71], ["patient", "SPECIES", 4, 11], ["renal involvement", "PROBLEM", 16, 33], ["proteinuria", "PROBLEM", 39, 50], ["positive urinary sediments", "PROBLEM", 55, 81], ["a neurologic disorder", "PROBLEM", 83, 104], ["seizures", "PROBLEM", 110, 118], ["hematologic disorder", "PROBLEM", 161, 181], ["pancytopenia", "PROBLEM", 187, 199], ["renal", "ANATOMY", 16, 21], ["involvement", "OBSERVATION", 22, 33], ["proteinuria", "OBSERVATION", 39, 50], ["positive", "OBSERVATION_MODIFIER", 55, 63], ["urinary sediments", "OBSERVATION", 64, 81], ["neurologic disorder", "OBSERVATION", 85, 104], ["pancytopenia", "OBSERVATION", 187, 199]]], ["The immunological criteria were fulfilled, as the ANA was positive, anti-dsDNA antibody strongly positive along with low levels of complement.", [["ANA", "PROTEIN", 50, 53], ["anti-dsDNA antibody", "PROTEIN", 68, 87], ["The immunological criteria", "TEST", 0, 26], ["the ANA", "TEST", 46, 53], ["anti-dsDNA antibody", "TEST", 68, 87], ["low levels of complement", "PROBLEM", 117, 141]]], ["The diagnosis of systemic lupus erythematosus was made with confidence, while excluding alternate possibilities and was inferred to be the etiology of her unique presentation.Discussion and evaluationThe rising ESR, low complement levels, and high titres of ds DNA were suggestive of ongoing active phase of the disease [8, 9] .", [["systemic lupus erythematosus", "DISEASE", 17, 45], ["DNA", "CELLULAR_COMPONENT", 261, 264], ["ds DNA", "DNA", 258, 264], ["systemic lupus erythematosus", "PROBLEM", 17, 45], ["evaluation", "TEST", 190, 200], ["The rising ESR", "TEST", 200, 214], ["low complement levels", "PROBLEM", 216, 237], ["high titres of ds DNA", "PROBLEM", 243, 264], ["the disease", "PROBLEM", 308, 319], ["systemic", "OBSERVATION_MODIFIER", 17, 25], ["lupus erythematosus", "OBSERVATION", 26, 45], ["rising", "OBSERVATION_MODIFIER", 204, 210], ["low complement", "OBSERVATION_MODIFIER", 216, 230], ["suggestive of", "UNCERTAINTY", 270, 283], ["ongoing", "OBSERVATION_MODIFIER", 284, 291], ["active", "OBSERVATION_MODIFIER", 292, 298], ["phase", "OBSERVATION_MODIFIER", 299, 304], ["disease", "OBSERVATION", 312, 319]]], ["Typically during the neurologic episodes, the ESR and plasma viscosity are elevated while C-reactive protein levels tend to be normal.", [["neurologic", "ANATOMY", 21, 31], ["plasma", "ANATOMY", 54, 60], ["plasma", "ORGANISM_SUBSTANCE", 54, 60], ["C-reactive protein", "GENE_OR_GENE_PRODUCT", 90, 108], ["the neurologic episodes", "PROBLEM", 17, 40], ["the ESR", "TEST", 42, 49], ["plasma viscosity", "TEST", 54, 70], ["elevated", "PROBLEM", 75, 83], ["C-reactive protein levels", "TEST", 90, 115], ["normal", "OBSERVATION", 127, 133]]], ["Lupus-related serum antibody tests are usually supportive with cerebral lupus [10] .", [["serum", "ANATOMY", 14, 19], ["cerebral", "ANATOMY", 63, 71], ["cerebral lupus", "DISEASE", 63, 77], ["serum", "ORGANISM_SUBSTANCE", 14, 19], ["serum antibody", "PROTEIN", 14, 28], ["Lupus", "PROBLEM", 0, 5], ["serum antibody tests", "TEST", 14, 34], ["cerebral lupus", "PROBLEM", 63, 77], ["cerebral", "ANATOMY", 63, 71], ["lupus", "OBSERVATION", 72, 77]]], ["Majority of seizures in SLE are reported to be generalized, although both generalized and partial seizures can occur [1, 2, 11] .", [["seizures", "DISEASE", 12, 20], ["SLE", "DISEASE", 24, 27], ["seizures", "DISEASE", 98, 106], ["SLE", "CANCER", 24, 27], ["seizures in SLE", "PROBLEM", 12, 27], ["partial seizures", "PROBLEM", 90, 106], ["seizures", "OBSERVATION", 12, 20], ["partial", "OBSERVATION_MODIFIER", 90, 97], ["seizures", "OBSERVATION", 98, 106]]], ["Seizures tend to occur early in the course of systemic lupus erythematosus [12] and in one case series, nearly 54% of patients had seizures within the first year of diagnosis of SLE [1] .", [["Seizures", "DISEASE", 0, 8], ["systemic lupus erythematosus", "DISEASE", 46, 74], ["seizures", "DISEASE", 131, 139], ["SLE", "DISEASE", 178, 181], ["patients", "ORGANISM", 118, 126], ["patients", "SPECIES", 118, 126], ["Seizures", "PROBLEM", 0, 8], ["systemic lupus erythematosus", "PROBLEM", 46, 74], ["seizures", "PROBLEM", 131, 139], ["SLE", "PROBLEM", 178, 181], ["systemic", "OBSERVATION_MODIFIER", 46, 54], ["lupus", "OBSERVATION", 55, 60]]], ["Serologically, the presence of certain autoimmune antibodies heralds the risk of seizure in SLE; these include moderate-to-high titers of IgG anti cardiolipin anti bodies [2, 3, 13, 14] , autoantibodies to beta-2-glycoproteins [14, 15] , moderate-to high-titer serum anti-Smith antibodies [13] , and anti-50 kDa antibody [16] .", [["serum", "ANATOMY", 261, 266], ["autoimmune antibodies", "DISEASE", 39, 60], ["seizure", "DISEASE", 81, 88], ["SLE", "DISEASE", 92, 95], ["cardiolipin", "CHEMICAL", 147, 158], ["SLE", "CANCER", 92, 95], ["IgG anti cardiolipin anti bodies", "GENE_OR_GENE_PRODUCT", 138, 170], ["beta-2-glycoproteins", "GENE_OR_GENE_PRODUCT", 206, 226], ["serum", "ORGANISM_SUBSTANCE", 261, 266], ["autoimmune antibodies", "PROTEIN", 39, 60], ["IgG anti cardiolipin", "PROTEIN", 138, 158], ["autoantibodies", "PROTEIN", 188, 202], ["beta-2-glycoproteins", "PROTEIN", 206, 226], ["serum anti-Smith antibodies", "PROTEIN", 261, 288], ["13", "PROTEIN", 290, 292], ["anti-50 kDa antibody", "PROTEIN", 300, 320], ["certain autoimmune antibodies", "PROBLEM", 31, 60], ["seizure in SLE", "PROBLEM", 81, 95], ["IgG anti cardiolipin anti bodies", "TEST", 138, 170], ["autoantibodies", "TEST", 188, 202], ["beta-2-glycoproteins", "TEST", 206, 226], ["serum anti-Smith antibodies", "TEST", 261, 288], ["anti-50 kDa antibody", "TEST", 300, 320], ["autoimmune", "OBSERVATION", 39, 49], ["moderate", "OBSERVATION_MODIFIER", 111, 119], ["moderate", "OBSERVATION_MODIFIER", 238, 246]]], ["Though seizures are common is SLE, status epilepticus is considered a rare phenomenon either at presentation or even along the course of the disease [17, 18] .", [["seizures", "DISEASE", 7, 15], ["SLE", "DISEASE", 30, 33], ["status epilepticus", "DISEASE", 35, 53], ["seizures", "PROBLEM", 7, 15], ["SLE", "PROBLEM", 30, 33], ["status epilepticus", "PROBLEM", 35, 53], ["a rare phenomenon", "PROBLEM", 68, 85], ["the disease", "PROBLEM", 137, 148]]], ["Our patient presented with status epilepticus and based on the clinical and serological findings, the active state of her disease could be taken as the cause for her presentation in status epilepticus.", [["status epilepticus", "DISEASE", 27, 45], ["status epilepticus", "DISEASE", 182, 200], ["patient", "ORGANISM", 4, 11], ["patient", "SPECIES", 4, 11], ["status epilepticus", "PROBLEM", 27, 45], ["serological findings", "TEST", 76, 96], ["her disease", "PROBLEM", 118, 129], ["status epilepticus", "PROBLEM", 182, 200], ["active", "OBSERVATION_MODIFIER", 102, 108]]], ["According to European League Against Rheumatism recommendations, if seizures are thought to reflect an acute inflammatory event or a concomitant lupus flare, glucocorticoids alone or in combination with immunosuppressive therapy should be given [19] .", [["seizures", "DISEASE", 68, 76], ["lupus", "DISEASE", 145, 150], ["glucocorticoids", "CHEMICAL", 158, 173], ["glucocorticoids", "SIMPLE_CHEMICAL", 158, 173], ["seizures", "PROBLEM", 68, 76], ["an acute inflammatory event", "PROBLEM", 100, 127], ["a concomitant lupus flare", "PROBLEM", 131, 156], ["glucocorticoids", "TREATMENT", 158, 173], ["immunosuppressive therapy", "TREATMENT", 203, 228], ["acute", "OBSERVATION_MODIFIER", 103, 108], ["inflammatory", "OBSERVATION", 109, 121], ["concomitant", "OBSERVATION_MODIFIER", 133, 144], ["lupus", "OBSERVATION", 145, 150]]], ["The combination of intravenous methylprednisolone and intravenous cyclophosphamide was shown to be effective in refractory seizures in the context of generalized lupus activity [20] .", [["intravenous", "ANATOMY", 19, 30], ["intravenous", "ANATOMY", 54, 65], ["methylprednisolone", "CHEMICAL", 31, 49], ["cyclophosphamide", "CHEMICAL", 66, 82], ["seizures", "DISEASE", 123, 131], ["lupus", "DISEASE", 162, 167], ["methylprednisolone", "CHEMICAL", 31, 49], ["cyclophosphamide", "CHEMICAL", 66, 82], ["intravenous", "IMMATERIAL_ANATOMICAL_ENTITY", 19, 30], ["methylprednisolone", "SIMPLE_CHEMICAL", 31, 49], ["intravenous", "IMMATERIAL_ANATOMICAL_ENTITY", 54, 65], ["cyclophosphamide", "SIMPLE_CHEMICAL", 66, 82], ["intravenous methylprednisolone", "TREATMENT", 19, 49], ["intravenous cyclophosphamide", "TREATMENT", 54, 82], ["refractory seizures", "PROBLEM", 112, 131], ["generalized lupus activity", "PROBLEM", 150, 176], ["generalized", "OBSERVATION_MODIFIER", 150, 161], ["lupus", "OBSERVATION", 162, 167]]], ["But in our patient, because of the delayed diagnosis of SLE, steroids was not given with the intention of treating SLE.", [["SLE", "DISEASE", 56, 59], ["steroids", "CHEMICAL", 61, 69], ["SLE", "DISEASE", 115, 118], ["steroids", "CHEMICAL", 61, 69], ["patient", "ORGANISM", 11, 18], ["steroids", "SIMPLE_CHEMICAL", 61, 69], ["patient", "SPECIES", 11, 18], ["SLE", "PROBLEM", 56, 59], ["steroids", "TREATMENT", 61, 69], ["SLE", "PROBLEM", 115, 118], ["SLE", "OBSERVATION", 56, 59]]], ["However, she was given dexamethasone intravenously as a part of meningitis treatment.Discussion and evaluationCardiac disease is common among patients with SLE with the involvement of valves, pericardium, myocardium, and coronary arteries.", [["Cardiac", "ANATOMY", 110, 117], ["valves", "ANATOMY", 184, 190], ["pericardium", "ANATOMY", 192, 203], ["myocardium", "ANATOMY", 205, 215], ["coronary arteries", "ANATOMY", 221, 238], ["dexamethasone", "CHEMICAL", 23, 36], ["meningitis", "DISEASE", 64, 74], ["Cardiac disease", "DISEASE", 110, 125], ["SLE", "DISEASE", 156, 159], ["dexamethasone", "CHEMICAL", 23, 36], ["dexamethasone", "SIMPLE_CHEMICAL", 23, 36], ["Cardiac", "ORGAN", 110, 117], ["patients", "ORGANISM", 142, 150], ["valves", "TISSUE", 184, 190], ["pericardium", "MULTI-TISSUE_STRUCTURE", 192, 203], ["myocardium", "MULTI-TISSUE_STRUCTURE", 205, 215], ["coronary arteries", "MULTI-TISSUE_STRUCTURE", 221, 238], ["patients", "SPECIES", 142, 150], ["dexamethasone intravenously", "TREATMENT", 23, 50], ["meningitis treatment", "TREATMENT", 64, 84], ["evaluation", "TEST", 100, 110], ["SLE", "PROBLEM", 156, 159], ["the involvement of valves, pericardium, myocardium, and coronary arteries", "PROBLEM", 165, 238], ["meningitis", "OBSERVATION", 64, 74], ["Cardiac", "ANATOMY", 110, 117], ["disease", "OBSERVATION", 118, 125], ["valves", "OBSERVATION", 184, 190], ["pericardium", "ANATOMY", 192, 203], ["myocardium", "ANATOMY", 205, 215], ["coronary arteries", "ANATOMY", 221, 238]]], ["Myocarditis is a rare but potentially fatal and often asymptomatic manifestation of SLE, which has an impact on damage accrual and survival [5] .", [["Myocarditis", "DISEASE", 0, 11], ["SLE", "DISEASE", 84, 87], ["SLE", "CANCER", 84, 87], ["Myocarditis", "PROBLEM", 0, 11], ["SLE", "PROBLEM", 84, 87], ["SLE", "OBSERVATION", 84, 87]]], ["In this case, we presumed the diagnosis of lupus myocarditis as she fulfilled the criteria for SLE, with most of the viral studies being negative and with no risk factors for atherosclerosis causing ischemic heart disease.", [["heart", "ANATOMY", 208, 213], ["lupus myocarditis", "DISEASE", 43, 60], ["SLE", "DISEASE", 95, 98], ["atherosclerosis", "DISEASE", 175, 190], ["ischemic heart disease", "DISEASE", 199, 221], ["heart", "ORGAN", 208, 213], ["lupus myocarditis", "PROBLEM", 43, 60], ["SLE", "PROBLEM", 95, 98], ["the viral studies", "TEST", 113, 130], ["atherosclerosis", "PROBLEM", 175, 190], ["ischemic heart disease", "PROBLEM", 199, 221], ["lupus", "OBSERVATION_MODIFIER", 43, 48], ["myocarditis", "OBSERVATION", 49, 60], ["atherosclerosis", "OBSERVATION", 175, 190], ["ischemic", "OBSERVATION_MODIFIER", 199, 207], ["heart", "ANATOMY", 208, 213], ["disease", "OBSERVATION", 214, 221]]], ["Most of such cases were diagnosed on similar basis in the literature [21] [22] [23] [24] [25] .", [["[21] [22] [23] [24] [25]", "SIMPLE_CHEMICAL", 69, 93]]], ["Treatment of lupus myocarditis has not been assessed in controlled trials since this is an infrequent manifestation of lupus.", [["lupus myocarditis", "DISEASE", 13, 30], ["lupus", "DISEASE", 119, 124], ["lupus", "CANCER", 119, 124], ["lupus myocarditis", "PROBLEM", 13, 30], ["lupus", "PROBLEM", 119, 124], ["lupus myocarditis", "OBSERVATION", 13, 30], ["lupus", "OBSERVATION", 119, 124]]], ["But dramatic improvement in cardiac function has been noted with aggressive therapy with oral or intravenous glucocorticoids, immunosuppressive therapy, and intravenous immunoglobulins [26] [27] [28] .Discussion and evaluationThe patient showed dramatic clinical improvement and by day 14 was asymptomatic.", [["cardiac", "ANATOMY", 28, 35], ["oral", "ANATOMY", 89, 93], ["intravenous", "ANATOMY", 97, 108], ["intravenous", "ANATOMY", 157, 168], ["cardiac", "ORGAN", 28, 35], ["oral", "ORGANISM_SUBDIVISION", 89, 93], ["intravenous", "IMMATERIAL_ANATOMICAL_ENTITY", 97, 108], ["intravenous immunoglobulins [26] [27] [28]", "SIMPLE_CHEMICAL", 157, 199], ["patient", "ORGANISM", 230, 237], ["patient", "SPECIES", 230, 237], ["aggressive therapy", "TREATMENT", 65, 83], ["oral or intravenous glucocorticoids", "TREATMENT", 89, 124], ["immunosuppressive therapy", "TREATMENT", 126, 151], ["intravenous immunoglobulins", "TREATMENT", 157, 184], ["evaluation", "TEST", 216, 226], ["asymptomatic", "PROBLEM", 293, 305], ["dramatic", "OBSERVATION_MODIFIER", 4, 12], ["improvement", "OBSERVATION_MODIFIER", 13, 24], ["cardiac", "ANATOMY", 28, 35], ["function", "OBSERVATION", 36, 44], ["dramatic", "OBSERVATION_MODIFIER", 245, 253]]], ["It was a challenge to decide whether the patient needed steroids or advanced immunosuppressive therapy.", [["steroids", "CHEMICAL", 56, 64], ["steroids", "CHEMICAL", 56, 64], ["patient", "ORGANISM", 41, 48], ["patient", "SPECIES", 41, 48], ["steroids", "TREATMENT", 56, 64], ["advanced immunosuppressive therapy", "TREATMENT", 68, 102]]], ["Her serological markers suggested active disease but not all patients with these serologic markers have active disease and these markers do not necessarily predict disease exacerbation.", [["patients", "ORGANISM", 61, 69], ["patients", "SPECIES", 61, 69], ["Her serological markers", "TEST", 0, 23], ["active disease", "PROBLEM", 34, 48], ["these serologic markers", "TEST", 75, 98], ["active disease", "PROBLEM", 104, 118], ["these markers", "TEST", 123, 136], ["disease exacerbation", "PROBLEM", 164, 184], ["active", "OBSERVATION_MODIFIER", 34, 40], ["disease", "OBSERVATION", 41, 48], ["active", "OBSERVATION_MODIFIER", 104, 110], ["disease", "OBSERVATION", 111, 118]]], ["Also, fluctuations in laboratory test values are poor predictors of disease exacerbations in SLE [29] .", [["exacerbations", "DISEASE", 76, 89], ["SLE", "DISEASE", 93, 96], ["laboratory test values", "TEST", 22, 44], ["disease exacerbations", "PROBLEM", 68, 89], ["fluctuations", "OBSERVATION_MODIFIER", 6, 18]]], ["Even in the presence of serological markers favoring disease, e.g., low complement and elevated anti-DNA antibody titers, patients may not have clinical evidence of active disease [30] .", [["anti-DNA antibody", "GENE_OR_GENE_PRODUCT", 96, 113], ["patients", "ORGANISM", 122, 130], ["serological markers", "PROTEIN", 24, 43], ["anti-DNA antibody", "PROTEIN", 96, 113], ["patients", "SPECIES", 122, 130], ["serological markers", "TEST", 24, 43], ["disease", "PROBLEM", 53, 60], ["low complement", "PROBLEM", 68, 82], ["elevated anti-DNA antibody titers", "PROBLEM", 87, 120], ["active disease", "PROBLEM", 165, 179], ["active", "OBSERVATION_MODIFIER", 165, 171], ["disease", "OBSERVATION", 172, 179]]], ["However, usually clinical and laboratory correlation in SLE tend to show a homogenous relationship and most SLE patients showing clinical-serological concordance with only minority showing discordance.", [["SLE", "DISEASE", 56, 59], ["SLE", "DISEASE", 108, 111], ["SLE", "CANCER", 56, 59], ["patients", "ORGANISM", 112, 120], ["patients", "SPECIES", 112, 120], ["laboratory correlation", "TEST", 30, 52], ["serological concordance", "TEST", 138, 161]]], ["Therefore, it is important to monitor both clinical and serological features in patients with SLE [31] .", [["SLE", "DISEASE", 94, 97], ["patients", "ORGANISM", 80, 88], ["patients", "SPECIES", 80, 88]]], ["Steiman, A.J. and colleagues suggested that treatment decisions in SLE patients must rely upon close clinical observation and therapy should be adjusted if there are signs of clinical worsening of the disease [32] .", [["SLE", "DISEASE", 67, 70], ["patients", "ORGANISM", 71, 79], ["patients", "SPECIES", 71, 79], ["therapy", "TREATMENT", 126, 133], ["clinical worsening of the disease", "PROBLEM", 175, 208]]], ["Considering risk versus that of benefit, starting steroids at very young age will cause detrimental side effects long term and since she did have any clinical features of active disease, a clinical decision was taken not to start immunosuppressive therapy in our patient.", [["steroids", "CHEMICAL", 50, 58], ["steroids", "CHEMICAL", 50, 58], ["patient", "ORGANISM", 263, 270], ["patient", "SPECIES", 263, 270], ["steroids", "TREATMENT", 50, 58], ["detrimental side effects", "PROBLEM", 88, 112], ["active disease", "PROBLEM", 171, 185], ["immunosuppressive therapy", "TREATMENT", 230, 255], ["active", "OBSERVATION_MODIFIER", 171, 177], ["disease", "OBSERVATION", 178, 185]]], ["Instead, we planned to monitor her closely for clinical or serological evidence of relapse and evolution.", [["relapse", "PROBLEM", 83, 90], ["relapse", "OBSERVATION", 83, 90]]], ["However, in the context of possible recurrence of seizures, especially with underlying SLE, she was continued on sodium valproate, with long-term neurology review and monitoring.", [["seizures", "DISEASE", 50, 58], ["SLE", "DISEASE", 87, 90], ["sodium valproate", "CHEMICAL", 113, 129], ["sodium valproate", "CHEMICAL", 113, 129], ["SLE", "CANCER", 87, 90], ["sodium valproate", "SIMPLE_CHEMICAL", 113, 129], ["seizures", "PROBLEM", 50, 58], ["underlying SLE", "PROBLEM", 76, 90], ["sodium valproate", "TREATMENT", 113, 129], ["monitoring", "TEST", 167, 177], ["possible", "UNCERTAINTY", 27, 35], ["recurrence", "OBSERVATION_MODIFIER", 36, 46], ["seizures", "OBSERVATION", 50, 58]]], ["She was reviewed recently, 6 months after the initial episode, and was doing well.Discussion and evaluationIn conclusion, systemic lupus erythematosus is a complex connective tissue disorder that has the propensity to inflict multi-organ dysfunction in varied ways and can have a variety of clinical presentations.", [["connective tissue", "ANATOMY", 164, 181], ["multi-organ", "ANATOMY", 226, 237], ["systemic lupus erythematosus", "DISEASE", 122, 150], ["connective tissue disorder", "DISEASE", 164, 190], ["multi-organ dysfunction", "DISEASE", 226, 249], ["connective tissue", "TISSUE", 164, 181], ["multi-organ", "ORGAN", 226, 237], ["evaluation", "TEST", 97, 107], ["systemic lupus erythematosus", "PROBLEM", 122, 150], ["a complex connective tissue disorder", "PROBLEM", 154, 190], ["multi-organ dysfunction", "PROBLEM", 226, 249], ["systemic", "OBSERVATION_MODIFIER", 122, 130], ["lupus erythematosus", "OBSERVATION", 131, 150], ["complex", "OBSERVATION_MODIFIER", 156, 163], ["connective tissue disorder", "OBSERVATION", 164, 190], ["dysfunction", "OBSERVATION", 238, 249]]], ["Our patient presented with status epilepticus and acute cardiomyopathy with heart failure, but showed dramatic improvement within 2 weeks.", [["heart", "ANATOMY", 76, 81], ["status epilepticus", "DISEASE", 27, 45], ["cardiomyopathy", "DISEASE", 56, 70], ["heart failure", "DISEASE", 76, 89], ["patient", "ORGANISM", 4, 11], ["heart", "ORGAN", 76, 81], ["patient", "SPECIES", 4, 11], ["status epilepticus", "PROBLEM", 27, 45], ["acute cardiomyopathy", "PROBLEM", 50, 70], ["heart failure", "PROBLEM", 76, 89], ["acute", "OBSERVATION_MODIFIER", 50, 55], ["cardiomyopathy", "OBSERVATION", 56, 70], ["heart", "ANATOMY", 76, 81], ["failure", "OBSERVATION", 82, 89], ["dramatic", "OBSERVATION_MODIFIER", 102, 110], ["improvement", "OBSERVATION_MODIFIER", 111, 122]]], ["Status epilepticus and acute myocarditis with heart failure are uncommon yet potentially fatal manifestations of SLE.", [["heart", "ANATOMY", 46, 51], ["Status epilepticus", "DISEASE", 0, 18], ["myocarditis", "DISEASE", 29, 40], ["heart failure", "DISEASE", 46, 59], ["SLE", "DISEASE", 113, 116], ["heart", "ORGAN", 46, 51], ["SLE", "CANCER", 113, 116], ["Status epilepticus", "PROBLEM", 0, 18], ["acute myocarditis", "PROBLEM", 23, 40], ["heart failure", "PROBLEM", 46, 59], ["SLE", "PROBLEM", 113, 116], ["epilepticus", "OBSERVATION", 7, 18], ["acute", "OBSERVATION_MODIFIER", 23, 28], ["myocarditis", "OBSERVATION", 29, 40], ["heart", "ANATOMY", 46, 51], ["failure", "OBSERVATION", 52, 59], ["SLE", "OBSERVATION", 113, 116]]], ["This case emphasizes the importance of considering autoimmune diseases into the spectrum of differential diagnosis early when atypical clinical presentations occur specially with multi-organ involvement as prompt diagnosis may help in reducing morbidity and mortality by allowing early appropriate and effective treatment.", [["multi-organ", "ANATOMY", 179, 190], ["autoimmune diseases", "DISEASE", 51, 70], ["autoimmune diseases", "PROBLEM", 51, 70], ["effective treatment", "TREATMENT", 302, 321]]]], "b72e220b6500d2251e103f23d64b2f96f6e082f2": [["centromeres in the human reference genome becomes an urgent interest, which intrigues the field to create new methods.", [["centromeres", "ANATOMY", 0, 11], ["centromeres", "CELLULAR_COMPONENT", 0, 11], ["human", "ORGANISM", 19, 24], ["human reference genome", "DNA", 19, 41], ["human", "SPECIES", 19, 24], ["human", "SPECIES", 19, 24], ["new", "OBSERVATION_MODIFIER", 106, 109]]]], "PMC7121236": [["Singaporeans (3.29 million) and Singapore Permanent Residents (0.53 million) live in a dynamic 21st century global city, engaging for most of the day in the working language English although they have \u201cethnic mother tongues \u201d officially designated as Mandarin , Malay, and Tamil and speak several other languages from their multilingual repertoire.IntroductionThe history of language education and languages in education in Singapore since its independence in 1965 has been marked by a strong bilingual policy , promoting English as the cornerstone, as the medium of education , for all levels of schooling, while compulsory second language provision is at the same time made for the three different ethnic groups in schools: Chinese (Mandarin ), Malay (Malay language), and Indian (Tamil language mainly but including options for Hindi , Punjabi , Guajarati, Bengali , and Urdu ).IntroductionEnglish-knowing bilingualism , defined as proficiency in English and a working knowledge of one\u2019s ethnic mother tongue , instilled after five decades in the centrally controlled Singapore schooling system, has given rise to a new phenomenon: that of an ascendant English-knowing bilingual community that draws upon its local roots and cultures to express its own non-English values and multilingual identity .", [["tongue", "ANATOMY", 1005, 1011], ["roots", "ANATOMY", 1218, 1223], ["tongue", "ORGAN", 1005, 1011], ["roots", "TISSUE", 1218, 1223], ["a new phenomenon", "PROBLEM", 1117, 1133], ["cultures", "TEST", 1228, 1236], ["marked", "OBSERVATION_MODIFIER", 474, 480], ["tongue", "ANATOMY", 1005, 1011]]], ["I define an ascendant English-knowing bilingual community as one that functions increasingly in English but, because of its collective association with other languages and cultures (mainly Asian in this case), taps these links for identity and rootedness.", [["cultures", "TEST", 172, 180]]], ["Ascendant English-knowing bilingual communities offer excellent sites for studying glocal English.The Idea of EnglishThe rapid spread of English throughout the world witnessed in the last three decades of the twentieth century was accompanied by intense scholarship that tried to establish paradigms for studying the phenomenon.", [["the phenomenon", "PROBLEM", 313, 327], ["rapid", "OBSERVATION_MODIFIER", 121, 126], ["spread", "OBSERVATION_MODIFIER", 127, 133]]], ["English figured prominently at the top of the applied linguistics agenda whether as an object of enquiry in language education or as a commodity of desire among eager learners of the language with implications for culture and development, pedagogy , and frameworks of study.", [["culture", "TEST", 214, 221], ["study", "TEST", 268, 273]]], ["Furthermore, the rise of the internet generation gave mobility and portability of English an added dimension\u2014that of changing functions, values and meanings of English in the midst of globalization and acceleration brought about by instant connectivity across the world.The Idea of English\u201cWhich English?\u201d", [["rise", "OBSERVATION_MODIFIER", 17, 21]]], ["The English as an International Language (EIL ) , World Englishes (WE) and the more recent English Lingua Franca (ELF) paradigms, produced scholarship of different foci in the teaching and learning of English and the research (Pakir 2010).", [["different", "OBSERVATION_MODIFIER", 154, 163], ["foci", "OBSERVATION", 164, 168]]], ["Older proponents of EIL , many found in the Inner Circle, focused on language proficiency and the importance of producing near-native like speakers of the language.", [["EIL", "DISEASE", 20, 23], ["Inner", "ANATOMY_MODIFIER", 44, 49]]], ["On the other end, ELF promoted a new concept of English as a contact language \u201cfor groups of English speakers having different first language backgrounds\u201d, thus agreeing that the world will see pluricentric Englishes but with an ELF core.The Idea of EnglishThese various categorizations of views of what it means for English were inevitable.", [["Englishes", "CANCER", 207, 216]]], ["As Halliday so aptly described it, English has this dual role, \u201cboth as an international language (one among many) and as the (only) global language\u201d and hence \u201cit is not surprising that it figures prominently in applied linguistic activities, with language education at the top of the list.", [["language education", "TREATMENT", 249, 267]]], ["It is prominent even in mother-tongue education \u2026 But in second or foreign language teaching it easily predominates\u201d (Halliday 2007, p.", [["tongue", "ANATOMY", 31, 37], ["tongue", "ORGANISM_SUBDIVISION", 31, 37], ["prominent", "OBSERVATION_MODIFIER", 6, 15], ["tongue", "ANATOMY", 31, 37]]], ["A global and yet local language, English is an unusual lingua franca in Singapore, a country that promotes extensive English-knowing bilingualism and one that is becoming an ascendant English-knowing bilingual community.", [["global", "OBSERVATION_MODIFIER", 2, 8], ["local language", "OBSERVATION", 17, 31]]], ["For example, a recent news clip reported that Yale-NUS professors, teaching at a new liberal arts college that opens at the National University of Singapore in August 2013, took a crash course in \u201cSingapore\u2019s unique colloquial language\u201d (Lee 2013, p.", [["a recent news clip", "PROBLEM", 13, 31]]], ["The widespread use of English in Singapore by so many different ethnic groups has led to cultural mixing and hybridity in the language and a variety has emerged that can be \u201ctaught\u201d or \u201ccaught\u201d in Singapore.Glocalization and SingaporeDifferent ideological perspectives on international spread of English and English as an emergent lingua franca include that of Graddol (1997, p.", [["hybridity", "DISEASE", 109, 118], ["cultural mixing and hybridity in the language", "PROBLEM", 89, 134], ["widespread", "OBSERVATION_MODIFIER", 4, 14]]], ["33) who posited the static and traditional import-export model versus the post-modern/globalised model.", [["the post-modern/globalised model", "TREATMENT", 70, 102]]], ["The second, and more dynamic model, speaks to the modelling of language and culture in terms of flow: communication flow and counter-flow, producing a tension between the global and the local.", [["culture", "TEST", 76, 83], ["communication flow", "TEST", 102, 120]]], ["At the sociolinguistic level, I suggested that the tension between global and local resolves itself in the emergence of Glocal English, one that is internationally oriented but locally appropriate and at the same time, one that could be locally oriented but globally understandable.", [["the tension between global", "PROBLEM", 47, 73], ["tension", "OBSERVATION", 51, 58], ["global", "OBSERVATION_MODIFIER", 67, 73], ["local", "OBSERVATION_MODIFIER", 78, 83]]], ["An English in Singapore that is internationally intelligible but requires explanation for linguistic features that reflect deeply rooted substratal language influences.", [["linguistic features", "PROBLEM", 90, 109], ["deeply rooted substratal language influences", "PROBLEM", 123, 167]]]], "PMC7455253": [["IntroductionTogether with substance use disorders, mental disorders are among the leading global contributors to the total burden of disease, as measured by the number of years lived with a disability.1 Compared with high-income countries (HICs),2 low-income and middle-income countries (LMICs) are disproportionately affected by mental health disorders because of the substantial mental health gap (ie, the gap between available treatment and the number of people with mental disorders in need of care).3 Indeed, the ratio of available mental health therapists per 100 000 population in LMICs is approximately 0\u00b75% of that in HICs.4 An analysis5 published in 2016 estimated that 79\u201393% of people with depression and 85\u201395% of people with anxiety are not covered by treatment in LMICs.", [["substance use disorders", "DISEASE", 26, 49], ["mental disorders", "DISEASE", 51, 67], ["disability", "DISEASE", 190, 200], ["HICs", "DISEASE", 627, 631], ["depression", "DISEASE", 702, 712], ["anxiety", "DISEASE", 739, 746], ["HICs", "CANCER", 627, 631], ["people", "ORGANISM", 690, 696], ["people", "ORGANISM", 727, 733], ["people", "SPECIES", 458, 464], ["people", "SPECIES", 690, 696], ["people", "SPECIES", 727, 733], ["disorders", "PROBLEM", 40, 49], ["mental disorders", "PROBLEM", 51, 67], ["disease", "PROBLEM", 133, 140], ["mental health disorders", "PROBLEM", 330, 353], ["the substantial mental health gap", "PROBLEM", 365, 398], ["treatment", "TREATMENT", 430, 439], ["mental disorders", "PROBLEM", 470, 486], ["An analysis5", "TEST", 634, 646], ["depression", "PROBLEM", 702, 712], ["anxiety", "PROBLEM", 739, 746], ["disease", "OBSERVATION", 133, 140]]], ["Inadequate access to mental health care can lead to considerable distress, chronicity, and increased cost of care at the individual level, as well as low productivity and low participation in the workforce at the country level.6 The scale of this problem is illustrated by the fact that more than 80% of the world population lives in LMICs.2", [["chronicity", "DISEASE", 75, 85], ["mental health care", "TREATMENT", 21, 39], ["considerable distress", "PROBLEM", 52, 73], ["chronicity", "PROBLEM", 75, 85], ["low productivity", "PROBLEM", 150, 166], ["considerable", "OBSERVATION_MODIFIER", 52, 64], ["distress", "OBSERVATION", 65, 73], ["increased", "OBSERVATION_MODIFIER", 91, 100], ["cost", "OBSERVATION_MODIFIER", 101, 105], ["low productivity", "OBSERVATION_MODIFIER", 150, 166]]]], "147ff8e618a1221e468571d56a4341272712abab": [["They can do this most effectively by putting in place measures that enhance their ability to find, test, trace, isolate and support (i.e. landing on ladders) and by avoiding setbacks that occur due to insufficient capacity in the health system and beyond (i.e. avoiding snakes).", [["snakes", "ORGANISM_SUBDIVISION", 270, 276], ["test", "TEST", 99, 103], ["insufficient capacity in the health system", "PROBLEM", 201, 243]]], ["In this case, countries that went into the pandemic with strong public health systems and systems of governance are more likely to land on ladders because the capacity is already in place.", [["the capacity", "PROBLEM", 155, 167]]], ["The role of the public is also central and unless people are made aware of the symptoms of COVID-19 and the importance of getting tested, it will be difficult to 'find' cases in the first place.", [["COVID", "DISEASE", 91, 96], ["people", "ORGANISM", 50, 56], ["people", "SPECIES", 50, 56], ["the symptoms", "PROBLEM", 75, 87], ["COVID", "TEST", 91, 96]]]]}